© 2000-2020 QIAGEN. All rights reserved.

Analysis Details for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Workspace	My Projects
Project	hd_microarray
Analysis	longFragmentHuman - 2020-01-20 08:06 PM
Date	Mon Jan 20 17:06:30 PST 2020
Analysis ID	18745804

Analysis Settings
Cutoff before duplicate resolution	true
Reference set	Ingenuity Knowledge Base (Genes Only)
Relationship to include	Direct and Indirect
Includes Endogenous Chemicals	Yes
Optional Analyses	My Pathways My List
Filter Summary	
Consider only molecules and/or relationships where
(confidence = Experimentally Observed) AND
(mol. types = biologic drug OR canonical pathway OR chemical - endogenous mammalian OR chemical - endogenous non-mammalian OR chemical - kinase inhibitor OR chemical - other OR chemical - protease inhibitor OR chemical drug OR chemical reagent OR chemical toxicant OR complex OR cytokine OR disease OR enzyme OR function OR G-protein coupled receptor OR group OR growth factor OR ion channel OR kinase OR ligand-dependent nuclear receptor OR mature microRNA OR microRNA OR other OR peptidase OR phosphatase OR transcription regulator OR translation regulator OR transmembrane receptor OR transporter)

Canonical Pathways for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Ingenuity Canonical Pathways	 -log(p-value)	zScore	Ratio	Molecules
Glucocorticoid Receptor Signaling	3.25E-01		2.98E-03	PIK3R5	
Systemic Lupus Erythematosus In T Cell Signaling Pathway	3.28E-01		3.00E-03	PIK3R5	
Neuroinflammation Signaling Pathway	3.61E-01		3.33E-03	PIK3R5	
Senescence Pathway	3.9E-01		3.64E-03	PIK3R5	
G-Protein Coupled Receptor Signaling	3.93E-01		3.68E-03	PIK3R5	
Colorectal Cancer Metastasis Signaling	4.18E-01		3.95E-03	PIK3R5	
Cardiac Hypertrophy Signaling	4.36E-01		4.17E-03	PIK3R5	
Systemic Lupus Erythematosus Signaling	4.52E-01		4.37E-03	PIK3R5	
EIF2 Signaling	4.6E-01		4.46E-03	PIK3R5	
Sperm Motility	4.61E-01		4.48E-03	PRKCQ	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	4.66E-01		4.55E-03	PIK3R5	
AMPK Signaling	4.79E-01		4.72E-03	PIK3R5	
Osteoarthritis Pathway	4.81E-01		4.74E-03	ITGA4	
Calcium Signaling	4.89E-01		4.85E-03	GRIA4	
Adrenomedullin signaling pathway	5.05E-01		5.08E-03	PIK3R5	
Superpathway of Inositol Phosphate Compounds	5.05E-01		5.08E-03	PIK3R5	
Clathrin-mediated Endocytosis Signaling	5.13E-01		5.18E-03	PIK3R5	
RAR Activation	5.13E-01		5.18E-03	PRKCQ	
Agranulocyte Adhesion and Diapedesis	5.15E-01		5.21E-03	ITGA4	
Regulation of the Epithelial-Mesenchymal Transition Pathway	5.15E-01		5.21E-03	PIK3R5	
ILK Signaling	5.18E-01		5.26E-03	PIK3R5	
Sertoli Cell-Sertoli Cell Junction Signaling	5.28E-01		5.41E-03	ITGA4	
Hepatic Cholestasis	5.3E-01		5.43E-03	PRKCQ	
Dendritic Cell Maturation	5.32E-01		5.46E-03	PIK3R5	
Ephrin Receptor Signaling	5.38E-01		5.56E-03	ITGA4	
RhoGDI Signaling	5.38E-01		5.56E-03	ITGA4	
Granulocyte Adhesion and Diapedesis	5.4E-01		5.59E-03	ITGA4	
GNRH Signaling	5.53E-01		5.78E-03	PRKCQ	
Germ Cell-Sertoli Cell Junction Signaling	5.57E-01		5.85E-03	PIK3R5	
Cdc42 Signaling	5.66E-01		5.99E-03	ITGA4	
Glioblastoma Multiforme Signaling	5.7E-01		6.06E-03	PIK3R5	
HMGB1 Signaling	5.7E-01		6.06E-03	PIK3R5	
3-phosphoinositide Biosynthesis	5.72E-01		6.10E-03	PIK3R5	
Dopamine-DARPP32 Feedback in cAMP Signaling	5.75E-01		6.13E-03	PRKCQ	
HOTAIR Regulatory Pathway	5.84E-01		6.29E-03	PIK3R5	
Relaxin Signaling	6.06E-01		6.67E-03	PIK3R5	
Corticotropin Releasing Hormone Signaling	6.19E-01		6.90E-03	PRKCQ	
Endocannabinoid Cancer Inhibition Pathway	6.24E-01		6.99E-03	PIK3R5	
Hereditary Breast Cancer Signaling	6.32E-01		7.14E-03	PIK3R5	
Insulin Receptor Signaling	6.35E-01		7.19E-03	PIK3R5	
Ovarian Cancer Signaling	6.35E-01		7.19E-03	PIK3R5	
Androgen Signaling	6.43E-01		7.35E-03	PRKCQ	
STAT3 Pathway	6.46E-01		7.41E-03	IL17RB	
Gα12/13 Signaling	6.6E-01		7.69E-03	PIK3R5	
Endocannabinoid Neuronal Synapse Pathway	6.66E-01		7.81E-03	GRIA4	
Atherosclerosis Signaling	6.72E-01		7.94E-03	ITGA4	
IL-6 Signaling	6.75E-01		8.00E-03	PIK3R5	
G Beta Gamma Signaling	6.85E-01		8.20E-03	PRKCQ	
Cholecystokinin/Gastrin-mediated Signaling	6.94E-01		8.40E-03	PRKCQ	
Role of Tissue Factor in Cancer	7.01E-01		8.55E-03	PIK3R5	
Sphingosine-1-phosphate Signaling	7.01E-01		8.55E-03	PIK3R5	
Neuroprotective Role of THOP1 in Alzheimer's Disease	7.04E-01		8.62E-03	TMPRSS2	
Endocannabinoid Developing Neuron Pathway	7.08E-01		8.70E-03	PIK3R5	
NGF Signaling	7.11E-01		8.77E-03	PIK3R5	
HIF1α Signaling	7.14E-01		8.85E-03	PIK3R5	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	7.18E-01		8.93E-03	PRKCQ	
Pancreatic Adenocarcinoma Signaling	7.29E-01		9.17E-03	PIK3R5	
CDK5 Signaling	7.32E-01		9.26E-03	CDK5R1	
Telomerase Signaling	7.36E-01		9.35E-03	PIK3R5	
IGF-1 Signaling	7.47E-01		9.62E-03	PIK3R5	
Chronic Myeloid Leukemia Signaling	7.51E-01		9.71E-03	PIK3R5	
Mouse Embryonic Stem Cell Pluripotency	7.51E-01		9.71E-03	PIK3R5	
SAPK/JNK Signaling	7.55E-01		9.80E-03	PIK3R5	
Protein Kinase A Signaling	7.61E-01		5.03E-03	PRKCQ,UBASH3B	
Apoptosis Signaling	7.66E-01		1.01E-02	PRKCQ	
VEGF Signaling	7.66E-01		1.01E-02	PIK3R5	
UVA-Induced MAPK Signaling	7.7E-01		1.02E-02	PIK3R5	
p53 Signaling	7.7E-01		1.02E-02	PIK3R5	
Salvage Pathways of Pyrimidine Ribonucleotides	7.75E-01		1.03E-02	PRKCQ	
α-Adrenergic Signaling	7.83E-01		1.05E-02	PRKCQ	
CCR5 Signaling in Macrophages	7.87E-01		1.06E-02	PRKCQ	
Fcγ Receptor-mediated Phagocytosis in Macrophages and Monocytes	7.87E-01		1.06E-02	PRKCQ	
Melanocyte Development and Pigmentation Signaling	7.87E-01		1.06E-02	PIK3R5	
Regulation of Actin-based Motility by Rho	7.87E-01		1.06E-02	ITGA4	
Factors Promoting Cardiogenesis in Vertebrates	7.91E-01		1.08E-02	PRKCQ	
Prostate Cancer Signaling	8E-01		1.10E-02	PIK3R5	
Acute Myeloid Leukemia Signaling	8.09E-01		1.12E-02	PIK3R5	
CTLA4 Signaling in Cytotoxic T Lymphocytes	8.09E-01		1.12E-02	PIK3R5	
Ceramide Signaling	8.13E-01		1.14E-02	PIK3R5	
RANK Signaling in Osteoclasts	8.13E-01		1.14E-02	PIK3R5	
PDGF Signaling	8.22E-01		1.16E-02	PIK3R5	
IL-4 Signaling	8.27E-01		1.18E-02	PIK3R5	
FGF Signaling	8.32E-01		1.19E-02	PIK3R5	
PEDF Signaling	8.42E-01		1.22E-02	PIK3R5	
FLT3 Signaling in Hematopoietic Progenitor Cells	8.52E-01		1.25E-02	PIK3R5	
IL-17 Signaling	8.52E-01		1.25E-02	PIK3R5	
JAK/Stat Signaling	8.52E-01		1.25E-02	PIK3R5	
Renal Cell Carcinoma Signaling	8.52E-01		1.25E-02	PIK3R5	
Agrin Interactions at Neuromuscular Junction	8.57E-01		1.27E-02	ITGA4	
Heparan Sulfate Biosynthesis	8.62E-01		1.28E-02	B3GAT1	
IL-7 Signaling Pathway	8.62E-01		1.28E-02	PIK3R5	
VDR/RXR Activation	8.62E-01		1.28E-02	PRKCQ	
Antiproliferative Role of Somatostatin Receptor 2	8.67E-01		1.30E-02	PIK3R5	
GDNF Family Ligand-Receptor Interactions	8.72E-01		1.32E-02	PIK3R5	
Neurotrophin/TRK Signaling	8.72E-01		1.32E-02	PIK3R5	
Angiopoietin Signaling	8.78E-01		1.33E-02	PIK3R5	
FcγRIIB Signaling in B Lymphocytes	8.78E-01		1.33E-02	PIK3R5	
Estrogen-Dependent Breast Cancer Signaling	8.83E-01		1.35E-02	PIK3R5	
Glioma Invasiveness Signaling	8.83E-01		1.35E-02	PIK3R5	
Leptin Signaling in Obesity	8.83E-01		1.35E-02	PIK3R5	
Caveolar-mediated Endocytosis Signaling	8.89E-01		1.37E-02	ITGA4	
Non-Small Cell Lung Cancer Signaling	8.89E-01		1.37E-02	PIK3R5	
Actin Nucleation by ARP-WASP Complex	8.94E-01		1.39E-02	ITGA4	
Melatonin Signaling	8.94E-01		1.39E-02	PRKCQ	
IL-15 Signaling	9E-01		1.41E-02	PIK3R5	
Small Cell Lung Cancer Signaling	9E-01		1.41E-02	PIK3R5	
GM-CSF Signaling	9.06E-01		1.43E-02	PIK3R5	
Role of JAK1 and JAK3 in γc Cytokine Signaling	9.11E-01		1.45E-02	PIK3R5	
SPINK1 General Cancer Pathway	9.11E-01		1.45E-02	PIK3R5	
Calcium-induced T Lymphocyte Apoptosis	9.3E-01		1.52E-02	PRKCQ	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	9.3E-01		6.41E-03	PIK3R5,PRKCQ	
CD40 Signaling	9.36E-01		1.54E-02	PIK3R5	
ErbB2-ErbB3 Signaling	9.36E-01		1.54E-02	PIK3R5	
Myc Mediated Apoptosis Signaling	9.36E-01		1.54E-02	PIK3R5	
Pyridoxal 5'-phosphate Salvage Pathway	9.36E-01		1.54E-02	PRKCQ	
Regulation of Cellular Mechanics by Calpain Protease	9.36E-01		1.54E-02	ITGA4	
IL-17A Signaling in Airway Cells	9.42E-01		1.56E-02	PIK3R5	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	9.42E-01		1.56E-02	PIK3R5	
IL-2 Signaling	9.62E-01		1.64E-02	PIK3R5	
Endometrial Cancer Signaling	9.69E-01		1.67E-02	PIK3R5	
Semaphorin Signaling in Neurons	9.69E-01		1.67E-02	DPYSL5	
Dermatan Sulfate Biosynthesis	9.76E-01		1.69E-02	B3GAT1	
MSP-RON Signaling Pathway	9.83E-01		1.72E-02	PIK3R5	
CNTF Signaling	9.9E-01		1.75E-02	PIK3R5	
Glutamate Receptor Signaling	9.9E-01		1.75E-02	GRIA4	
Xenobiotic Metabolism Signaling	9.9E-01		6.97E-03	PIK3R5,PRKCQ	
Chondroitin Sulfate Biosynthesis	9.97E-01		1.79E-02	B3GAT1	
EGF Signaling	1E00		1.82E-02	PIK3R5	
Role of IL-17A in Arthritis	1.01E00		1.85E-02	PIK3R5	
Lymphotoxin β Receptor Signaling	1.02E00		1.89E-02	PIK3R5	
Systemic Lupus Erythematosus In B Cell Signaling Pathway	1.02E00		7.27E-03	PIK3R5,PRKCQ	
UVC-Induced MAPK Signaling	1.04E00		1.96E-02	PRKCQ	
Amyloid Processing	1.04E00		2.00E-02	CDK5R1	
Melanoma Signaling	1.04E00		2.00E-02	PIK3R5	
Ephrin A Signaling	1.07E00		2.13E-02	PIK3R5	
nNOS Signaling in Neurons	1.07E00		2.13E-02	PRKCQ	
Phospholipase C Signaling	1.07E00		7.78E-03	ITGA4,PRKCQ	
Role of Oct4 in Mammalian Embryonic Stem Cell Pluripotency	1.08E00		2.17E-02	SALL4	
Apelin Pancreas Signaling Pathway	1.1E00		2.27E-02	PIK3R5	
IL-23 Signaling Pathway	1.1E00		2.27E-02	PIK3R5	
Opioid Signaling Pathway	1.1E00		8.10E-03	PRKCQ,RGS17	
Pyrimidine Ribonucleotides De Novo Biosynthesis	1.11E00		2.33E-02	NUDT18	
Signaling by Rho Family GTPases	1.11E00		8.20E-03	ITGA4,PIK3R5	
Mechanisms of Viral Exit from Host Cells	1.13E00		2.44E-02	PRKCQ	
Pyrimidine Ribonucleotides Interconversion	1.13E00		2.44E-02	NUDT18	
Inhibition of Matrix Metalloproteases	1.15E00		2.56E-02	TFPI2	
Docosahexaenoic Acid (DHA) Signaling	1.16E00		2.63E-02	PIK3R5	
Actin Cytoskeleton Signaling	1.19E00		9.17E-03	ITGA4,PIK3R5	
Role of NFAT in Cardiac Hypertrophy	1.21E00		9.35E-03	PIK3R5,PRKCQ	
Integrin Signaling	1.21E00		9.39E-03	ITGA4,PIK3R5	
IL-9 Signaling	1.22E00		3.03E-02	PIK3R5	
mTOR Signaling	1.22E00		9.52E-03	PIK3R5,PRKCQ	
Thrombin Signaling	1.23E00		9.62E-03	PIK3R5,PRKCQ	
Breast Cancer Regulation by Stathmin1	1.26E00		1.00E-02	PIK3R5,PRKCQ	
IL-8 Signaling	1.26E00		1.00E-02	PIK3R5,PRKCQ	
Role of p14/p19ARF in Tumor Suppression	1.27E00		3.45E-02	PIK3R5	
ERK/MAPK Signaling	1.29E00		1.04E-02	ITGA4,PIK3R5	
NRF2-mediated Oxidative Stress Response	1.3E00		1.06E-02	PIK3R5,PRKCQ	
Synaptic Long Term Depression	1.3E00		1.06E-02	GRIA4,PRKCQ	
Endothelin-1 Signaling	1.31E00		1.06E-02	PIK3R5,PRKCQ	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	1.31E00		1.06E-02	PIK3R5,PRKCQ	
B Cell Receptor Signaling	1.32E00		1.08E-02	PIK3R5,PRKCQ	
Role of NFAT in Regulation of the Immune Response	1.34E00		1.10E-02	PIK3R5,PRKCQ	
NF-κB Signaling	1.35E00		1.12E-02	PIK3R5,PRKCQ	
T Cell Exhaustion Signaling Pathway	1.36E00		1.14E-02	PIK3R5,PRKCQ	
PI3K/AKT Signaling	1.37E00		1.15E-02	IL17RB,ITGA4	
CXCR4 Signaling	1.4E00		1.20E-02	PIK3R5,PRKCQ	
Molecular Mechanisms of Cancer	1.43E00		7.67E-03	ITGA4,PIK3R5,PRKCQ	
eNOS Signaling	1.44E00		1.26E-02	PIK3R5,PRKCQ	
Aldosterone Signaling in Epithelial Cells	1.44E00		1.27E-02	PIK3R5,PRKCQ	
Gαq Signaling	1.45E00		1.27E-02	PIK3R5,PRKCQ	
Regulation of eIF4 and p70S6K Signaling	1.45E00		1.27E-02	ITGA4,PIK3R5	
PKCθ Signaling in T Lymphocytes	1.46E00		1.29E-02	PIK3R5,PRKCQ	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	1.46E00		1.30E-02	PIK3R5,PRKCQ	
Hepatic Fibrosis Signaling Pathway	1.49E00		8.15E-03	ITGA4,PIK3R5,PRKCQ	
Type II Diabetes Mellitus Signaling	1.53E00		1.41E-02	PIK3R5,PRKCQ	
Human Embryonic Stem Cell Pluripotency	1.57E00		1.48E-02	PIK3R5,SALL4	
IL-12 Signaling and Production in Macrophages	1.59E00		1.52E-02	PIK3R5,PRKCQ	
Synaptic Long Term Potentiation	1.61E00		1.55E-02	GRIA4,PRKCQ	
p70S6K Signaling	1.61E00		1.55E-02	PIK3R5,PRKCQ	
14-3-3-mediated Signaling	1.62E00		1.57E-02	PIK3R5,PRKCQ	
P2Y Purigenic Receptor Signaling Pathway	1.62E00		1.57E-02	PIK3R5,PRKCQ	
PTEN Signaling	1.62E00		1.59E-02	ITGA4,PIK3R5	
CCR3 Signaling in Eosinophils	1.64E00		1.61E-02	PIK3R5,PRKCQ	
Th1 Pathway	1.66E00		1.65E-02	PIK3R5,PRKCQ	
CD28 Signaling in T Helper Cells	1.66E00		1.67E-02	PIK3R5,PRKCQ	
GP6 Signaling Pathway	1.67E00		1.68E-02	PIK3R5,PRKCQ	
Natural Killer Cell Signaling	1.67E00		1.68E-02	PIK3R5,PRKCQ	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	1.67E00		1.68E-02	PIK3R5,SALL4	
Synaptogenesis Signaling Pathway	1.68E00		9.62E-03	GRIA4,MAP1B,PIK3R5	
Renin-Angiotensin Signaling	1.68E00		1.69E-02	PIK3R5,PRKCQ	
Fc Epsilon RI Signaling	1.68E00		1.71E-02	PIK3R5,PRKCQ	
fMLP Signaling in Neutrophils	1.69E00		1.72E-02	PIK3R5,PRKCQ	
Apelin Endothelial Signaling Pathway	1.7E00		1.74E-02	PIK3R5,PRKCQ	
iCOS-iCOSL Signaling in T Helper Cells	1.73E00		1.80E-02	PIK3R5,PRKCQ	
Glioma Signaling	1.74E00		1.82E-02	PIK3R5,PRKCQ	
Paxillin Signaling	1.75E00		1.85E-02	ITGA4,PIK3R5	
PD-1, PD-L1 cancer immunotherapy pathway	1.77E00		1.89E-02	PIK3R5,PRKCQ	
Phosphatidylethanolamine Biosynthesis II	1.77E00		1.11E-01	CHKA	
T Cell Receptor Signaling	1.77E00		1.90E-02	PIK3R5,PRKCQ	
Apelin Cardiomyocyte Signaling Pathway	1.82E00		2.02E-02	PIK3R5,PRKCQ	
Nitric Oxide Signaling in the Cardiovascular System	1.82E00		2.02E-02	PIK3R5,PRKCQ	
Amyotrophic Lateral Sclerosis Signaling	1.84E00		2.06E-02	GRIA4,PIK3R5	
PAK Signaling	1.84E00		2.06E-02	ITGA4,PIK3R5	
FAK Signaling	1.86E00		2.11E-02	ITGA4,PIK3R5	
ErbB Signaling	1.86E00		2.13E-02	PIK3R5,PRKCQ	
Cardiac Hypertrophy Signaling (Enhanced)	1.88E00		8.21E-03	IL17RB,ITGA4,PIK3R5,PRKCQ	
Glycoaminoglycan-protein Linkage Region Biosynthesis	1.88E00		1.43E-01	B3GAT1	
Phosphatidylcholine Biosynthesis I	1.88E00		1.43E-01	CHKA	
Axonal Guidance Signaling	1.88E00		8.25E-03	DPYSL5,ITGA4,PIK3R5,PRKCQ	
HER-2 Signaling in Breast Cancer	1.96E00		2.38E-02	PIK3R5,PRKCQ	
TR/RXR Activation	1.96E00		2.38E-02	PIK3R5,SLC16A3	
VEGF Family Ligand-Receptor Interactions	1.96E00		2.38E-02	PIK3R5,PRKCQ	
LPS-stimulated MAPK Signaling	1.98E00		2.44E-02	PIK3R5,PRKCQ	
Prolactin Signaling	1.99E00		2.47E-02	PIK3R5,PRKCQ	
Huntington's Disease Signaling	1.99E00		1.27E-02	CDK5R1,PIK3R5,PRKCQ	
IL-3 Signaling	2.01E00		2.53E-02	PIK3R5,PRKCQ	
Erythropoietin Signaling	2.04E00		2.63E-02	PIK3R5,PRKCQ	
Macropinocytosis Signaling	2.04E00		2.63E-02	PIK3R5,PRKCQ	
Growth Hormone Signaling	2.1E00		2.82E-02	PIK3R5,PRKCQ	
ErbB4 Signaling	2.15E00		2.99E-02	PIK3R5,PRKCQ	
CREB Signaling in Neurons	2.15E00		1.45E-02	GRIA4,PIK3R5,PRKCQ	
Thrombopoietin Signaling	2.2E00		3.17E-02	PIK3R5,PRKCQ	
Gap Junction Signaling	2.21E00		1.52E-02	GRIA4,PIK3R5,PRKCQ	
Leukocyte Extravasation Signaling	2.21E00		1.52E-02	ITGA4,PIK3R5,PRKCQ	
UVB-Induced MAPK Signaling	2.36E00		3.85E-02	PIK3R5,PRKCQ	
Th1 and Th2 Activation Pathway	2.38E00		1.75E-02	IL17RB,PIK3R5,PRKCQ	
Tec Kinase Signaling	2.43E00		1.83E-02	ITGA4,PIK3R5,PRKCQ	
Th2 Pathway	2.66E00		2.21E-02	IL17RB,PIK3R5,PRKCQ	
Phagosome Formation	2.77E00		2.40E-02	ITGA4,PIK3R5,PRKCQ	
Rac Signaling	2.91E00		2.68E-02	CDK5R1,ITGA4,PIK3R5	
HGF Signaling	2.92E00		2.70E-02	ITGA4,PIK3R5,PRKCQ	
Virus Entry via Endocytic Pathways	2.96E00		2.80E-02	ITGA4,PIK3R5,PRKCQ	
Neuropathic Pain Signaling In Dorsal Horn Neurons	3.03E00		2.97E-02	GRIA4,PIK3R5,PRKCQ	
Neuregulin Signaling	3.1E00		3.12E-02	CDK5R1,ITGA4,PRKCQ	
NF-κB Activation by Viruses	3.3E00		3.66E-02	ITGA4,PIK3R5,PRKCQ	
Reelin Signaling in Neurons	3.99E00		3.10E-02	CDK5R1,ITGA4,MAP1B,PIK3R5	

Upstream Regulators for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Analysis	ID	Upstream Regulator	Molecule Type	Predicted Activation State	Activation z-score	Notes	Bias Term	Bias-corrected z-score	p-value of overlap	Target molecules in dataset	Mechanistic Network	
longFragmentHuman - 2020-01-20 08:06 PM	 	RUNX1	transcription regulator	 	 	 	 	 	3.02E-05	CST7,DEPTOR,ITGA4,PRKCQ,SPATA6	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MITF	transcription regulator	 	 	 	 	 	9.78E-05	CDK5R1,CHKA,ESRP1,FRMD4B,ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	azathioprine	chemical drug	 	 	 	 	 	2.05E-04	ATP9A,ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	NEUROG2	transcription regulator	 	 	 	 	 	3.37E-04	CDK5R1,NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PAX6	transcription regulator	 	 	 	 	 	7.69E-04	CHKA,KIF1B,NKX2-2,SPAG1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	EP300	transcription regulator	 	 	 	 	 	1.62E-03	CHKA,CST7,FRMD4B,KIF1B,TMPRSS2	CREBBP,EP300	
longFragmentHuman - 2020-01-20 08:06 PM	 	B3GAT2	enzyme	 	 	 	 	 	1.96E-03	B3GAT1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	CHMP4C	other	 	 	 	 	 	1.96E-03	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	EVL	other	 	 	 	 	 	1.96E-03	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	KIF21A	other	 	 	 	 	 	1.96E-03	MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	UBAP1	other	 	 	 	 	 	1.96E-03	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	dihydroxyphenylethylene glycol	chemical - endogenous mammalian	 	 	 	 	 	1.96E-03	MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	miR-616-3p (miRNAs w/seed GUCAUUG)	mature microrna	 	 	 	 	 	1.96E-03	TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PD 0325901	chemical drug	 	 	 	 	 	2.03E-03	CHKA,DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	NANOG	transcription regulator	 	 	 	 	 	2.07E-03	MAP1B,NKX2-2,SALL4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	TGFB1	growth factor	 	 	 	 	 	2.39E-03	ADGRG2,CDK5R1,DEPTOR,DMTN,ESRP1,GSE1,IL17RB,ITGA4,KLF15,SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	QKI	other	 	 	 	 	 	2.53E-03	DACT1,MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	NEUROD1	transcription regulator	 	 	 	 	 	2.66E-03	CDK5R1,NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	FMR1	translation regulator	 	 	 	 	 	3.00E-03	MAP1B,NKX2-2,QPCT	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	HNRNPA2B1	other	 	 	 	 	 	3.00E-03	ADGRG2,TFPI2,UBASH3B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	tretinoin	chemical - endogenous mammalian	 	 	 	 	 	3.56E-03	CDK5R1,CHKA,DPYSL5,ITGA4,KIF1B,KLF15,MAP1B,NKX2-2,SALL4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	FUZ	other	 	 	 	 	 	3.92E-03	NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	INK4	group	 	 	 	 	 	3.92E-03	TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	STAM	other	 	 	 	 	 	3.92E-03	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	abiraterone	chemical drug	 	 	 	 	 	3.92E-03	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	HOXA3	transcription regulator	 	 	 	 	 	4.17E-03	ITGA4,SPATA6	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	RARA	ligand-dependent nuclear receptor	 	 	 	 	 	5.29E-03	ITGA4,MAP1B,SALL4,TTC9	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	DHPS	enzyme	 	 	 	 	 	5.88E-03	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	EEF1D	translation regulator	 	 	 	 	 	5.88E-03	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	HOXB2	transcription regulator	 	 	 	 	 	5.88E-03	NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	Mn2+	chemical - endogenous mammalian	 	 	 	 	 	5.88E-03	ATP13A2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SOCS2-AS1	other	 	 	 	 	 	5.88E-03	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	necrostatin-1s	chemical reagent	 	 	 	 	 	5.88E-03	CST7	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	CREBBP	transcription regulator	 	 	 	 	 	7.32E-03	CST7,FRMD4B,KIF1B,TMPRSS2	CREBBP,EP300	
longFragmentHuman - 2020-01-20 08:06 PM	 	PKD1	ion channel	 	 	 	 	 	7.37E-03	IL17RB,QPCT,SPATA6	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	AKR1C3	enzyme	 	 	 	 	 	7.83E-03	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	CHMP2B	other	 	 	 	 	 	7.83E-03	GRIA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	EEF2K	kinase	 	 	 	 	 	7.83E-03	MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SIX4	transcription regulator	 	 	 	 	 	7.83E-03	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	TDP2	transcription regulator	 	 	 	 	 	9.78E-03	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	NGF	growth factor	 	 	 	 	 	1.01E-02	CDK5R1,DPYSL5,GRIA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	budesonide	chemical drug	 	 	 	 	 	1.05E-02	CDK5R1,PRKCQ	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	CHD8	enzyme	 	 	 	 	 	1.17E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	EIF5A	translation regulator	 	 	 	 	 	1.17E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	FES	kinase	 	 	 	 	 	1.17E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SMARCD1	transcription regulator	 	 	 	 	 	1.17E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	prednisolone	chemical drug	 	 	 	 	 	1.21E-02	CDK5R1,ITGA4,NUDT18	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	L-triiodothyronine	chemical - endogenous mammalian	 	 	 	 	 	1.22E-02	KIF1B,NUDT18,PRKCQ,TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SB203580	chemical - kinase inhibitor	 	 	 	 	 	1.27E-02	CDK5R1,CST7,ITGA4,TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MYOC	other	 	 	 	 	 	1.29E-02	ESRP1,RGS17	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	methylselenic acid	chemical reagent	 	 	 	 	 	1.32E-02	MAP1B,SH3BP5,TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	RASSF1	other	 	 	 	 	 	1.35E-02	FRMD4B,MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	DAB1	other	 	 	 	 	 	1.37E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MFAP2	other	 	 	 	 	 	1.37E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	recombinant human endostatin	chemical drug	 	 	 	 	 	1.37E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	TCF	group	 	 	 	 	 	1.38E-02	ADGRG2,QPCT	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SOX2	transcription regulator	 	 	 	 	 	1.38E-02	NKX2-2,PRKCQ,SALL4,TMEM163	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	ASCL1	transcription regulator	 	 	 	 	 	1.41E-02	CDK5R1,PRKCQ	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	6-amino-4-(4-phenoxyphenylethylamino)quinazoline	chemical reagent	 	 	 	 	 	1.56E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	Calcineurin B	group	 	 	 	 	 	1.56E-02	B3GAT1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	HEYL	transcription regulator	 	 	 	 	 	1.56E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	LASP1	transporter	 	 	 	 	 	1.56E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MM-401	chemical reagent	 	 	 	 	 	1.56E-02	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	POU3F3	transcription regulator	 	 	 	 	 	1.56E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	UGT2B15	enzyme	 	 	 	 	 	1.56E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	UGT2B17	enzyme	 	 	 	 	 	1.56E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MYD88	other	 	 	 	 	 	1.57E-02	ITGA4,SH3BP5,SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MKNK1	kinase	 	 	 	 	 	1.68E-02	KIF1B,MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	AGRN	other	 	 	 	 	 	1.75E-02	MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	HCAR1	g-protein coupled receptor	 	 	 	 	 	1.75E-02	SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	INPP4B	phosphatase	 	 	 	 	 	1.75E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MNX1	transcription regulator	 	 	 	 	 	1.75E-02	NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SEMA3A	other	 	 	 	 	 	1.75E-02	MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	propylthiouracil	chemical drug	 	 	 	 	 	1.91E-02	CHKA,QPCT	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	LCOR	transcription regulator	 	 	 	 	 	1.95E-02	TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	LINC01139	other	 	 	 	 	 	1.95E-02	SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PA2G4	transcription regulator	 	 	 	 	 	1.95E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	RYBP	transcription regulator	 	 	 	 	 	1.95E-02	NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SYK	kinase	 	 	 	 	 	2.01E-02	PRKCQ,TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	IFNG	cytokine	 	 	 	 	 	2.08E-02	ADGRG2,CDK5R1,IL17RB,ITGA4,NKX2-2,PRKCQ,SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	H3C14	other	 	 	 	 	 	2.14E-02	PIK3R5	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	NCKAP1L	other	 	 	 	 	 	2.14E-02	DMTN	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	VASP	other	 	 	 	 	 	2.14E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	VEGFC	growth factor	 	 	 	 	 	2.14E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	mGluR	group	 	 	 	 	 	2.14E-02	MAP1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	androstenediol	chemical - endogenous mammalian	 	 	 	 	 	2.33E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	miR-148a-3p (and other miRNAs w/seed CAGUGCA)	mature microrna	 	 	 	 	 	2.33E-02	UBASH3B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	putrescine	chemical - endogenous mammalian	 	 	 	 	 	2.33E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PELP1	other	 	 	 	 	 	2.47E-02	MAP1B,PRKCQ	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PPP3CB	phosphatase	 	 	 	 	 	2.52E-02	B3GAT1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	RV 538	chemical reagent	 	 	 	 	 	2.52E-02	ATP13A2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	XRCC5	enzyme	 	 	 	 	 	2.52E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	BET	group	 	 	 	 	 	2.71E-02	DMTN	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	D-tubocurarine	chemical drug	 	 	 	 	 	2.71E-02	TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	POU3F2	transcription regulator	 	 	 	 	 	2.71E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	diacylglycerol	chemical - endogenous mammalian	 	 	 	 	 	2.71E-02	PRKCQ	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	mir-290	microrna	 	 	 	 	 	2.91E-02	SALL4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	CREB3	transcription regulator	 	 	 	 	 	3.10E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	DIRAS3	enzyme	 	 	 	 	 	3.10E-02	TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	hydrogen sulfide	chemical - endogenous mammalian	 	 	 	 	 	3.10E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MTOR	kinase	 	 	 	 	 	3.14E-02	CHKA,SLC16A3,TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MAPK1	kinase	 	 	 	 	 	3.23E-02	CDK5R1,DEPTOR,NKX2-2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	CD28	transmembrane receptor	 	 	 	 	 	3.25E-02	ITGA4,SLC16A3,TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	ARG1	enzyme	 	 	 	 	 	3.29E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	IL1RAP	transmembrane receptor	 	 	 	 	 	3.29E-02	IL17RB	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PDGFRA	kinase	 	 	 	 	 	3.29E-02	PRKCQ	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	bombesin	chemical - endogenous mammalian	 	 	 	 	 	3.29E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	selumetinib	chemical drug	 	 	 	 	 	3.29E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	ITGAL	transmembrane receptor	 	 	 	 	 	3.48E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	NFASC	other	 	 	 	 	 	3.48E-02	KIF1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SLC6A3	transporter	 	 	 	 	 	3.48E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	c-Src	group	 	 	 	 	 	3.48E-02	CHKA	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	TLX3	transcription regulator	 	 	 	 	 	3.67E-02	GRIA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	miR-486-5p (and other miRNAs w/seed CCUGUAC)	mature microrna	 	 	 	 	 	3.67E-02	UBASH3B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	Pam3-Cys-Ser-Lys4	chemical reagent	 	 	 	 	 	3.72E-02	ITGA4,SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SMARCD3	transcription regulator	 	 	 	 	 	3.86E-02	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	mir-486	microrna	 	 	 	 	 	3.86E-02	UBASH3B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	salvin	chemical toxicant	 	 	 	 	 	3.86E-02	CDK5R1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	MAPT	other	 	 	 	 	 	3.89E-02	CDK5R1,MAP1B,SLC16A3	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	ethanol	chemical - endogenous mammalian	 	 	 	 	 	4.01E-02	ANKS1B,MAP1B,TFPI2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	HMGA2	enzyme	 	 	 	 	 	4.04E-02	KLF15	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	SRA1	transcription regulator	 	 	 	 	 	4.04E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	TRIM21	enzyme	 	 	 	 	 	4.04E-02	SALL4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	XRCC6	enzyme	 	 	 	 	 	4.04E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	miR-293-5p (and other miRNAs w/seed CUCAAAC)	mature microrna	 	 	 	 	 	4.04E-02	KLF15	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	IgG1	complex	 	 	 	 	 	4.23E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	LILRB1	transmembrane receptor	 	 	 	 	 	4.23E-02	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	PBX3	transcription regulator	 	 	 	 	 	4.23E-02	CHD9	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	WDR5	transcription regulator	 	 	 	 	 	4.23E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	BTRC	enzyme	 	 	 	 	 	4.42E-02	DEPTOR	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	ibrutinib	chemical drug	 	 	 	 	 	4.42E-02	ITGA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	miR-30a-3p (and other miRNAs w/seed UUUCAGU)	mature microrna	 	 	 	 	 	4.42E-02	KIF1B	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	ETV1	transcription regulator	 	 	 	 	 	4.61E-02	TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	WDR77	transcription regulator	 	 	 	 	 	4.61E-02	SPAG1	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	UCN-01	chemical drug	 	 	 	 	 	4.80E-02	PRKCQ	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	calpain	complex	 	 	 	 	 	4.80E-02	GRIA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	lead	chemical toxicant	 	 	 	 	 	4.80E-02	GRIA4	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	metribolone	chemical reagent	 	 	 	 	 	4.94E-02	CDK5R1,SLC16A3,TMPRSS2	 	
longFragmentHuman - 2020-01-20 08:06 PM	 	KLF2	transcription regulator	 	 	 	 	 	4.96E-02	ITGA4,TFPI2	 	

Causal Networks for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Master Regulator	Molecule Type	Depth	Predicted Activation State	Notes	Activation z-score	p-value of overlap	Network bias-corrected p-value	Participating regulators	Target molecules in dataset	Causal network	Target-connected regulators	Relationships Between Master Regulators(Increases/Downstream)	Relationships Between Master Regulators(Decreases/Downstream)	Relationships Between Master Regulators(Affects/Downstream)	Relationships Between Master Regulators(Increases/Upstream)	Relationships Between Master Regulators(Decreases/Upstream)	Relationships Between Master Regulators(Affects/Upstream)	Relationships Between Master Regulators(Increases/Both)	Relationships Between Master Regulators(Decreases/Both)	Relationships Between Master Regulators(Affects/Both)	
TRERF1	transcription regulator	3	 	 	0.000	7.13E-07	1.60E-03	AKT1,CCND1,CDK2,CDK6,CDKN1B,Cyclin A,estrogen receptor,FOXO1,ISL1,MAPT,MYC,NCOA1,NFATC3,NR4A1,P38 MAPK,PTEN,RB1,RBL2,SOX2,STAT3,TRERF1,ZEB1	 	21 (22)	18	 	NUPR1	 	 	CDK2	 	 	 	 	
PPAR ligand-PPAR-Retinoic acid-RXRα	complex	3	 	 	0.000	1.10E-06	2.60E-03	ERBB2,F3,Focal adhesion kinase,HNF4A,IGFBP2,MAPK1,MYC,NR3C1,NR4A1,PPAR ligand-PPAR-Retinoic acid-RXRα,PPARA,PPARD,PTEN,RAF1,SRC (family),STAT1,STAT5B,TGFB1,TP53,tretinoin	 	25 (20)	19	 	 	 	 	 	 	 	 	 	
infliximab	biologic drug	3	 	 	0.000	2.17E-06	3.90E-03	AKT1,Calcineurin A,CD38,EGFR,EP300,ERBB2,F3,FOXP3,Hdac,HIF1A,IKBKE,IL15,infliximab,MAPK1,MTOR,NCOA3,NFkB (complex),Nr1h,P38 MAPK,PPARD,PRKCD,PTEN,REL,RUNX1,STAT3,SYK,TBK1,TGFB1,TNF,TP53,ZAP70	 	26 (31)	29	 	 	 	 	BATF,TNF	 	 	 	 	
TCL1A	transcription regulator	3	 	 	0.000	4.22E-06	1.20E-03	AKT1,AR,CLOCK,DNMT3A,ERBB2,ESR1,FOXO1,GATA1,GSK3A,JUN,MET,MITF,MYC,NFATC1,NFATC2,NR4A1,PTEN,SOX2,TCL1A,TGFB1	 	21 (20)	18	SB203580,SOX2-OCT4-NANOG	RARA,tretinoin	 	 	 	 	 	 	 	
naftopidil	chemical drug	3	 	 	0.000	6.29E-06	3.10E-03	AR,calpain,CASP3,DICER1,MTOR,naftopidil,PRKCD,PTEN,SMAD2,SP1,STAT3,TGFB1	 	16 (12)	9	 	 	 	 	SMAD2	 	 	 	 	
Cyclin D	group	3	 	 	0.000	6.57E-06	3.70E-03	AKT1,CCND1,CCND3,Cdk,CDK2,CDK4,CDK4/6,CDK6,CDKN1B,Cyclin A,Cyclin D,Cyclin E,E2f,estrogen receptor,FOXO1,ISL1,MAPK1,MAPT,MTOR,MYC,NCOA1,NFATC3,NR4A1,P38 MAPK,PTEN,RB1,RUNX1,SOX2,STAT3,ZEB1	 	20 (30)	20	EGF,INK4,TNF	CAK,CDKN2C,Ro31-8220,tretinoin,U0126	 	CDK2	 	 	 	 	 	
BOP1	other	3	 	 	0.000	7.38E-06	3.40E-03	AKT1,AR,BOP1,calpain,CCND1,CDK2,CDKN1B,estrogen receptor,FOXO1,Jnk,MAPK1,MAPT,MYC,NCOA1,NFATC1,NFkB (complex),NR4A1,P38 MAPK,PTEN,RB1,RBL2,RHOA,SOX2,VASP	 	18 (24)	21	 	 	 	CDK2	 	 	 	 	 	
TNF	cytokine	2	 	 	0.000	7.92E-06	9.50E-03	AKT1,Calcineurin A,CD38,EGFR,EP300,ERBB2,F3,Hdac,HIF1A,IKBKE,IL15,MAPK1,MTOR,NCOA3,NFkB (complex),Nr1h,P38 MAPK,PPARD,PRKCD,PTEN,REL,STAT3,SYK,TBK1,TGFB1,TNF,TP53,ZAP70	 	25 (28)	28	budesonide,calcimycin,CAPN1,CLEC7A,curdlan,FCGR3A/FCGR3B,Ifn gamma,IL1RAP,L-triiodothyronine,MAC,mevastatin,MKNK1,NCR2,NFATC4,palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH,Pam3-Cys-Ser-Lys4,SYK/ZAP,tetradecanoylphorbol acetate,zearalenone	CBL,cyclomaltodextrin,eptifibatide,HCAR1,ibrutinib,infliximab,LILRB1,LY6E,miR-148a-3p (and other miRNAs w/seed CAGUGCA),N-chlorotaurine,prednisolone,resveratrol,RV 538,S1PR1,SB203580,tretinoin,TRIM21,tylophorine,tyrphostin AG 127,U0126,VLDLR,VTN,ZFA-fmk,zinc sulfate	 	15(S)-HETE,BTRC,Calcineurin A,calpain,CCNE1,CD59,CDK2,Collagen(s),CREB3,Cyclin D,DDX5,EFHD2,Focal adhesion kinase,ganglioside GM2,HBEGF,HPSE,ITGA2,ITGB6,MET,POU2F1,POU3F2,Sfk,SMAD2,SRA1,VEGFC	CDKN2C,heparan sulfate,mir-290,MITF,NEUROD1,PAX6,QKI,TPO	 	 	 	 	
CCNE1	transcription regulator	3	 	 	0.000	8.17E-06	2.70E-03	AR,CCNE1,CDK2,CDK6,CDKN1B,ERBB2,FOXM1,ID2,ISL1,MET,MYC,NANOG,NCOA1,NFATC3,NR4A1,POU5F1,RB1,RBL2,SOX2,ZEB1	 	20 (20)	16	E2F2,EGF,ITGA2,L-triiodothyronine,salvin,tetradecanoylphorbol acetate,TNF,UCN-01	bosutinib,Interferon alpha,PCGF2,Ro 25-6760,tretinoin,U0126	 	 	 	 	 	 	 	
RAR ligand-RARα-Retinoic acid-RXRα	complex	3	 	 	0.000	1.08E-05	1.48E-02	ERBB2,F3,Focal adhesion kinase,IGFBP2,MAPK1,MTOR,MYC,NFkB (complex),NR4A1,PPARA,PPARD,PTEN,RAF1,RAR ligand-RARα-Retinoic acid-RXRα,RARA,RXRA,SRC (family),STAT1,TGFB1,TP53,tretinoin	 	23 (21)	19	 	 	 	 	 	 	 	 	 	
EGFR ligand	group	3	 	 	0.000	1.35E-05	6.80E-03	AKT1,AR,AREG,BTC,calpain,DIO2,EGF,EGFR,EGFR ligand,ERBB2,ERBB3,ERBB4,EREG,ESR1,ETV1,Focal adhesion kinase,FOXO1,HBEGF,ISL1,Jnk,Mapk,MET,MYC,P38 MAPK,RUNX1,SPRY2,SRC (family),STAT1,STAT3,STAT5B,STAT6,SYK,TGFA,ZEB1	 	22 (34)	27	 	 	 	 	 	 	 	 	 	
CDK2	kinase	3	 	 	0.000	1.71E-05	1.00E-02	Akt,CDK2,CDKN1B,CHEK1,ERBB2,estrogen receptor,FOXO1,FOXP3,MAPT,MDM2,MYC,NCOA1,NFAT5,NFATC1,NR4A1,PGR,PPARA,PPARD,RASSF1,RB1,RBL2,RIPK1,RUNX1,SNAI1,SOX2,SP1,SPHK1,STAT3,STAT5B,TP53,VIM	 	23 (31)	23	BAX,BOP1,CAK,calpain,CD79A,Cyclin D,EGF,ITGA2,L-triiodothyronine,MAC,MITF,putrescine,SAICAR,SYK,TNF,zearalenone	alitretinoin,CDKN2C,Interferon alpha,mevastatin,mir-290,NGF,NUPR1,O6-benzylguanine,PAX6,PCGF2,resveratrol,Ro 25-6760,tetradecanoylphorbol acetate,TRERF1,tretinoin,U0126,UCN-01	 	 	 	 	 	 	 	
Plexin B	group	3	 	 	0.000	1.88E-05	8.50E-03	AR,ERBB2,ERK,Jnk,Mapk,MAPK1,MYC,NFATC1,NFkB (complex),P38 MAPK,Plexin B,PLXNB1,PLXNB2,Rac,RAF1,RRAS,STAT1,STAT3,ZAP70	 	15 (19)	14	 	 	 	 	 	 	 	 	 	
TPO	enzyme	3	 	 	0.000	2.10E-05	4.00E-04	calpain,CTTN,EGFR,Focal adhesion kinase,MAP3K8,MYD88,P38 MAPK,SYK,SYK/ZAP,TPO,ZAP70	 	11 (11)	8	 	calcimycin,prednisolone,propylthiouracil,tetradecanoylphorbol acetate,TNF	 	SYK/ZAP	 	 	 	 	 	
tylophorine	chemical drug	3	 	 	0.000	2.19E-05	6.30E-03	AKT1,Ap1,AR,CCND1,CDKN1B,CLOCK,ERBB2,ESR1,FOXO1,GATA1,HNF4A,IRF4,JUN,MET,NFATC1,NFATC2,NFkB (complex),NR3C1,NR4A1,PRKCD,PTEN,RARG,SOX2,TGFB1,tylophorine	 	21 (25)	23	 	 	 	 	TNF	 	 	 	 	
PP2/AG1879 tyrosine kinase inhibitor	chemical - kinase inhibitor	2	 	 	0.000	2.20E-05	1.37E-02	AKT1,c-Src,EGFR,ERBB2,ERK,Focal adhesion kinase,IRF4,Jnk,Mapk,MAPK1,MAPT,MET,NFkB (complex),P38 MAPK,PP2/AG1879 tyrosine kinase inhibitor,PRKCD,RAF1,SRC,SRC (family),STAT1,STAT3,STAT5B,STAT6,ZAP70	 	17 (24)	23	 	 	 	 	c-Src,CBL,Collagen(s),Focal adhesion kinase,ICAM1,ITGB4,LYN,MET,RHOG,Sfk,SYK/ZAP	 	 	 	 	
R-348	chemical drug	3	 	 	0.000	2.26E-05	8.60E-03	AKT1,CD247,EP300,ERK,FOXO1,JAK3,Jnk,Mapk,MAPK1,MYD88,NFATC1,NFkB (complex),P38 MAPK,PRKCD,R-348,REL,STAT1,STAT3,STAT5B,STAT6,SYK	 	16 (21)	19	 	 	 	 	SYK	 	 	 	 	
ELOB	transcription regulator	3	 	 	0.000	2.55E-05	1.89E-02	AKT1,AR,AURKA,calpain,CCND1,CXCR4,ELOB,EP300,ERBB2,HIF1A,MET,MYC,NR2E1,PPARA,PRKCD,PRKCI,PTEN,RASSF1,RNA polymerase II,SMARCD3,SOX2,SPRY2,STAT3,TP53,Ubiquitin,VEGFA,VHL	 	19 (27)	21	 	 	 	 	 	 	 	 	 	
LXR ligand-LXR-Retinoic acid-RXRα	complex	3	 	 	0.000	2.60E-05	2.16E-02	ERBB2,F3,Focal adhesion kinase,IGFBP2,LXR ligand-LXR-Retinoic acid-RXRα,MAPK1,MYC,Nr1h,NR4A1,PPARD,PTEN,RAF1,SRC (family),STAT1,TGFB1,TP53,tretinoin	 	22 (17)	16	 	 	 	 	 	 	 	 	 	
IL-1R/TLR	group	3	 	 	0.000	2.91E-05	1.16E-02	AR,calpain,IL-1R/TLR,IL10RA,IL1R1,MAPK1,MAPT,MYC,MYD88,OSM,PKD1,PRKCD,PTEN,REL,STAT3,SYK,TLR2,TLR3,TLR4,TLR6,TLR7,TLR9	 	18 (22)	14	 	 	 	MYD88	 	 	 	 	 	
HSP90AA1	enzyme	3	 	 	0.000	2.96E-05	1.44E-02	c-Src,CCND1,EGFR,ERBB2,ERK,ESR1,ESR2,Focal adhesion kinase,FOXO1,GATA1,HNF4A,HSP90AA1,MAPK1,MET,MYC,NFATC1,NFATC4,RAF1,SPRY2,SRC (family),STAT1,STAT3,STAT5B,TP53	 	22 (24)	23	 	prednisolone	 	c-Src	 	 	 	 	 	
TLR2/3/4/9	group	3	 	 	0.000	2.98E-05	1.75E-02	AKT1,AR,calpain,IL10RA,IL1B,MAPK1,MAPT,MYC,MYD88,OSM,P38 MAPK,PKD1,PRKCD,PTEN,REL,SRC (family),STAT1,STAT3,SYK,TLR2,TLR2/3/4/9,TLR3,TLR4,TLR9	 	20 (24)	20	 	 	 	ICAM1,MYD88	 	 	 	 	 	
PXR ligand-PXR-Retinoic acid-RXRα	complex	3	 	 	0.000	3.29E-05	2.32E-02	alitretinoin,ERBB2,Focal adhesion kinase,FOXO1,HNF4A,IGFBP2,MYC,Nr1h,NR1I2,PPARA,PPARD,PTEN,PXR ligand-PXR-Retinoic acid-RXRα,RAF1,RXRA,SRC (family),STAT1,TGFB1,TP53,tretinoin	 	22 (20)	16	 	 	 	 	 	 	 	 	 	
CCNE1	transcription regulator	2	 	 	0.000	3.39E-05	4.00E-03	AR,CCNE1,CDKN1B,ID2,MYC,NANOG,POU5F1,RB1,RBL2,SOX2	 	13 (10)	9	E2F2,EGF,ITGA2,L-triiodothyronine,salvin,tetradecanoylphorbol acetate,TNF,UCN-01	bosutinib,Interferon alpha,PCGF2,Ro 25-6760,tretinoin,U0126	 	 	 	 	 	 	 	
CLEC1B	transmembrane receptor	3	 	 	0.000	3.41E-05	1.15E-02	AKT1,calpain,CD247,CLEC1B,EP300,Focal adhesion kinase,FOXO1,GPIIB-IIIA,Jnk,Mapk,MAPK1,MYD88,NFATC3,NFkB (complex),P38 MAPK,PLCG2,PRKCD,REL,STAT3,SYK,SYK/ZAP,ZAP70	 	15 (22)	18	 	 	 	SYK,SYK/ZAP	 	 	 	 	 	
FXR ligand-FXR-Retinoic acid-RXRα	complex	3	 	 	0.000	3.52E-05	2.70E-02	ERBB2,F3,FXR ligand-FXR-Retinoic acid-RXRα,HNF4A,IGFBP2,MAPK1,MYC,NR1H4,NR4A1,PPARA,PPARD,PTEN,RAF1,RXRA,TGFB1,TP53,tretinoin	 	22 (17)	14	 	 	 	VLDLR	 	 	 	 	 	
torin1	chemical reagent	3	 	 	0.000	3.57E-05	1.80E-03	Akt,AKT1,AKT2,CLOCK,ERBB2,ERK1/2,FOXO1,JUN,MAPK1,MET,MITF,MTOR,MYC,NFAT5,NFATC1,NFATC2,NFATC4,NR4A1,PPARA,SOX2,TGFB1,TNF,torin1	 	18 (23)	19	 	 	 	 	 	 	 	 	 	
RARA	ligand-dependent nuclear receptor	3	 	 	0.000	3.59E-05	1.68E-02	BTRC,CTNNB1,ERBB2,ESR1,estrogen receptor,F3,FOS,GATA1,IGFBP2,JUN,KMT2A,MAPK1,NFATC1,NR4A1,PPARA,PPARD,PTEN,RARA,RXRA,STAT1,TCF4,TCF7L2,TGFB1,tretinoin	 	22 (24)	19	alitretinoin,CSF3,L-triiodothyronine	CAK,tetradecanoylphorbol acetate	 	HOXA3	TCL1A	 	 	 	 	
CDK2-Cyclin D1	complex	3	 	 	0.000	4.29E-05	1.59E-02	AKT1,AR,CCND1,CDK2,CDK2-Cyclin D1,CDKN1B,estrogen receptor,FOXO1,MAPT,MYC,NCOA1,NR4A1,P38 MAPK,PTEN,RB1,RBL2,SOX2,STAT3	 	18 (18)	16	 	 	 	 	 	 	 	 	 	
DDX5	enzyme	3	 	 	0.000	4.33E-05	1.92E-02	AKT1,AR,DDX5,EGFR,ERBB2,ESR1,GATA1,HNF4A,let-7,NCOA1,Nr1h,NR4A1,P38 MAPK,PPARA,PPARD,PRDM1,STAT5B	 	19 (17)	16	EGF,SRA1,TNF	 	 	BAX	 	 	 	 	 	
Fcr	other	3	 	 	0.000	4.42E-05	1.74E-02	AKT1,CD247,EGFR,EP300,ERBB2,ERK,estrogen receptor,Fcr,FOXO1,Jnk,Mapk,MAPK1,MYD88,NADPH oxidase,NFkB (complex),P38 MAPK,PRKCD,REL,STAT3,SYK,tyrosine kinase	 	16 (21)	18	 	 	 	SYK	 	 	 	 	 	
resveratrol	chemical drug	2	 	 	0.000	4.45E-05	2.39E-02	c-Src,CDKN1B,cisplatin,ESR1,FOXO1,IL10,Jnk,JUN,Mapk,Mek,MTOR,MYC,NFkB (complex),Nr1h,POU5F1,PRKCD,resveratrol,STAT3,TBK1,TGFB1,TNF,TP53,VEGFA,ZEB1	 	21 (24)	23	 	 	 	BAX,GDF15,ITGAL	c-Src,CDK2,Collagen(s),ICAM1,MITF,SMAD2,TNF	 	 	 	 	
tretinoin	chemical - endogenous mammalian	2	 	 	0.000	4.63E-05	3.77E-02	ERBB2,F3,Focal adhesion kinase,IGFBP2,MAPK1,MTOR,MYC,NFkB (complex),NR4A1,PPARD,PTEN,RAF1,SRC (family),STAT1,TGFB1,TP53,tretinoin	 	22 (17)	17	 	 	 	alitretinoin,ARG1,BAX,CD47,CDKN2C,CEACAM1,Collagen(s),CSF3,ETV1,FCAR,Focal adhesion kinase,GDF15,HBEGF,HOXA3,HOXB2,ICAM1,Interferon alpha,ITGAL,ITGB2,LY6E,LYN,NEUROD1,NLRC4,PAX6,POU2F1,SYN1,TSC22D3,VEGFC,VWF	ASCL1,CCNE1,CDK2,Cyclin D,ELOC,SMAD2,TCL1A,TNF	 	 	 	 	
CAPN1	peptidase	3	 	 	0.000	4.76E-05	7.30E-03	26s Proteasome,AKT1,AR,beta-estradiol,CAPN1,CCND1,CDKN1B,CLOCK,ERBB2,ERK,ETV1,FOXO1,HNF4A,ITGB3,MET,MYC,NCOA1,NFATC1,NFATC2,NFkB (complex),NFKBIA,NR3C1,PTEN,REL,SOX2,TRPC5	 	20 (26)	21	Mn2+	 	 	TNF	 	 	 	 	 	
CD59	other	3	 	 	0.000	4.82E-05	2.74E-02	calpain,CASP3,CD59,Complement,DICER1,EGFR,ERBB2,FAS,FOXO1,IFNG,Jnk,MAC,Mapk,MAPK1,MET,NFkB (complex),P38 MAPK,PRKCD,PTEN,SRC (family),TP53,ZAP70	 	18 (22)	18	TNF	 	 	 	 	 	 	 	 	
lacidipine	chemical drug	3	 	 	0.000	5.04E-05	2.49E-02	APP,calpain,CASP3,CXCL12,DICER1,lacidipine,Mapk,MMP9,MTOR,NFkB (complex),P38 MAPK,PRKCD,PTEN,TGFB1,TNF,VEGFA	 	17 (16)	13	 	 	 	 	 	 	 	 	 	
ofloxacin	chemical drug	3	 	 	0.000	5.27E-05	3.09E-02	AKT1,AR,benzo(a)pyrene,calpain,CASP3,CYP1A2,DICER1,EGFR,ERBB2,Focal adhesion kinase,FOXO1,HBEGF,HIF1A,Jnk,Mapk,MAPK1,MET,NFkB (complex),ofloxacin,P38 MAPK,PRKCD,PTEN,SPRY2,SRC (family),STAT1,STAT3,STAT5B,STAT6,VAV2	 	19 (29)	25	 	 	 	 	 	 	 	 	 	
entospletinib	chemical drug	3	 	 	0.000	5.43E-05	1.69E-02	AKT1,CD247,CTTN,EGFR,entospletinib,EP300,ERK,Focal adhesion kinase,FOXO1,Jnk,Mapk,MAPK1,MYD88,NFkB (complex),P38 MAPK,PRKCD,REL,STAT3,SYK	 	15 (19)	17	 	 	 	 	SYK	 	 	 	 	
lanraplenib	chemical drug	3	 	 	0.000	5.43E-05	1.69E-02	AKT1,CD247,CTTN,EGFR,EP300,ERK,Focal adhesion kinase,FOXO1,Jnk,lanraplenib,Mapk,MAPK1,MYD88,NFkB (complex),P38 MAPK,PRKCD,REL,STAT3,SYK	 	15 (19)	17	 	 	 	 	SYK	 	 	 	 	
MITF	transcription regulator	1	 	 	0.000	6.18E-05	9.00E-04	MITF	 	5 (1)	1	cyclomaltodextrin,ETV1,PAX6,SH3BP2,tetradecanoylphorbol acetate	LYN,resveratrol,SB203580,TNF	 	CD151,CDK2,INPP4B,MET	 	 	 	 	 	
VPS26A	transporter	3	 	 	0.000	6.31E-05	3.40E-02	AKT1,AR,CD247,CD3,EGFR,ERBB2,ESR1,IGF2R,Jnk,Mapk,MAPK1,NFkB (complex),Nr1h,NR3C1,NR4A1,SRC,SRC (family),TGFB1,VPS26A,ZAP70	 	18 (20)	18	 	 	 	 	 	 	 	 	 	
vitamin K1	chemical - endogenous mammalian	3	 	 	0.000	6.37E-05	7.70E-03	EGFR,ESR1,Focal adhesion kinase,FOXO1,GATA1,HNF4A,Jnk,JUN,MAPK1,MET,MTOR,MYC,NFATC1,NFATC3,NFATC4,NGF,Nr1h,Pka,PPARA,PPARD,RARA,SRC (family),STAT1,STAT3,TGFB1,TNF,vitamin K1	 	20 (27)	25	 	 	 	MET	 	 	 	 	 	
dipyrone	chemical drug	3	 	 	0.000	6.69E-05	1.71E-02	aspirin,calpain,CASP3,DICER1,dipyrone,ERBB2,ERK,F3,JUN,MAPK1,MTOR,P38 MAPK,PPARA,PPARD,PRKCD,PTGS1,PTGS2,STAT3,STAT6,TP53	 	16 (20)	15	 	 	 	 	 	 	 	 	 	
estrone	chemical - endogenous mammalian	3	 	 	0.000	7.03E-05	2.09E-02	AKT1,calpain,CASP3,CDKN1B,CLOCK,ERBB2,ERK,ESR1,ESR2,estrone,FOXO1,GATA1,MET,MYC,NFATC1,NFATC2,NR1I3,NR3C1,NR4A1,SOX2,STAT5B,STAT6,TP53	 	21 (23)	21	androstenediol	 	 	 	 	 	 	 	 	
palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH	chemical reagent	3	 	 	0.000	7.06E-05	1.73E-02	AKT1,c-Src,calpain,CCND1,estrogen receptor,HNF4A,IL10RA,IL1B,IRF4,MAP3K8,MAPK1,MTOR,MYD88,NFATC2,NFkB (complex),P38 MAPK,palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH,PRKCD,REL,STAT1,STAT3,TLR2	 	17 (22)	21	 	 	 	ICAM1,TNF	 	 	 	 	 	
ZFA-fmk	chemical reagent	3	 	 	0.000	7.12E-05	1.83E-02	calpain,CASP3,CASP7,CCND1,CSF2,DICER1,EGFR,estrogen receptor,F3,Focal adhesion kinase,HNF4A,ICAM1,IL1B,IRF4,Mapk,MET,NFkB (complex),P38 MAPK,PLAU,PRKCD,PTEN,STAT1,STAT3,TGFB1,VTN,ZFA-fmk	 	17 (26)	22	 	 	 	 	TNF	 	 	 	 	
CBL	transcription regulator	2	 	 	0.000	7.20E-05	1.91E-02	AKT1,AR,CBL,CD247,ERBB2,Mapk,MET,MTOR,RIPK1,SPRY2,SRC,STAT3,SYK,TGFB1,ZAP70	 	15 (15)	14	c-Src,CD79A,EGF,Fc receptor,Interferon alpha,Sfk,VTN	PP2/AG1879 tyrosine kinase inhibitor,tetradecanoylphorbol acetate	 	 	RIPK1,TNF	 	 	 	 	
PRI-724	chemical drug	3	 	 	0.000	7.31E-05	3.25E-02	BTRC,CREBBP,CTNNB1,ESR1,ESRRA,estrogen receptor,FOXO1,GATA1,HNF4A,KLF1,MYC,NANOG,NCOA1,NR3C1,P38 MAPK,PPARA,PRI-724,RAF1,RBL2,SP1,STAT3,TCF4,TCF7L2,TP53	 	20 (24)	21	 	 	 	 	 	 	 	 	 	
MAC	complex	2	 	 	0.000	7.62E-05	7.60E-03	EGFR,ERBB2,FOXO1,Jnk,MAC,MAPK1,MET,NFkB (complex),P38 MAPK,SRC (family),SYK,ZAP70	 	13 (12)	11	 	VTN	 	AKR1C3,CDK2,MET,SYK,TNF	 	 	 	 	 	
flufenamic acid	chemical drug	3	 	 	0.000	7.63E-05	1.89E-02	AR,aspirin,EGFR,ERBB2,ESR1,F3,flufenamic acid,HNF4A,IL2,Jnk,KCNN4,Mapk,NFATC1,Nr1h,NR4A1,P38 MAPK,PPARA,PPARD,PPARG,SRC,SRC (family),STAT1,STAT3,STAT5B,STAT6,TP53,TRPV1	 	19 (27)	22	 	 	 	 	 	 	 	 	 	
LY6E	other	3	 	 	0.000	7.92E-05	1.87E-02	AR,calpain,CD247,ERBB2,ESR1,Fc gamma receptor,FCGR2B,FOXO1,HNF4A,LY6E,MAPK1,MYD88,NFAT5,PTPN6,SMAD3,SRC (family),STAT1,STAT6,SYK,SYK/ZAP,TGFB1,VDR,ZAP70	 	17 (23)	17	tretinoin	 	 	 	Interferon alpha,SYK/ZAP,TNF	 	 	 	 	
E2F2	transcription regulator	3	 	 	0.000	8.19E-05	2.74E-02	AKT1,AR,CCND1,CDK2,CDKN1B,E2F2,estrogen receptor,FOXO1,MAPT,MYC,NCOA1,NR4A1,P38 MAPK,PTEN,RB1,RBL2,SOX2,STAT3	 	18 (18)	16	CIP2A,NGF	 	 	CCNE1,CDKN2C	 	 	 	 	 	
Ro 25-6760	chemical toxicant	3	 	 	0.000	8.62E-05	3.58E-02	AR,CDK2,CDK6,CDKN1B,estrogen receptor,FOXO1,ISL1,MAPT,MYC,NCOA1,NFATC3,RB1,RBL2,Ro 25-6760,SOX2,SP1,STAT3,TP53,ZEB1	 	18 (19)	16	 	 	 	 	CCNE1,CDK2	 	 	 	 	
EFHD2	other	3	 	 	0.000	8.76E-05	1.97E-02	AKT1,BLNK,CD247,EFHD2,EP300,ERK,FOXO1,Jnk,Mapk,MAPK1,MYD88,NFATC3,NFkB (complex),P38 MAPK,PLCG2,PRKCD,REL,STAT3,SYK	 	14 (19)	16	TNF	 	 	SYK	 	 	 	 	 	
MPIG6B	other	3	 	 	0.000	9.25E-05	1.32E-02	calpain,EGFR,Focal adhesion kinase,FOXO1,MPIG6B,MYD88,NFkB (complex),P38 MAPK,RUNX1,Sfk,SRC,STAT3,SYK,SYK/ZAP,ZAP70	 	13 (15)	12	 	 	 	 	Sfk,SYK/ZAP	 	 	 	 	
CDK2-CyclinE	complex	3	 	 	0.000	9.43E-05	1.57E-02	AKT1,AR,CCND1,CDC25A,CDK2,CDK2-CyclinE,CDKN1B,Cyclin E,estrogen receptor,FOXO1,MAPT,MYC,NCOA1,NFkB (complex),NPM1,NR4A1,P38 MAPK,PTEN,Rb,RB1,SOX2	 	16 (21)	15	 	 	 	 	 	 	 	 	 	
G2535	chemical reagent	3	 	 	0.000	9.54E-05	4.12E-02	AKT1,BTRC,calpain,CCND1,CSF2,EGFR,ERBB2,estrogen receptor,Focal adhesion kinase,FOXO1,G2535,HNF4A,ICAM1,IL1B,IRF4,Jnk,Mapk,MAPK1,MET,NFkB (complex),NFKBIA,P38 MAPK,PRKCD,REL,SPRY2,SRC (family),STAT1,STAT3,STAT5B,STAT6,TP53	 	21 (31)	29	 	 	 	 	 	 	 	 	 	
TH17 Cytokine	group	3	 	 	0.000	9.74E-05	1.69E-02	AKT1,EP300,ERK,IL17A,IL21,IL22,IL23A,Jnk,Mapk,MAPK1,MTOR,NFATC1,NFkB (complex),P38 MAPK,PRKCD,STAT1,STAT3,STAT5B,SYK,TBK1,TH17 Cytokine	 	15 (21)	16	SELPLG	 	 	 	 	 	 	 	 	
PANX1	transporter	3	 	 	0.000	1.01E-04	3.12E-02	calpain,CASP1,EGFR,FOXO1,Hif1,HIF1A,IL1B,IL33,Jnk,Mapk,NFATC3,NFkB (complex),P38 MAPK,PANX1,PRKCD,PTEN,reactive oxygen species,SRC (family),STAT1,STAT3,SYK,TBK1,TGFB1,TLR2,TNF	 	17 (25)	22	 	 	 	 	 	 	 	 	 	
SYK/ZAP	group	2	 	 	0.000	1.11E-04	1.80E-03	calpain,MAP3K8,MYD88,P38 MAPK,SYK,SYK/ZAP,ZAP70	 	9 (7)	6	CLEC1B,Collagen(s),FCGR3A/FCGR3B,TPO	curdlan,LY6E,MPIG6B,PP2/AG1879 tyrosine kinase inhibitor,PRDM1	 	MYD88,SYK,TNF,VEGFC	calpain	 	 	 	 	
tyrphostin AG 127	chemical - kinase inhibitor	3	 	 	0.000	1.11E-04	3.34E-02	calpain,CASP1,CASP3,CYP2E1,DICER1,ERK,ethanol,FOXO1,IKBKE,IL33,IRAK1,Jnk,Mapk,MAPK1,NFkB (complex),P38 MAPK,PRKCD,PTEN,STAT3,TBK1,TP53,tyrphostin AG 127	 	16 (22)	17	 	 	 	 	BAX,TNF	 	 	 	 	
Alborhagin	chemical toxicant	3	 	 	0.000	1.11E-04	2.35E-02	AKT1,Alborhagin,CD247,EP300,ERK,FOXO1,Jnk,Mapk,MAPK1,MYD88,NFATC3,NFkB (complex),P38 MAPK,PLCG2,PRKCD,REL,STAT3,SYK	 	14 (18)	16	 	 	 	SYK	 	 	 	 	 	
ibrutinib	chemical drug	3	 	 	0.000	1.13E-04	3.22E-02	AKT1,BTK,BTRC,CD247,EP300,FOXO1,GATA3,ibrutinib,MAPK1,MTOR,MYD88,NFkB (complex),NFKB1,NR3C1,P38 MAPK,PRKCD,REL,RELA,STAT3,STAT5B,SYK,TP53	 	17 (22)	19	 	 	 	 	SYK,TNF	 	 	 	 	
zearalenone	chemical toxicant	3	 	 	0.000	1.14E-04	3.22E-02	AR,calpain,CASP3,CASP9,CCND1,CDK2,CDKN1B,DICER1,estrogen receptor,FOXO1,Histone h3,KMT2A,MAPT,MYC,NCOA1,NFkB (complex),NR4A1,P38 MAPK,PRKCD,PTEN,RB1,RBL2,SOX2,STAT3,zearalenone	 	18 (25)	20	 	 	 	CDK2,TNF	 	 	 	 	 	
Tween 20	chemical toxicant	3	 	 	0.000	1.21E-04	3.98E-02	AKT1,calpain,EGFR,EGR1,ERBB2,ERK,FAS,Focal adhesion kinase,FOXO1,Jnk,JUN,Mapk,MAPK1,Mek,MET,P38 MAPK,PPARA,PRKCD,PTEN,PTGS2,SPRY2,SRC (family),STAT1,STAT3,STAT5B,STAT6,TP53,Tween 20	 	19 (28)	26	 	 	 	 	 	 	 	 	 	
CDKN2C	transcription regulator	3	 	 	0.000	1.22E-04	2.52E-02	AKT1,CCND1,CDK2,CDK4,CDK6,CDKN1B,CDKN2C,CSF2,estrogen receptor,FOXO1,HNF4A,ICAM1,ISL1,MAPT,MYC,NCOA1,NFATC3,NFkB (complex),NR4A1,P38 MAPK,PRKCD,PTEN,RB1,SOX2,STAT3,ZEB1	 	20 (26)	22	E2F2,tretinoin	TNF	 	 	CDK2,Cyclin D	 	 	 	 	
tetradecanoylphorbol acetate	chemical drug	2	 	 	0.000	1.26E-04	4.28E-02	calpain,CD44,CSF1,DIO2,EGFR,ERBB2,ESR1,F3,Focal adhesion kinase,GATA3,HES1,IL2,ITGAL,ITGB2,Jnk,Mapk,MAPK1,MTOR,MYC,NFATC1,NFATC2,NR4A1,OSM,P38 MAPK,REL,RUNX1,STAT1,tetradecanoylphorbol acetate,TP53,VASP	 	22 (30)	30	 	 	 	ARG1,BAX,calpain,CCNE1,CEACAM1,CSF3,EGF,EIF5A,Focal adhesion kinase,GDF15,GNAI2,HBEGF,HPSE,ICAM1,Ifn gamma,IL23A,Interferon alpha,ITGA2,ITGAL,ITGB2,LYN,MITF,NAB2,putrescine,Retnla,S1PR1,SYK,TNF,TSG101,VASP,VEGFC,VLDLR	ASCL1,CBL,CDK2,DSG3,HMGA2,MKNK1,RARA,SELPLG,SLC6A3,TPO,TSC22D3	 	 	 	 	
NUPR1	transcription regulator	3	 	 	0.000	1.27E-04	1.71E-02	AKT1,ATF4,CDK2,CDK4,CDKN1B,EP300,EPO,ESR1,FOXO1,FOXO3,HNF4A,KLF1,MTOR,MYC,NCOA1,NUPR1,RBL2,SOX2,STAT3	 	19 (19)	15	 	 	 	GDF15,HBEGF	AGRN,CDK2,ETV1,LRP8,MYD88,SIX4,TRERF1	 	 	 	 	
TSG101	transcription regulator	3	 	 	0.000	1.27E-04	1.68E-02	AKT1,AR,ASCL1,CXCR4,EGFR,ERBB2,ERK,FOXO1,GATA1,HNF4A,IRF4,MAPK1,Mek,MET,MYC,NFATC1,NFkB (complex),Nr1h,NR3C1,P38 MAPK,SPRY2,STAT3,STAT5B,TCF7L2,TSG101	 	19 (25)	24	tetradecanoylphorbol acetate	 	 	 	 	 	 	 	 	
zinc sulfate	chemical drug	3	 	 	0.000	1.34E-04	2.07E-02	AKT1,AR,CCND1,CDKN1B,CLOCK,ERBB2,ESR1,FMR1,FOXO1,GATA3,IL10,MAPK1,MAPT,MET,MYC,NFATC1,NFATC2,NR3C1,NR4A1,PI3K (complex),PTEN,RARG,REL,RPS6KB1,SOX2,STAT3,zinc sulfate	 	19 (27)	24	 	 	 	Collagen(s)	TNF	 	 	 	 	
C1GALT1	enzyme	3	 	 	0.000	1.46E-04	2.15E-02	AKT1,C1GALT1,EGFR,ERK,FOXO1,ITGB2,MAPK1,MET,NGF,P38 MAPK,RUNX1,Sfk,SRC,STAT6,SYK	 	13 (15)	13	 	 	 	ITGB2,MET,Sfk	 	 	 	 	 	
ELOC	transcription regulator	3	 	 	0.000	1.55E-04	4.52E-02	AKT1,AR,AURKA,CCND1,CXCR4,ELOC,EP300,ERBB2,HIF1A,MET,MYC,NR2E1,PPARA,PRKCD,PRKCI,PTEN,RASSF1,RNA polymerase II,SMARCD3,SOX2,SPRY2,STAT3,TP53,Ubiquitin,VEGFA,VHL	 	18 (26)	20	 	tretinoin	 	 	 	 	 	 	 	
CST5	other	3	 	 	0.000	1.56E-04	3.93E-02	AR,calpain,CASP3,CASP8,CST5,DICER1,EGFR,FOXO1,HNF4A,IL1B,MTOR,PRKCD,PTEN,Smad,SMAD2,SMAD3,SMAD7,SRC (family),STAT1,STAT3,TBK1,TGFB1,VDR	 	17 (23)	18	 	 	 	 	SMAD2,VASP	 	 	 	 	
FRS3	other	3	 	 	0.000	1.63E-04	1.72E-02	AKT1,ASCL1,CCND1,CXCR4,EGFR,ERBB2,ERK,Focal adhesion kinase,FOXO1,FRS3,Jnk,Mapk,Mek,MET,MYC,NFATC1,P38 MAPK,SPRY2,SRC (family),STAT1,STAT5B,STAT6,TCF7L2,TP53	 	17 (24)	21	 	 	 	 	 	 	 	 	 	
EGF	growth factor	2	 	 	0.000	1.64E-04	4.97E-02	AKT1,AR,c-Src,calpain,DIO2,EGF,EGFR,ERBB2,ESR1,ESRRA,estrogen receptor,Focal adhesion kinase,FOXO1,ISL1,Jnk,Mapk,MET,MTOR,MYC,P38 MAPK,RUNX1,SPRY2,SRC (family),STAT1,STAT3,STAT5B,SYK,TP53,ZEB1	 	21 (29)	29	L-triiodothyronine,tetradecanoylphorbol acetate	SB203580,U0126	 	c-Src,calpain,CBL,CCNE1,CDK2,CEACAM1,Cyclin D,DDX5,FLNA,Focal adhesion kinase,HBEGF,ITGA2,ITGB4,MET,NGF,RHOG,SMAD2,SORBS3,STAM,SYK,VEGFC	ICAM1	 	 	 	 	
propylthiouracil	chemical drug	3	 	 	0.000	1.67E-04	4.00E-02	APP,CaMKII,DIO2,DIO3,EGFR,ERBB2,ERK,IFNG,JUN,L-triiodothyronine,Mapk,MAPK1,P38 MAPK,propylthiouracil,RARA,STAT1,tyrosine kinase,VASP	 	15 (18)	14	 	 	 	 	L-triiodothyronine,TPO	 	 	 	 	
cerdulatinib	chemical drug	3	 	 	0.000	1.74E-04	3.35E-02	AKT1,CD247,cerdulatinib,EP300,FOXO1,JAK,Jnk,Mapk,MAPK1,MYD88,NFkB (complex),P38 MAPK,PRKCD,REL,STAT1,STAT3,STAT5B,STAT6,SYK	 	15 (19)	17	 	 	 	 	SYK	 	 	 	 	
AMFR	transmembrane receptor	3	 	 	0.000	1.79E-04	2.66E-02	AMFR,CD247,CD3D,CD82,CYP2E1,EGFR,ERK,ethanol,Focal adhesion kinase,FOXO1,HMGCR,MAPK1,MET,MYC,NFkB (complex),VCP	 	13 (16)	10	 	 	 	 	 	 	 	 	 	
APBB3	other	3	 	 	0.000	1.85E-04	4.49E-02	APBB3,CD247,CD28,CDKN1B,EGFR,EP300,Focal adhesion kinase,FOXO1,FYN,LYN,MAPK1,MAPT,MYD88,NFATC1,NFkB (complex),PDCD1,PRKCD,REL,STAT1,STAT3,SYK,VAV1,ZAP70	 	16 (23)	19	 	 	 	LYN,SYK	 	 	 	 	 	
pubchem compound 57554513	chemical reagent	3	 	 	0.000	1.96E-04	3.59E-02	CD247,EP300,ERBB2,ERK,Focal adhesion kinase,FOXO1,MAPK1,MYD88,NFkB (complex),PRKCD,PTPRO,pubchem compound 57554513,PXN,REL,STAT3,SYK	 	14 (16)	13	 	 	 	SYK	 	 	 	 	 	
NEUROG2	transcription regulator	1	 	 	0.000	2.05E-04	8.00E-04	NEUROG2	 	2 (1)	1	HEYL	 	 	NEUROD1,PAX6	 	 	 	 	 	
azathioprine	chemical drug	1	 	 	0.000	2.05E-04	4.00E-04	azathioprine	 	2 (1)	1	 	 	 	 	 	 	 	 	 	
CAK	complex	3	 	 	0.000	2.09E-04	3.02E-02	CAK,CCNH,Cdk,CDK2,CDK4,CDK6,CDK7,CDKN1B,ESR1,FOXO1,ISL1,MNAT1,MYC,NCOA1,NFATC3,NR4A1,PPARA,PTEN,RARA,RB1,RBL2,RXRA,SOX2,tretinoin,ZEB1	 	19 (25)	16	 	alitretinoin	 	CDK2	Cyclin D,RARA	 	 	 	 	
N-chlorotaurine	chemical - kinase inhibitor	3	 	 	0.000	2.22E-04	2.16E-02	ESR1,FOXO1,GNRH1,HNF4A,IL1B,IRF4,MAPK1,MET,MYC,N-chlorotaurine,NCOA1,NEUROD1,NFATC4,NFkB (complex),NFKBIA,nitric oxide,NOS2,NR4A1,P38 MAPK,PRKCD,RARA,REL,RUNX1,SNAI1,SRC (family),STAT1,SYK,TNF	 	18 (28)	24	 	 	 	BAX	TNF	 	 	 	 	
CIP2A	other	3	 	 	0.000	2.64E-04	3.96E-02	AURKA,CDKN1B,CIP2A,ERK,ESR1,FOXO1,JUN,Mapk,MAPK1,MAPT,MET,MTORC1,MYC,NCOA1,PAX6,PP2A,RASSF1,SLC6A3,STAT3	 	15 (19)	16	 	 	 	E2F2,LASP1	 	 	 	 	 	
NCoR/SMRT corepressor	complex	3	 	 	0.000	2.80E-04	4.81E-02	AR,ESR2,F3,FOXO1,GPS2,HDAC3,HNF4A,MTOR,NCOA1,NCoR/SMRT corepressor,NCOR1,NCOR2,P38 MAPK,POU2F1,PPARA,PPARD,TGFB1,VDR	 	14 (18)	13	 	 	 	 	 	 	 	 	 	
IL7R MET	complex	3	 	 	0.000	3.00E-04	3.12E-02	AKT1,ERK,Focal adhesion kinase,IL2RG,IL7R MET,Jnk,Mapk,MAPK1,MET,NFkB (complex),NGF,SRC,SRC (family),STAT1,STAT3,STAT6	 	12 (16)	14	 	 	 	 	 	 	 	 	 	
alitretinoin	chemical drug	2	 	 	0.000	3.03E-04	2.26E-02	alitretinoin,CCND1,CDKN1B,estrogen receptor,MAPK1,Nr1h,NR4A1,P38 MAPK,PPARA,RARA,RARB,RARG,RB1,STAT1,VDR	 	13 (15)	14	tretinoin	 	 	BAX,RARA	CAK,CDK2	 	 	 	 	
4-((4-(3,4-dichlorophenyl)-1,2,5-thiadiazol-3-yl)oxy)butan-1-ol	chemical reagent	3	 	 	0.000	3.05E-04	1.51E-02	4-((4-(3,4-dichlorophenyl)-1,2,5-thiadiazol-3-yl)oxy)butan-1-ol,CLOCK,ERK,GRIN2B,LAT,Mapk,MAPK1,NFATC3,NFATC4,NFkB (complex),P38 MAPK,PRKCG,RARA,RTN4,STAT1	 	12 (15)	11	 	 	 	 	 	 	 	 	 	
S1PR1	G-protein coupled receptor	2	 	 	0.000	3.07E-04	1.77E-02	Mapk,MTOR,S1PR1,SRC,STAT3,TGFB1	 	11 (6)	5	SMAD2,tetradecanoylphorbol acetate	 	 	ICAM1	Interferon alpha,TNF	 	 	 	 	
CD47	transmembrane receptor	3	 	 	0.000	3.17E-04	3.47E-02	CD247,CD47,CDC42,CDH5,CDKN1B,EGFR,EP300,estrogen receptor,FOXO1,FYN,LYN,MAPT,MYC,NFATC1,PDCD1,PRKCD,Rac,REL,SIRPA,STAT5B,SYK,TP53,VAV1,ZAP70	 	16 (24)	16	tretinoin	SB203580	 	LYN,SYK	 	 	 	 	 	
Lefty	group	3	 	 	0.000	3.18E-04	1.88E-02	AR,Lefty,LEFTY2,Mapk,MTOR,SMAD2,SP1,STAT3,TGFB1	 	12 (9)	6	 	 	 	 	SMAD2	 	 	 	 	
hydrogen sulfide	chemical - endogenous mammalian	3	 	 	0.000	3.23E-04	1.25E-02	Akt,AKT1,CD247,CLOCK,ERBB2,FOXO1,GATA3,HNF4A,hydrogen sulfide,IL10,IRS1,MAPK1,MAPK14,MYC,NCOA1,NOS3,PI3K (complex),Pkg,PPARA,PTEN,REL,RUNX1,SOX2,STAT3,TGFB1,VASP,ZAP70	 	18 (27)	21	 	 	 	VASP	lead	 	 	 	 	
mevastatin	chemical drug	3	 	 	0.000	3.59E-04	2.20E-02	AR,CCND1,CDK2,CDK5,CLOCK,ERBB2,HNF4A,MAPK1,mevastatin,MTOR,MYC,NCOA1,NFAT5,NFATC1,Nr1h,NR1I2,NR4A1,PTEN,Rac,Ras homolog,RB1,RBL2,RHOA,SOX2,ZAP70	 	16 (25)	18	 	 	 	TNF	CDK2	 	 	 	 	
LYN	kinase	2	 	 	0.000	3.80E-04	2.28E-02	AKT1,CDKN1B,ERK,LYN,MAPK1,NFkB (complex),PDCD1,PRKCD,STAT1,STAT3,SYK	 	11 (11)	10	APBB3,calcimycin,CD47,CSF3,SH3BP2,tetradecanoylphorbol acetate,tretinoin	bosutinib,dasatinib,PP2/AG1879 tyrosine kinase inhibitor	 	 	MITF	 	 	 	 	
PCGF2	transcription regulator	3	 	 	0.000	3.90E-04	4.83E-02	AKT1,AR,CDK2,CDKN1B,CLOCK,ERBB2,ERK,ESR1,FOXO1,Jnk,MAP3K8,MET,MYC,NCOA1,NFATC1,NFATC2,NR3C1,NR4A1,P38 MAPK,PCGF2,PTEN,RB1,SOX2	 	18 (23)	21	 	 	 	 	CCNE1,CDK2	 	 	 	 	
GH1	growth factor	2	 	 	0.000	3.92E-04	4.90E-02	AKT1,AR,CBX5,ERBB2,ERK,GH1,Jnk,Mapk,MAPK1,Mek,NR3C1,SRC,STAT1,STAT3,STAT5B	 	13 (15)	14	L-triiodothyronine,T3-TR-RXR	 	 	 	 	 	 	 	 	
MET	kinase	2	 	 	0.000	3.96E-04	2.67E-02	AKT1,ERK,Focal adhesion kinase,Jnk,Mapk,MAPK1,MET,NFkB (complex),NGF,SRC,SRC (family),STAT3	 	11 (12)	12	c-Src,C1GALT1,EGF,heparan sulfate,ITGB4,MAC,MITF,MNX1,MYD88,PAX6,SAICAR,TNF,vitamin K1	dasatinib,ganglioside GM2,PP2/AG1879 tyrosine kinase inhibitor,SU6657,TPX-0022,U0126	 	Focal adhesion kinase,HBEGF,NGF,TRIM21	 	 	 	 	 	
PIM/FLT3 kinase inhibitor SEL24	chemical drug	3	 	 	0.000	4.04E-04	4.48E-02	AKT1,AR,CDKN1B,FLT3,MAP3K8,Mapk,MAPT,MYC,NFATC1,NFATC2,NFkB (complex),PIM/FLT3 kinase inhibitor SEL24,PIM1,PIM2,PIM3,RUNX1,STAT6	 	13 (17)	12	 	 	 	 	 	 	 	 	 	
SORBS3	other	3	 	 	0.000	4.80E-04	3.70E-02	AR,EGFR,ERBB2,ESR2,FOXO1,GATA1,Jnk,MAPK1,MET,MTOR,MYC,NCOA1,NFATC1,NFATC3,NFATC4,Nr1h,NR3C1,RUNX1,SNAI1,SORBS3,SYK	 	17 (21)	20	EGF	 	 	 	 	 	 	 	 	
calcimycin	chemical reagent	2	 	 	0.000	5.03E-04	3.25E-02	calcimycin,calpain,ERK,F3,Jnk,Mapk,MAPK1,MTOR,NFATC1,NFATC2,P38 MAPK,REL,SRC,STAT6	 	12 (14)	13	 	 	 	calpain,ICAM1,Ifn gamma,LYN,Sfk,TNF	NGF,SYN1,TPO	 	 	 	 	
CLEC7A	transmembrane receptor	2	 	 	0.000	5.40E-04	8.70E-03	CLEC7A,ERK,Jnk,NFATC2,NFATC3,NFkB (complex),P38 MAPK,REL,SYK	 	9 (9)	8	curdlan	 	 	Cr3,CSF3,IL23A,SYK,TNF	 	 	 	 	 	
Interferon alpha	group	2	 	 	0.000	5.41E-04	4.73E-02	CCND1,CD247,Interferon alpha,MAPK1,MKNK1,MTOR,NFkB (complex),NR3C1,P38 MAPK,STAT1,STAT3,STAT5B,STAT6,ZAP70	 	14 (14)	14	androstenediol,FCGR3A/FCGR3B,tetradecanoylphorbol acetate,tretinoin	LY6E,S1PR1,SB203580	 	BAX,CBL,ICAM1,Ifn gamma,MKNK1,NCR2,TRIM21	CCNE1,CDK2	 	 	 	 	
Irs3	other	3	 	 	0.000	5.68E-04	4.65E-02	AKT1,AR,CCND1,CD247,CDKN1B,CLOCK,ERBB2,ESR1,GATA3,IL10,Irs3,MAPK1,MET,MYC,NFATC1,NFATC2,NR3C1,NR4A1,PI3K (complex),PTEN,PTPN11,REL,SOX2,SPRY2,STAT5B,TBK1,TP53,ZAP70	 	18 (28)	25	 	 	 	 	 	 	 	 	 	
NLRC4	other	3	 	 	0.000	5.80E-04	4.72E-02	BAX,calpain,CASP1,CASP7,CCND1,CSF2,estrogen receptor,HNF4A,ICAM1,IL1B,IL33,IRF4,Jnk,Mapk,NFkB (complex),NLRC4,P38 MAPK,PRKCD,STAT1,STAT3,TBK1,TRAF2	 	14 (22)	18	tretinoin	 	 	BAX	 	 	 	 	 	
buparlisib	chemical drug	3	 	 	0.000	5.85E-04	3.22E-02	ADRB,Akt,AKT1,AR,buparlisib,CCND1,CDKN1B,CLOCK,EP300,ERBB2,FOXO1,MET,MTOR,MYC,NFAT5,NFATC1,NFATC2,NR3C1,NR4A1,PI3K (family),PIK3CA,PIK3CG,SOX2,SYK,TP53	 	17 (25)	20	 	 	 	 	 	 	 	 	 	
glabridin	chemical - endogenous non-mammalian	3	 	 	0.000	5.95E-04	4.14E-02	AMPK,CDKN1B,CXCR4,ERBB2,Focal adhesion kinase,FOXO1,glabridin,IL1B,IL2,IRF4,MAPK1,MET,MKNK1,MTOR,MYC,NFkB (complex),Nr1h,NR4A1,Pkc(s),PPARA,PRKCD,REL,SATB1,Sod,SRC (family),STAT1,STAT3	 	18 (27)	23	 	 	 	 	 	 	 	 	 	
Ifn gamma	complex	2	 	 	0.000	5.98E-04	3.22E-02	EGFR,HOXA10,Ifn gamma,IFNG,Jnk,MAPK1,NFkB (complex),P38 MAPK,STAT1,STAT3	 	12 (10)	9	calcimycin,FCGR3A/FCGR3B,Interferon alpha,tetradecanoylphorbol acetate	SB203580	 	ICAM1,MYD88,TNF	 	 	 	 	 	
dasatinib	chemical drug	2	 	 	0.000	6.31E-04	1.76E-02	dasatinib,EGFR,ERK,JUN,MET,P38 MAPK,PRKCD,SRC,SRC (family),STAT3,SYK	 	10 (11)	10	 	 	 	 	Collagen(s),LYN,MET,Sfk,SYK	 	 	 	 	
Sfk	group	2	 	 	0.000	6.61E-04	3.89E-02	EGFR,ERK,Focal adhesion kinase,FOXO1,NFkB (complex),P38 MAPK,RUNX1,Sfk,SRC,STAT3,SYK	 	11 (11)	10	C1GALT1,calcimycin,DAB1,ITGB2,LRP8,SELPLG,TNF,VLDLR	bosutinib,dasatinib,MPIG6B,PP2/AG1879 tyrosine kinase inhibitor,saracatinib	 	CBL,Focal adhesion kinase,ICAM1,SYK	 	 	 	 	 	
(Z)-5-(4-trifluoromethylbenzylidene)thiazolidine-2,4-dione	chemical reagent	3	 	 	0.000	6.81E-04	4.77E-02	(Z)-5-(4-trifluoromethylbenzylidene)thiazolidine-2,4-dione,AKT1,AR,CDKN1B,MAP3K8,MYC,NFATC1,NFATC2,PIM1,PIM2,RUNX1,STAT6	 	12 (12)	9	 	 	 	 	 	 	 	 	 	
TRAF2/3/5	group	3	 	 	0.000	6.86E-04	4.59E-02	HNF4A,IKBKE,Jnk,MAPK1,NFkB (complex),NIK,P38 MAPK,REL,RIPK1,STAT3,TBK1,TRAF2,TRAF2/3/5,TRAF3,TRAF5,ZAP70	 	11 (16)	13	 	 	 	 	 	 	 	 	 	
miconazole	chemical drug	3	 	 	0.000	6.88E-04	4.75E-02	benzo(a)pyrene,clopidogrel,CYP,CYP19A1,CYP1A2,CYP2B6,CYP2C19,CYP2C9,CYP2E1,CYP3A4,ethanol,FOXO1,GATA1,GATA3,Jnk,MAPK1,miconazole,Nr1h,NR3C1,P38 MAPK,STAT1,STAT3,STAT5B,STAT6	 	13 (24)	15	 	 	 	 	 	 	 	 	 	
MIP1	group	3	 	 	0.000	7.05E-04	2.86E-02	CCL15,CCL3,CCL4,ERK,F3,GNAI2,ICAM1,Jnk,Mapk,MAPK1,MIP1,P38 MAPK,PRKCD,STAT1,STAT3,SYK	 	10 (16)	12	 	 	 	 	 	 	 	 	 	
PAX6	transcription regulator	1	 	 	0.000	7.83E-04	3.10E-03	PAX6	 	3 (1)	1	NEUROD1,NEUROG2,tretinoin	SOX2-OCT4-NANOG,TNF,U0126	 	MET,MITF	ASCL1,CDK2,SMAD2	 	 	 	 	
O6-benzylguanine	chemical drug	3	 	 	0.000	9.14E-04	4.53E-02	AKT1,AMPK,CDK2,CLOCK,ERBB2,ESR1,FOXO1,HNF4A,Jnk,MAPK1,MET,MKNK1,MYC,NCOA1,NFATC1,NFATC2,NR4A1,O6-benzylguanine,P38 MAPK,PTEN,SOX2,VASP	 	17 (22)	19	 	 	 	 	CDK2	 	 	 	 	
ITGB2	transmembrane receptor	2	 	 	0.000	9.41E-04	3.87E-02	AKT1,ERK,ITGB2,MAPK1,NFkB (complex),P38 MAPK,STAT1,STAT3,STAT6,SYK	 	10 (10)	10	C1GALT1,Focal adhesion kinase,ICAM1,SELPLG,tetradecanoylphorbol acetate,tretinoin	GDF15,VASP	 	BAX,Sfk,SYK	 	 	 	 	 	
deguelin	chemical drug	3	 	 	0.000	9.55E-04	4.18E-02	Akt,AKT1,AR,CCND1,CLOCK,deguelin,EP300,ERBB2,ESR1,HNF4A,MAPK1,MET,NFAT5,NFATC1,NFATC2,NR4A1,POU5F1,PRKAA,RARG,SH2B2,SMAD3,SOX2,STAT3,STAT5B,TGFB1,TP53,VDR	 	18 (27)	22	 	 	 	BAX	 	 	 	 	 	
CSF3	cytokine	2	 	 	0.000	1.02E-03	4.29E-02	CDKN1B,CSF3,ERK,Jnk,JUN,MAPK1,NFkB (complex),P38 MAPK,RARA,STAT1,SYK	 	11 (11)	10	budesonide,CLEC7A,MYD88,Pam3-Cys-Ser-Lys4,tetradecanoylphorbol acetate,tretinoin	CEACAM1,cyclomaltodextrin,PRDM1,U0126	 	ARG1,BATF,LYN,RARA,SYK	BAX,ICAM1	 	 	 	 	
leuprolide	biologic drug	3	 	 	0.000	1.04E-03	3.02E-02	AKT1,CLOCK,CYP19A1,ERBB2,FOXO1,GATA3,IL10,leuprolide,MAPK1,MAPK3,MET,MYC,NCOA1,NFATC1,NFATC2,NFATC4,PI3K (complex),REL,RUNX1,SNAI1,SOX2,STAT5B,TP53	 	16 (23)	19	 	 	 	BAX	 	 	 	 	 	
SMAD2	transcription regulator	2	 	 	0.000	1.05E-03	4.10E-02	AR,MTOR,SMAD2,SP1,STAT3,TGFB1	 	11 (6)	5	EGF,GNAI2,ITGB6,LASP1,MKNK1,POU2F1,TNF	CST5,Lefty,naftopidil,PAX6,resveratrol,SB203580,tretinoin,U0126	 	S1PR1,VEGFC	 	 	 	 	 	
FMR1	translation regulator	1	 	 	0.000	1.12E-03	4.50E-03	FMR1	 	3 (1)	1	mGluR,Muscarinic cholinergic receptor	U0126	 	 	SYN1	 	 	 	 	
ethylene glycol tetraacetic acid	chemical reagent	2	 	 	0.000	1.25E-03	4.23E-02	calpain,ethylene glycol tetraacetic acid,Mapk,MAPK1,NFATC2,NFkB (complex),P38 MAPK,REL,SYK	 	10 (9)	8	 	 	 	 	calpain,SYK	 	 	 	 	
DUB	group	3	 	 	0.000	1.26E-03	4.51E-02	CASP1,CDKN1B,DIO2,DUB,EGFR,NFATC1,NFATC2,P38 MAPK,PTEN,RARA,REL,RIPK1,STAT5B,TBK1,Usp17le (includes others),USP18,USP2,USP20,USP21,USP33,USP37,USP7,USP8,USP9X,ZAP70	 	12 (25)	13	 	 	 	 	 	 	 	 	 	
acid phosphatase	group	3	 	 	0.000	1.29E-03	1.99E-02	acid phosphatase,ACP1,ACPP,ERBB2,Focal adhesion kinase,Mapk,MAPK1,SRC,SYK,ZAP70	 	9 (10)	7	 	 	 	 	 	 	 	 	 	
BAX	transporter	3	 	 	0.000	1.61E-03	3.98E-02	BAX,calpain,CASP3,CASP8,CDK2,CHEK1,GATA1,HNF4A,ITPR1,Jnk,JUN,MYC,NCOA1,NFATC1,NFATC2,NFATC3,NFATC4,PRKCD,PTEN,RASSF1,SOX2,TBK1,TGFB1,TRAF2	 	16 (24)	18	alitretinoin,androstenediol,DDX5,deguelin,EIF5A,IgG1,Interferon alpha,ITGB2,ITGB4,leuprolide,N-chlorotaurine,NLRC4,resveratrol,SMARCD1,tetradecanoylphorbol acetate,tretinoin,UCN-01	CSF3,Focal adhesion kinase,L-triiodothyronine,NGF,prednisolone,SB203580,tyrphostin AG 127,U0126	 	CDK2,ETV1	 	 	 	 	 	
1,2-dioctanoyl-sn-glycerol	chemical reagent	3	 	 	0.000	1.66E-03	3.44E-02	1,2-dioctanoyl-sn-glycerol,AKT1,ALOX5,CDKN1B,CLOCK,CXCR4,ESR1,FOXO1,NCOA1,NFATC1,Nr1h,NR3C1,Pkc(s),PP2A,PPARA,PRKCD,PTEN,RARG,SOX2,STAT3,TGFB1	 	15 (21)	17	 	 	 	 	 	 	 	 	 	
NEUROD1	transcription regulator	1	 	 	0.000	1.69E-03	3.30E-03	NEUROD1	 	2 (1)	1	ASCL1,NEUROG2,POU3F2,tretinoin	Focal adhesion kinase,TNF	 	PAX6	 	 	 	 	 	
prednisolone	chemical drug	2	 	 	0.000	1.72E-03	3.72E-02	IL1B,MAPT,NFkB (complex),NR3C1,P38 MAPK,prednisolone	 	9 (6)	6	 	 	 	TSC22D3	BAX,HSP90AA1,TNF,TPO	 	 	 	 	
HPSE	enzyme	2	 	 	0.000	1.78E-03	3.04E-02	EGFR,ERK,F3,HPSE,P38 MAPK,SRC,SRC (family),STAT3,STAT5B	 	9 (9)	8	ETV1,tetradecanoylphorbol acetate,TNF	 	 	 	 	 	 	 	 	
ATP7A	transporter	3	 	 	0.000	1.87E-03	4.77E-02	ATP7A,EGFR,ERK,LOX,MAPK1,NFkB (complex),P38 MAPK,PLA2G4A,SRC (family),SYK	 	9 (10)	7	 	 	 	 	 	 	 	 	 	
PD 0325901	chemical drug	1	 	 	0.000	1.91E-03	2.20E-03	PD 0325901	 	2 (1)	1	 	 	 	Retnla	ETV1	 	 	 	 	
B3GAT2	enzyme	1	 	 	0.000	1.96E-03	3.80E-03	B3GAT2	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
CHMP4C	other	1	 	 	0.000	1.96E-03	3.60E-03	CHMP4C	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
EVL	other	1	 	 	0.000	1.96E-03	2.00E-03	EVL	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
UBAP1	other	1	 	 	0.000	1.96E-03	3.60E-03	UBAP1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
dihydroxyphenylethylene glycol	chemical - endogenous mammalian	1	 	 	0.000	1.96E-03	6.70E-03	dihydroxyphenylethylene glycol	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
miR-616-3p (miRNAs w/seed GUCAUUG)	mature microRNA	1	 	 	0.000	1.96E-03	6.50E-03	miR-616-3p (miRNAs w/seed GUCAUUG)	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
FCAR	transmembrane receptor	2	 	 	0.000	2.02E-03	9.60E-03	AKT1,ERK,FCAR,Mapk,MAPK1,SYK	 	6 (6)	5	tretinoin	 	 	SYK	 	 	 	 	 	
GLG1	other	3	 	 	0.000	2.12E-03	4.44E-02	AKT1,calpain,Cr3,Focal adhesion kinase,GLG1,ITGA5,ITGB2,MTOR,P38 MAPK,PRKCD,SYK	 	8 (11)	8	 	 	 	Cr3	 	 	 	 	 	
ITGB6	other	2	 	 	0.000	2.15E-03	4.92E-02	AR,Focal adhesion kinase,ITGB6,Mapk,RAF1,TGFB1	 	10 (6)	5	TNF	 	 	Collagen(s),Focal adhesion kinase,SMAD2	 	 	 	 	 	
CD79A	transmembrane receptor	2	 	 	0.000	2.19E-03	1.65E-02	CD79A,MAPK1,PRKCD,PRMT1,SYK,VASP	 	7 (6)	5	 	CD72,PRDM1	 	CBL,CDK2,SYK,VASP	 	 	 	 	 	
T3-TR-RXR	complex	2	 	 	0.000	2.23E-03	1.19E-02	L-triiodothyronine,T3-TR-RXR	 	5 (2)	2	 	 	 	AKR1C3,GH1	 	 	 	 	 	
15(S)-HETE	chemical - endogenous mammalian	2	 	 	0.000	2.28E-03	4.59E-02	15(S)-HETE,AKT1,EGFR,EP300,F3,MAPK1,P38 MAPK,PPARD,STAT3	 	9 (9)	8	TNF	 	 	 	 	 	 	 	 	
QKI	other	1	 	 	0.000	2.40E-03	5.60E-03	QKI	 	2 (1)	1	 	TNF	 	 	 	 	 	 	 	
GDF15	growth factor	2	 	 	0.000	2.76E-03	2.36E-02	EGFR,ERBB2,GDF15,Hif1,ITGB2,MAPK1	 	7 (6)	5	(-)-epicatechin gallate,MYD88,NUPR1,RASSF1,resveratrol,tetradecanoylphorbol acetate,tretinoin	L-triiodothyronine,PA2G4	 	 	Focal adhesion kinase,ITGB2	 	 	 	 	
SOX2-OCT4-NANOG	complex	2	 	 	0.000	2.81E-03	1.11E-02	NANOG,POU5F1,SOX2,SOX2-OCT4-NANOG	 	5 (4)	3	 	 	 	TCL1A	PAX6	 	 	 	 	
ITGB4	transmembrane receptor	2	 	 	0.000	2.83E-03	3.01E-02	AKT1,EGFR,ITGB4,Mapk,MET,MTOR,NFAT5,SRC,STAT3	 	8 (9)	8	EGF	PP2/AG1879 tyrosine kinase inhibitor,PPP3CA,SYK	 	BAX,MET	 	 	 	 	 	
Collagen(s)	complex	2	 	 	0.000	2.86E-03	4.23E-02	AKT1,Collagen(s),Focal adhesion kinase,MAPK1,P38 MAPK,STAT3,SYK	 	8 (7)	6	ITGA2,ITGB6,L-triiodothyronine,TNF,tretinoin,zinc sulfate	dasatinib,PP2/AG1879 tyrosine kinase inhibitor,resveratrol,SB203580	 	Focal adhesion kinase,SYK,SYK/ZAP	 	 	 	 	 	
VWF	other	2	 	 	0.000	2.92E-03	4.75E-02	EGR1,MAPK1,MYC,P38 MAPK,SYK,VWF	 	9 (6)	5	tretinoin	PKD1	 	SYK	 	 	 	 	 	
SH3BP2	other	2	 	 	0.000	3.02E-03	1.74E-02	AKT1,ERK,Jnk,NFATC2,SH3BP2,SRC (family),STAT1,SYK	 	7 (8)	7	 	 	 	IgG1,LYN,MITF,SYK	 	 	 	 	 	
FLNA	other	2	 	 	0.000	3.07E-03	3.88E-02	AR,calpain,FLNA,Jnk,MAPK1,NFkB (complex),SYK	 	8 (7)	6	EGF,MKNK1	U0126	 	RHOG,SYK	calpain	 	 	 	 	
ITGA2	transmembrane receptor	2	 	 	0.000	3.22E-03	1.10E-02	ERK,Focal adhesion kinase,ITGA2,P38 MAPK,SRC,SYK	 	6 (6)	5	EGF,tetradecanoylphorbol acetate,TNF	NGF	 	CCNE1,CDK2,Collagen(s),Focal adhesion kinase,SYK	 	 	 	 	 	
heparan sulfate	chemical - endogenous mammalian	2	 	 	0.000	3.38E-03	3.12E-02	heparan sulfate,MAPK1,MAPT,MET,NFkB (complex),P38 MAPK,SRC	 	8 (7)	6	 	TNF	 	MET	 	 	 	 	 	
Calcineurin A-Calcineurin B-Runx1	complex	2	 	 	0.000	3.42E-03	8.10E-03	Calcineurin A,Calcineurin A-Calcineurin B-Runx1,Calcineurin B,RUNX1	 	3 (4)	3	 	 	 	 	 	 	 	 	 	
LRP8	transmembrane receptor	2	 	 	0.000	3.56E-03	3.90E-03	AKT1,DAB1,LRP8,MAPT,SRC (family)	 	4 (5)	4	 	NUPR1	 	Sfk	DAB1	 	 	 	 	
ACP1	phosphatase	2	 	 	0.000	3.90E-03	3.08E-02	ACP1,Focal adhesion kinase,Mapk,MAPK1,SRC,SYK,ZAP70	 	7 (7)	6	 	 	 	 	Focal adhesion kinase,SYK	 	 	 	 	
CHD8	enzyme	1	 	 	0.000	3.92E-03	7.70E-03	CHD8	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
FES	kinase	1	 	 	0.000	3.92E-03	2.00E-03	FES	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
FUZ	other	1	 	 	0.000	3.92E-03	9.20E-03	FUZ	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
INK4	group	1	 	 	0.000	3.92E-03	6.50E-03	INK4	 	1 (1)	1	 	 	 	Cyclin D	 	 	 	 	 	
STAM	other	1	 	 	0.000	3.92E-03	3.60E-03	STAM	 	1 (1)	1	EGF	 	 	 	 	 	 	 	 	
abiraterone	chemical drug	1	 	 	0.000	3.92E-03	5.90E-03	abiraterone	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
IL23A	cytokine	2	 	 	0.000	3.98E-03	4.07E-02	IL23A,NFATC1,P38 MAPK,PRKCD,STAT1,STAT3,SYK	 	8 (7)	6	CLEC7A,MYD88,Retnla,tetradecanoylphorbol acetate	SB203580,U0126	 	 	 	 	 	 	 	
VLDLR	transporter	2	 	 	0.000	4.14E-03	6.20E-03	AKT1,DAB1,MAPT,SRC (family),VLDLR	 	4 (5)	4	FXR ligand-FXR-Retinoic acid-RXRα,tetradecanoylphorbol acetate	EGLN	 	Sfk	DAB1,TNF	 	 	 	 	
HOXA3	transcription regulator	1	 	 	0.000	4.17E-03	1.31E-02	HOXA3	 	2 (1)	1	RARA,tretinoin	 	 	 	 	 	 	 	 	
calmidazolium	chemical drug	2	 	 	0.000	4.46E-03	1.29E-02	calmidazolium,F3,Mapk,MAPK1,SRC	 	5 (5)	4	 	 	 	 	 	 	 	 	 	
Muscarinic cholinergic receptor	group	2	 	 	0.000	4.56E-03	8.20E-03	Focal adhesion kinase,Mapk,Muscarinic cholinergic receptor,SYK,ZAP70	 	5 (5)	4	 	 	 	FMR1,Focal adhesion kinase,SYK	 	 	 	 	 	
SAICAR	chemical - endogenous mammalian	2	 	 	0.000	4.57E-03	4.80E-02	EGFR,ERBB2,MAPK1,MET,SAICAR,SYK	 	8 (6)	5	 	 	 	CDK2,MET,SYK	 	 	 	 	 	
dephostatin	chemical reagent	2	 	 	0.000	4.87E-03	2.79E-02	dephostatin,MAPK1,NFASC,P38 MAPK,PRKCD	 	6 (5)	4	 	 	 	 	 	 	 	 	 	
cyclomaltodextrin	chemical drug	2	 	 	0.000	4.95E-03	1.23E-02	cyclomaltodextrin,MTOR,P38 MAPK,PRKCD	 	5 (4)	3	 	 	 	MITF	CSF3,TNF	 	 	 	 	
ganglioside GM2	chemical - endogenous mammalian	2	 	 	0.000	5.32E-03	2.52E-02	c-Src,FGF2,ganglioside GM2,MAPK1,MET,SRC	 	6 (6)	5	TNF	 	 	 	c-Src,MET	 	 	 	 	
NGF	growth factor	1	 	 	0.000	5.54E-03	1.14E-02	NGF	 	3 (1)	1	EGF,MET	calcimycin	 	AGRN,E2F2,SYN1	ASCL1,BAX,CDK2,ITGA2	 	 	 	 	
PKD1	ion channel	1	 	 	0.000	5.62E-03	1.69E-02	PKD1	 	3 (1)	1	MYD88	 	 	 	HBEGF,VWF	 	 	 	 	
indinavir	chemical drug	2	 	 	0.000	5.83E-03	2.49E-02	indinavir,MKNK1,MTOR,P38 MAPK	 	6 (4)	3	 	 	 	 	MKNK1	 	 	 	 	
DHPS	enzyme	1	 	 	0.000	5.88E-03	7.10E-03	DHPS	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
HOXB2	transcription regulator	1	 	 	0.000	5.88E-03	1.70E-02	HOXB2	 	1 (1)	1	tretinoin	 	 	 	 	 	 	 	 	
Mn2+	chemical - endogenous mammalian	1	 	 	0.000	5.88E-03	5.50E-03	Mn2+	 	1 (1)	1	 	 	 	CAPN1	ICAM1	 	 	 	 	
SIX4	transcription regulator	1	 	 	0.000	5.88E-03	9.80E-03	SIX4	 	1 (1)	1	 	NUPR1	 	 	 	 	 	 	 	
SOCS2-AS1	other	1	 	 	0.000	5.88E-03	1.00E-02	SOCS2-AS1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
necrostatin-1s	chemical reagent	1	 	 	0.000	5.88E-03	1.03E-02	necrostatin-1s	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
barium	chemical reagent	2	 	 	0.000	5.88E-03	1.01E-02	barium,ERK,Focal adhesion kinase,Jnk,SRC	 	4 (5)	4	 	 	 	Focal adhesion kinase	 	 	 	 	 	
FTO	enzyme	2	 	 	0.000	6.04E-03	3.29E-02	FTO,MTOR,NFATC3,NFATC4,P38 MAPK,PRKCD	 	6 (6)	5	 	 	 	NFATC4	 	 	 	 	 	
CD151	other	2	 	 	0.000	6.26E-03	4.51E-02	CD151,ERBB2,JUN,P38 MAPK,SRC,STAT3	 	7 (6)	5	MITF	 	 	 	 	 	 	 	 	
pexmetinib	chemical drug	2	 	 	0.000	6.89E-03	1.86E-02	MAPK1,P38 MAPK,pexmetinib,SRC	 	5 (4)	3	 	 	 	 	 	 	 	 	 	
Cr3	complex	2	 	 	0.000	7.13E-03	1.40E-02	Cr3,ERK,ITGB2,PRKCD,SYK	 	5 (5)	4	CLEC7A,GLG1,SB203580	 	 	SYK	 	 	 	 	 	
CEACAM1	transporter	2	 	 	0.000	7.63E-03	4.40E-02	c-Src,CEACAM1,Mapk,SRC (family),STAT3,SYK	 	6 (6)	5	EGF,tetradecanoylphorbol acetate,tretinoin	SB203580	 	c-Src,ICAM1	CSF3,SYK,VEGFC	 	 	 	 	
AKR1C3	enzyme	1	 	 	0.000	7.83E-03	2.28E-02	AKR1C3	 	1 (1)	1	L-triiodothyronine,MAC,T3-TR-RXR	 	 	 	 	 	 	 	 	
EEF2K	kinase	1	 	 	0.000	7.83E-03	1.37E-02	EEF2K	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
Fc receptor	group	2	 	 	0.000	7.87E-03	3.92E-02	ERK,Fc receptor,Focal adhesion kinase,Jnk,NFATC2,SYK	 	6 (6)	5	 	 	 	CBL,Focal adhesion kinase,SYK	 	 	 	 	 	
FCGR2C	transmembrane receptor	2	 	 	0.000	8.19E-03	1.21E-02	FCGR2C,SYK,ZAP70	 	3 (3)	2	 	 	 	SYK	 	 	 	 	 	
curdlan	chemical - endogenous non-mammalian	2	 	 	0.000	8.21E-03	3.77E-02	curdlan,ERK,Jnk,NFkB (complex),P38 MAPK,SYK	 	6 (6)	5	 	 	 	CLEC7A,IgG1,SYK,TNF	SYK/ZAP	 	 	 	 	
budesonide	chemical drug	1	 	 	0.000	9.06E-03	1.71E-02	budesonide	 	2 (1)	1	 	 	 	Calcineurin A,CSF3,TNF,TSC22D3	GNAI2	 	 	 	 	
EIF5A	translation regulator	1	 	 	0.000	9.78E-03	8.30E-03	EIF5A	 	1 (1)	1	tetradecanoylphorbol acetate	 	 	BAX	 	 	 	 	 	
SMARCD1	transcription regulator	1	 	 	0.000	9.78E-03	1.26E-02	SMARCD1	 	1 (1)	1	 	 	 	BAX	 	 	 	 	 	
TDP2	transcription regulator	1	 	 	0.000	9.78E-03	1.99E-02	TDP2	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
ASCL1	transcription regulator	1	 	 	0.000	9.78E-03	2.87E-02	ASCL1	 	2 (1)	1	 	EGLN,NGF,PAX6,tetradecanoylphorbol acetate,tretinoin	 	NEUROD1	 	 	 	 	 	
L-triiodothyronine	chemical - endogenous mammalian	1	 	 	0.000	9.96E-03	4.10E-02	L-triiodothyronine	 	4 (1)	1	 	propylthiouracil	 	AKR1C3,CCNE1,CDK2,Collagen(s),EGF,GH1,RARA,TNF	BAX,GDF15,GNAI2	 	 	 	 	
SOX2-OCT4	complex	2	 	 	0.000	1.03E-02	3.50E-02	POU5F1,SOX2,SOX2-OCT4	 	4 (3)	2	 	 	 	 	 	 	 	 	 	
FCGR3A/FCGR3B	transmembrane receptor	2	 	 	0.000	1.04E-02	2.49E-02	FCGR3A/FCGR3B,P38 MAPK,SYK,ZAP70	 	5 (4)	3	 	 	 	Ifn gamma,Interferon alpha,SYK/ZAP,TNF	SYK	 	 	 	 	
RHOG	enzyme	2	 	 	0.000	1.05E-02	2.31E-02	AKT1,ERK,Jnk,RHOG,SYK	 	5 (5)	4	EGF,FLNA,ICAM1	PP2/AG1879 tyrosine kinase inhibitor	 	SYK	 	 	 	 	 	
alpha2-adrenergic receptor	group	2	 	 	0.000	1.05E-02	6.40E-03	alpha2-adrenergic receptor,Focal adhesion kinase,GNAI2	 	2 (3)	2	 	 	 	Focal adhesion kinase,GNAI2	 	 	 	 	 	
SH2D2A	other	2	 	 	0.000	1.12E-02	1.11E-02	c-Src,SH2D2A,SRC,ZAP70	 	3 (4)	3	 	 	 	c-Src	IgG1	 	 	 	 	
SELPLG	other	2	 	 	0.000	1.13E-02	2.98E-02	ITGB2,MAPK1,SELPLG,SYK	 	5 (4)	3	 	tetradecanoylphorbol acetate	 	ITGB2,Sfk,SYK,TH17 Cytokine	 	 	 	 	 	
prednisolone	chemical drug	1	 	 	0.000	1.17E-02	2.71E-02	prednisolone	 	3 (1)	1	 	 	 	TSC22D3	BAX,HSP90AA1,TNF,TPO	 	 	 	 	
SB203580	chemical - kinase inhibitor	1	 	 	0.000	1.19E-02	1.88E-02	SB203580	 	4 (1)	1	 	 	 	Cr3,TCL1A	ARG1,BAX,CD47,CEACAM1,chondroitin sulfate,Collagen(s),EGF,ICAM1,Ifn gamma,IL23A,Interferon alpha,MITF,MKNK1,SMAD2,TNF,VEGFC	 	 	 	 	
NCR2	transmembrane receptor	2	 	 	0.000	1.23E-02	1.92E-02	NCR2,SYK,ZAP70	 	3 (3)	2	Interferon alpha	 	 	SYK,TNF	 	 	 	 	 	
MAP kinase inhibitor	chemical drug	2	 	 	0.000	1.29E-02	1.13E-02	MAP kinase inhibitor,Mapk,SLC6A3	 	2 (3)	2	 	 	 	SLC6A3	 	 	 	 	 	
(-)-epicatechin gallate	chemical - endogenous non-mammalian	2	 	 	0.000	1.30E-02	2.23E-02	(-)-epicatechin gallate,ERK,Hif1,P38 MAPK	 	4 (4)	3	 	 	 	GDF15	 	 	 	 	 	
RASSF1	other	1	 	 	0.000	1.35E-02	2.52E-02	RASSF1	 	2 (1)	1	 	UCN-01	 	COL4A2,GDF15,HBEGF	 	 	 	 	 	
MYD88	other	1	 	 	0.000	1.37E-02	2.06E-02	MYD88	 	3 (1)	1	Ifn gamma,IL-1R/TLR,SYK,SYK/ZAP,TLR2/3/4/9	NUPR1	 	BATF,CSF3,GDF15,ICAM1,IL23A,MET,PKD1	ARG1,IgG1	 	 	 	 	
DAB1	other	1	 	 	0.000	1.37E-02	2.58E-02	DAB1	 	1 (1)	1	 	LRP8,VLDLR	 	Sfk	 	 	 	 	 	
MFAP2	other	1	 	 	0.000	1.37E-02	1.12E-02	MFAP2	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
POU3F3	transcription regulator	1	 	 	0.000	1.37E-02	3.15E-02	POU3F3	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
recombinant human endostatin	chemical drug	1	 	 	0.000	1.37E-02	8.70E-03	recombinant human endostatin	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone	chemical reagent	2	 	 	0.000	1.37E-02	4.89E-02	carbonyl cyanide p-(trifluoromethoxy)phenylhydrazone,MAPK1,MTOR,PRKCD	 	5 (4)	3	 	 	 	 	 	 	 	 	 	
6-amino-4-(4-phenoxyphenylethylamino)quinazoline	chemical reagent	1	 	 	0.000	1.56E-02	1.07E-02	6-amino-4-(4-phenoxyphenylethylamino)quinazoline	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
AGRN	other	1	 	 	0.000	1.56E-02	2.61E-02	AGRN	 	1 (1)	1	MKNK1,NGF	NUPR1	 	 	 	 	 	 	 	
Calcineurin B	group	1	 	 	0.000	1.56E-02	1.93E-02	Calcineurin B	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
HEYL	transcription regulator	1	 	 	0.000	1.56E-02	1.27E-02	HEYL	 	1 (1)	1	 	 	 	NEUROG2	 	 	 	 	 	
LASP1	transporter	1	 	 	0.000	1.56E-02	1.81E-02	LASP1	 	1 (1)	1	CIP2A	 	 	SMAD2	PPP3CA	 	 	 	 	
MM-401	chemical reagent	1	 	 	0.000	1.56E-02	1.78E-02	MM-401	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
EGLN	group	2	 	 	0.000	1.59E-02	4.43E-02	EGLN,EGLN1,GATA3,KLF2	 	4 (4)	4	 	 	 	 	ASCL1,VLDLR	 	 	 	 	
GTPL714	chemical reagent	2	 	 	0.000	1.62E-02	2.86E-02	Calcineurin A,ERK,GTPL714,Jnk,P38 MAPK	 	4 (5)	4	 	 	 	 	Calcineurin A	 	 	 	 	
MKNK1	kinase	1	 	 	0.000	1.68E-02	4.55E-02	MKNK1	 	2 (1)	1	Interferon alpha	indinavir,SB203580,tetradecanoylphorbol acetate,U0126	 	AGRN,FLNA,KLC1,SMAD2,TNF	 	 	 	 	 	
eptifibatide	biologic drug	2	 	 	0.000	1.71E-02	4.05E-02	eptifibatide,MAPK1,SYK	 	4 (3)	2	 	 	 	SYK	TNF	 	 	 	 	
RARA	ligand-dependent nuclear receptor	1	 	 	0.000	1.72E-02	4.79E-02	RARA	 	3 (1)	1	alitretinoin,CSF3,L-triiodothyronine	CAK,tetradecanoylphorbol acetate	 	HOXA3	TCL1A	 	 	 	 	
HCAR1	G-protein coupled receptor	1	 	 	0.000	1.75E-02	2.00E-02	HCAR1	 	1 (1)	1	 	 	 	 	TNF	 	 	 	 	
INPP4B	phosphatase	1	 	 	0.000	1.75E-02	3.09E-02	INPP4B	 	1 (1)	1	MITF	 	 	 	 	 	 	 	 	
MNX1	transcription regulator	1	 	 	0.000	1.75E-02	2.84E-02	MNX1	 	1 (1)	1	 	 	 	MET	 	 	 	 	 	
CDCP1	other	2	 	 	0.000	1.76E-02	2.93E-02	CDCP1,Focal adhesion kinase,P38 MAPK,SRC	 	4 (4)	3	 	 	 	 	Focal adhesion kinase	 	 	 	 	
MAGT1	enzyme	2	 	 	0.000	1.82E-02	2.36E-02	MAGT1,PRKCD,SYK	 	3 (3)	2	 	 	 	 	SYK	 	 	 	 	
SU6657	chemical - kinase inhibitor	2	 	 	0.000	1.88E-02	4.65E-02	MAPK1,MET,SRC,SU6657	 	4 (4)	3	 	 	 	 	MET	 	 	 	 	
CD72	transmembrane receptor	2	 	 	0.000	1.89E-02	3.76E-02	CD72,ERK,Jnk,SYK	 	4 (4)	3	 	 	 	 	CD79A,SYK	 	 	 	 	
SYK	kinase	1	 	 	0.000	1.91E-02	2.25E-02	SYK	 	2 (1)	1	Alborhagin,APBB3,CD47,CD79A,CLEC1B,CLEC7A,Collagen(s),Cr3,CSF3,curdlan,EFHD2,EGF,eptifibatide,Fc receptor,FCAR,FCGR2C,Fcr,FLNA,ITGA2,ITGB2,MAC,Muscarinic cholinergic receptor,NCR2,pubchem compound 57554513,RHOG,SAICAR,SELPLG,Sfk,SH3BP2,SYK/ZAP,tetradecanoylphorbol acetate,VWF	ACP1,CD72,CEACAM1,cerdulatinib,dasatinib,entospletinib,ethylene glycol tetraacetic acid,FCGR3A/FCGR3B,ibrutinib,lanraplenib,MAGT1,R-348,U0126	 	CDK2,ICAM1,MYD88	ITGB4,TSC22D3	 	 	 	 	
LCOR	transcription regulator	1	 	 	0.000	1.95E-02	1.92E-02	LCOR	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
LINC01139	other	1	 	 	0.000	1.95E-02	1.94E-02	LINC01139	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
PA2G4	transcription regulator	1	 	 	0.000	1.95E-02	2.59E-02	PA2G4	 	1 (1)	1	 	 	 	 	GDF15	 	 	 	 	
POU3F2	transcription regulator	1	 	 	0.000	1.95E-02	3.66E-02	POU3F2	 	1 (1)	1	TNF	 	 	NEUROD1	 	 	 	 	 	
VEGFC	growth factor	1	 	 	0.000	1.95E-02	2.42E-02	VEGFC	 	1 (1)	1	EGF,SMAD2,SYK/ZAP,tetradecanoylphorbol acetate,TNF,tretinoin	CEACAM1,SB203580	 	 	 	 	 	 	 	
androstenediol	chemical - endogenous mammalian	1	 	 	0.000	1.95E-02	8.40E-03	androstenediol	 	1 (1)	1	 	 	 	BAX,estrone,Interferon alpha	 	 	 	 	 	
mGluR	group	1	 	 	0.000	1.95E-02	2.84E-02	mGluR	 	1 (1)	1	 	 	 	FMR1	 	 	 	 	 	
PRDM1	transcription regulator	2	 	 	0.000	1.99E-02	3.77E-02	PDCD1,PRDM1	 	3 (2)	2	 	LILRB1	 	 	CD79A,CSF3,IgG1,SYK/ZAP	 	 	 	 	
opioid	chemical drug	2	 	 	0.000	2.11E-02	2.23E-02	Mapk,MAPT,opioid	 	2 (3)	2	 	 	 	 	 	 	 	 	 	
COL4A2	other	2	 	 	0.000	2.13E-02	3.29E-02	COL4A2,Focal adhesion kinase,MTOR	 	3 (3)	2	RASSF1	 	 	 	Focal adhesion kinase	 	 	 	 	
NCKAP1L	other	1	 	 	0.000	2.14E-02	2.83E-02	NCKAP1L	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
NR2E1	ligand-dependent nuclear receptor	1	 	 	0.000	2.14E-02	2.59E-02	NR2E1	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
VASP	other	1	 	 	0.000	2.14E-02	7.70E-03	VASP	 	1 (1)	1	CD79A,hydrogen sulfide,tetradecanoylphorbol acetate	CST5,Ro31-8220	 	 	ARG1,ITGB2,Retnla	 	 	 	 	
putrescine	chemical - endogenous mammalian	1	 	 	0.000	2.14E-02	1.79E-02	putrescine	 	1 (1)	1	ARG1,tetradecanoylphorbol acetate	 	 	CDK2	 	 	 	 	 	
CDON	other	2	 	 	0.000	2.16E-02	4.02E-02	CDON,NEUROG1,NFATC3,P38 MAPK	 	4 (4)	3	 	 	 	 	 	 	 	 	 	
Pam3-Cys-Ser-Lys4	chemical reagent	1	 	 	0.000	2.18E-02	1.83E-02	Pam3-Cys-Ser-Lys4	 	2 (1)	1	 	 	 	BATF,calpain,CSF3,ICAM1,TNF	 	 	 	 	 	
Retnla	other	2	 	 	0.000	2.19E-02	3.85E-02	Calcineurin A,ERK,Jnk,P38 MAPK,Retnla	 	4 (5)	4	PD 0325901,tetradecanoylphorbol acetate,U0126	VASP	 	Calcineurin A,IL23A	IgG1	 	 	 	 	
CA3	enzyme	2	 	 	0.000	2.29E-02	1.11E-02	CA3,Focal adhesion kinase,SRC	 	2 (3)	2	 	 	 	Focal adhesion kinase	 	 	 	 	 	
HMGA2	enzyme	1	 	 	0.000	2.33E-02	1.17E-02	HMGA2	 	1 (1)	1	 	tetradecanoylphorbol acetate	 	 	 	 	 	 	 	
ITGAL	transmembrane receptor	1	 	 	0.000	2.33E-02	1.42E-02	ITGAL	 	1 (1)	1	GNAI2,ICAM1,resveratrol,tetradecanoylphorbol acetate,tretinoin	 	 	 	 	 	 	 	 	
PPP3CB	phosphatase	1	 	 	0.000	2.33E-02	2.52E-02	PPP3CB	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
miR-148a-3p (and other miRNAs w/seed CAGUGCA)	mature microRNA	1	 	 	0.000	2.33E-02	2.98E-02	miR-148a-3p (and other miRNAs w/seed CAGUGCA)	 	1 (1)	1	 	 	 	 	TNF	 	 	 	 	
RV 538	chemical reagent	1	 	 	0.000	2.52E-02	1.41E-02	RV 538	 	1 (1)	1	 	 	 	 	ICAM1,TNF	 	 	 	 	
SLC6A3	transporter	1	 	 	0.000	2.52E-02	4.23E-02	SLC6A3	 	1 (1)	1	MAP kinase inhibitor	tetradecanoylphorbol acetate	 	 	 	 	 	 	 	
DSG3	other	2	 	 	0.000	2.54E-02	2.81E-02	DSG3,P38 MAPK,SRC (family)	 	3 (3)	2	 	tetradecanoylphorbol acetate	 	 	 	 	 	 	 	
NAB2	transcription regulator	2	 	 	0.000	2.54E-02	3.64E-02	EGR1,EGR2,F3,NAB2	 	3 (4)	3	tetradecanoylphorbol acetate	 	 	 	 	 	 	 	 	
bosutinib	chemical drug	2	 	 	0.000	2.54E-02	2.02E-02	bosutinib,c-Src,SRC,SRC (family)	 	3 (4)	3	 	 	 	 	c-Src,CCNE1,LYN,Sfk	 	 	 	 	
BET	group	1	 	 	0.000	2.71E-02	4.75E-02	BET	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
chondroitin sulfate	chemical - endogenous mammalian	2	 	 	0.000	2.83E-02	3.87E-02	chondroitin sulfate,MAPT,P38 MAPK	 	3 (3)	2	 	SB203580	 	 	 	 	 	 	 	
hydrogen sulfide	chemical - endogenous mammalian	1	 	 	0.000	2.91E-02	1.06E-02	hydrogen sulfide	 	1 (1)	1	 	 	 	VASP	lead	 	 	 	 	
mir-290	microRNA	1	 	 	0.000	2.91E-02	2.80E-02	mir-290	 	1 (1)	1	 	TNF	 	 	CDK2	 	 	 	 	
ARG1	enzyme	1	 	 	0.000	3.10E-02	2.42E-02	ARG1	 	1 (1)	1	CSF3,tetradecanoylphorbol acetate,tretinoin	MYD88,SB203580,VASP	 	putrescine	 	 	 	 	 	
CREB3	transcription regulator	1	 	 	0.000	3.10E-02	3.16E-02	CREB3	 	1 (1)	1	TNF	 	 	 	 	 	 	 	 	
NFATC4	transcription regulator	1	 	 	0.000	3.10E-02	2.25E-02	NFATC4	 	1 (1)	1	FTO	 	 	TNF	 	 	 	 	 	
SYN1	transporter	2	 	 	0.000	3.25E-02	1.89E-02	SRC,SRC (family),SYN1	 	2 (3)	2	NGF,tretinoin	calcimycin,FMR1	 	 	 	 	 	 	 	
IL1RAP	transmembrane receptor	1	 	 	0.000	3.29E-02	1.11E-02	IL1RAP	 	1 (1)	1	 	 	 	TNF	 	 	 	 	 	
c-Src	group	1	 	 	0.000	3.29E-02	3.71E-02	c-Src	 	1 (1)	1	CEACAM1,EGF,HSP90AA1,SH2D2A	bosutinib,ganglioside GM2,PP2/AG1879 tyrosine kinase inhibitor,resveratrol,saracatinib	 	CBL,MET	 	 	 	 	 	
selumetinib	chemical drug	1	 	 	0.000	3.29E-02	1.57E-02	selumetinib	 	1 (1)	1	 	 	 	 	 	 	 	 	 	
C1GALT1	enzyme	2	 	 	0.000	3.29E-02	2.29E-02	C1GALT1,ITGB2,MET	 	2 (3)	2	 	 	 	ITGB2,MET,Sfk	 	 	 	 	 	
complement receptor	complex	2	 	 	0.000	3.46E-02	2.34E-02	complement receptor,Focal adhesion kinase,ITGB2	 	2 (3)	2	 	 	 	Focal adhesion kinase	 	 	 	 	 	
POU2F1	transcription regulator	1	 	 	0.000	3.48E-02	3.31E-02	POU2F1	 	1 (1)	1	TNF,tretinoin	 	 	SMAD2	 	 	 	 	 	
IgG1	complex	1	 	 	0.000	3.67E-02	2.41E-02	IgG1	 	1 (1)	1	BATF,curdlan,SH3BP2	MYD88,PRDM1,Retnla,SH2D2A	 	BAX	 	 	 	 	 	
SRA1	transcription regulator	1	 	 	0.000	3.86E-02	2.91E-02	SRA1	 	1 (1)	1	TNF	 	 	DDX5	 	 	 	 	 	
TRIM21	enzyme	1	 	 	0.000	3.86E-02	2.28E-02	TRIM21	 	1 (1)	1	Interferon alpha,MET	 	 	 	TNF	 	 	 	 	
salvin	chemical toxicant	1	 	 	0.000	3.86E-02	2.22E-02	salvin	 	1 (1)	1	 	 	 	CCNE1	 	 	 	 	 	
BTRC	enzyme	1	 	 	0.000	4.04E-02	4.78E-02	BTRC	 	1 (1)	1	TNF	 	 	 	 	 	 	 	 	
PPP3CA	phosphatase	1	 	 	0.000	4.04E-02	3.34E-02	PPP3CA	 	1 (1)	1	 	LASP1	 	 	ITGB4	 	 	 	 	
calpain	complex	1	 	 	0.000	4.04E-02	2.43E-02	calpain	 	1 (1)	1	calcimycin,EGF,Pam3-Cys-Ser-Lys4,tetradecanoylphorbol acetate,TNF	ethylene glycol tetraacetic acid,FLNA,SYK/ZAP,U0126	 	CDK2	 	 	 	 	 	
ibrutinib	chemical drug	1	 	 	0.000	4.04E-02	2.25E-02	ibrutinib	 	1 (1)	1	 	 	 	 	SYK,TNF	 	 	 	 	
U0126	chemical - kinase inhibitor	1	 	 	0.000	4.07E-02	4.39E-02	U0126	 	3 (1)	1	 	 	 	Focal adhesion kinase,Retnla,TSC22D3	BAX,calpain,CCNE1,CDK2,CSF3,Cyclin D,EGF,FLNA,FMR1,HBEGF,ICAM1,IL23A,MET,MKNK1,PAX6,SMAD2,SYK,TNF	 	 	 	 	
saracatinib	chemical drug	2	 	 	0.000	4.12E-02	2.43E-02	saracatinib,SRC,SRC (family)	 	2 (3)	2	 	 	 	 	c-Src,Sfk	 	 	 	 	
TPX-0022	chemical drug	2	 	 	0.000	4.16E-02	3.67E-02	MET,SRC (family),TPX-0022	 	2 (3)	2	 	 	 	 	MET	 	 	 	 	
BATF	transcription regulator	1	 	 	0.000	4.23E-02	3.49E-02	BATF	 	1 (1)	1	CSF3,MYD88,Pam3-Cys-Ser-Lys4	infliximab	 	IgG1	 	 	 	 	 	
ETV1	transcription regulator	1	 	 	0.000	4.23E-02	3.08E-02	ETV1	 	1 (1)	1	BAX,tretinoin	NUPR1,PD 0325901	 	HPSE,MITF	 	 	 	 	 	
LILRB1	transmembrane receptor	1	 	 	0.000	4.23E-02	3.80E-02	LILRB1	 	1 (1)	1	 	 	 	 	Focal adhesion kinase,PRDM1,TNF	 	 	 	 	
UCN-01	chemical drug	1	 	 	0.000	4.61E-02	2.92E-02	UCN-01	 	1 (1)	1	 	 	 	BAX,CCNE1	CDK2,RASSF1	 	 	 	 	
Calcineurin A	group	1	 	 	0.000	4.80E-02	4.18E-02	Calcineurin A	 	1 (1)	1	budesonide,Retnla,TNF	GTPL714	 	 	 	 	 	 	 	
lead	chemical toxicant	1	 	 	0.000	4.80E-02	4.99E-02	lead	 	1 (1)	1	 	hydrogen sulfide	 	 	 	 	 	 	 	
Focal adhesion kinase	group	1	 	 	0.000	5.17E-02	4.50E-02	Focal adhesion kinase	 	1 (1)	1	alpha2-adrenergic receptor,barium,CA3,Collagen(s),complement receptor,EGF,Fc receptor,ITGA2,ITGB6,MET,Muscarinic cholinergic receptor,Sfk,tetradecanoylphorbol acetate,TNF,tretinoin,U0126,VTN	ACP1,CDCP1,COL4A2,GDF15,LILRB1,PP2/AG1879 tyrosine kinase inhibitor	 	ICAM1,ITGB2	BAX,NEUROD1	 	 	 	 	
GNAI2	enzyme	1	 	 	0.000	5.17E-02	3.13E-02	GNAI2	 	1 (1)	1	alpha2-adrenergic receptor,tetradecanoylphorbol acetate	budesonide,L-triiodothyronine	 	ITGAL,SMAD2	 	 	 	 	 	
VTN	other	1	 	 	0.000	5.17E-02	2.45E-02	VTN	 	1 (1)	1	 	 	 	CBL,Focal adhesion kinase	MAC,TNF	 	 	 	 	
RIPK1	kinase	1	 	 	0.000	6.28E-02	3.05E-02	RIPK1	 	1 (1)	1	 	CBL	 	 	 	 	 	 	 	
KLC1	other	2	 	 	0.000	6.34E-02	4.84E-02	Jnk,KLC1,MAPT	 	2 (3)	2	MKNK1	 	 	 	 	 	 	 	 	
ICAM1	transmembrane receptor	1	 	 	0.000	7.20E-02	3.55E-02	ICAM1	 	1 (1)	1	calcimycin,CEACAM1,Focal adhesion kinase,Ifn gamma,Interferon alpha,MYD88,palmitoyl-Cys((RS)-2,3-di(palmitoyloxy)-propyl)-Ala-Gly-OH,Pam3-Cys-Ser-Lys4,S1PR1,Sfk,SYK,tetradecanoylphorbol acetate,TLR2/3/4/9,tretinoin	CSF3,EGF,Mn2+,PP2/AG1879 tyrosine kinase inhibitor,resveratrol,Ro31-8220,RV 538,SB203580,TSC22D3,U0126	 	ITGAL,ITGB2,RHOG	 	 	 	 	 	
HBEGF	growth factor	1	 	 	0.000	7.75E-02	4.75E-02	HBEGF	 	1 (1)	1	EGF,MET,NUPR1,RASSF1,tetradecanoylphorbol acetate,TNF,tretinoin	PKD1,U0126	 	 	 	 	 	 	 	
ITGB2	transmembrane receptor	1	 	 	0.000	8.29E-02	3.02E-02	ITGB2	 	1 (1)	1	C1GALT1,Focal adhesion kinase,ICAM1,SELPLG,tetradecanoylphorbol acetate,tretinoin	GDF15,VASP	 	BAX,Sfk,SYK	 	 	 	 	 	
Ro31-8220	chemical - kinase inhibitor	1	 	 	0.000	8.47E-02	3.90E-02	Ro31-8220	 	1 (1)	1	 	 	 	 	Cyclin D,ICAM1,VASP	 	 	 	 	
TSC22D3	transcription regulator	1	 	 	0.000	8.83E-02	3.04E-02	TSC22D3	 	1 (1)	1	budesonide,prednisolone,tretinoin,U0126	SYK,tetradecanoylphorbol acetate	 	 	ICAM1	 	 	 	 	

Diseases and Bio Functions for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of pons	7.29E-05	 	 	 	 	CDK5R1,MAP1B	2	
Digestive System Development and Function, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of anus	9.71E-05	 	 	 	 	DACT1,SALL4	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastrointestinal adenocarcinoma	Gastrointestinal adenocarcinoma	1.60E-04	 	 	 	 	SALL4,PRKCQ,RGS17,PIK3R5,TMEM163,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ACTR3B,UBASH3B,GSE1,KIF1B,CDK5R1,ATP10B,ITGA4,ANKS1B,ESRP1	36	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	development	Development of digestive organ tumor	2.18E-04	 	 	 	 	SALL4,RGS17,PIK3R5,TFPI2,TMEM163,B3GAT1,DEPTOR,CHKA,LINGO2,DIP2A,ATP9A,QPCT,CHD9,TMPRSS2,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ESRP1	26	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of neurons	2.74E-04	 	 	 	 	ATP13A2,CDK5R1,DACT1,PRKCQ,SALL4,MAP1B,DPYSL5,NKX2-2	8	
Organismal Injury and Abnormalities	fistula	Fistula	3.13E-04	 	 	 	 	SALL4,ITGA4	2	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long term synaptic depression	Long term synaptic depression of synapse	3.43E-04	 	 	 	 	CDK5R1,MAP1B,DPYSL5	3	
Cell Morphology, Nervous System Development and Function, Neurological Disease, Tissue Morphology	abnormal morphology	Abnormal morphology of neurons	3.92E-04	 	 	 	 	ATP13A2,CDK5R1,DACT1,PRKCQ,SALL4,MAP1B,NKX2-2	7	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of PBMCs	4.12E-04	 	 	 	 	ITGA4,DEPTOR	2	
Cancer, Organismal Injury and Abnormalities	development	Development of carcinoma	4.71E-04	 	 	 	 	SALL4,PRKCQ,RGS17,PIK3R5,TFPI2,TMEM163,B3GAT1,DEPTOR,CHKA,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	32	
Cancer, Organismal Injury and Abnormalities	abdominal adenocarcinoma	Abdominal adenocarcinoma	4.97E-04	 	 	 	 	SALL4,PRKCQ,RGS17,PIK3R5,TMEM163,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ACTR3B,UBASH3B,GSE1,KIF1B,CDK5R1,ATP10B,ITGA4,ANKS1B,ESRP1	38	
Cancer, Organismal Injury and Abnormalities	incidence	Incidence of tumor	6.01E-04	 	 	 	 	SALL4,PRKCQ,RGS17,PIK3R5,TMEM163,B3GAT1,TFPI2,DEPTOR,CHKA,SLC16A3,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	33	
Nervous System Development and Function, Organ Morphology, Organismal Development	size	Size of corpus callosum	7.17E-04	 	 	 	 	CDK5R1,MAP1B	2	
Behavior	spatial learning	Spatial learning	8.24E-04	 	 	 	 	ATP13A2,CDK5R1,QPCT,B3GAT1	4	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of hippocampus layer	8.62E-04	 	 	 	 	CDK5R1,MAP1B	2	
Cellular Movement	migration	Migration of cells	8.74E-04	 	 	 	 	PRKCQ,PIK3R5,B3GAT1,TFPI2,DEPTOR,SLC16A3,DIP2A,GSE1,DMTN,QPCT,CDK5R1,MAP1B,ITGA4,IL17RB,ESRP1	15	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Hypersensitivity Response, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of mast cells	9.39E-04	 	 	 	 	PRKCQ,ITGA4	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	large intestine adenocarcinoma	Large intestine adenocarcinoma	9.91E-04	 	 	 	 	SALL4,PRKCQ,PIK3R5,TMEM163,B3GAT1,TFPI2,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ACTR3B,UBASH3B,GSE1,KIF1B,CDK5R1,ATP10B,ITGA4,ANKS1B,ESRP1	34	
Embryonic Development, Nervous System Development and Function, Organ Development	stratification	Stratification of cerebral cortex	1.02E-03	 	 	 	 	CDK5R1,MAP1B	2	
Cancer, Organismal Injury and Abnormalities	advanced malignant tumor	Advanced malignant tumor	1.06E-03	 	 	 	 	GSE1,KIF1B,QPCT,CST7,TMPRSS2,PIK3R5,TFPI2,ITGA4,ESRP1,SLC16A3	10	
Developmental Disorder	ectopia	Ectopia	1.19E-03	 	 	 	 	CDK5R1,MAP1B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal adenocarcinoma	Colorectal adenocarcinoma	1.25E-03	 	 	 	 	SALL4,ACTR3B,PIK3R5,TMEM163,B3GAT1,LINGO2,UBASH3B,DIP2A,GSE1,ATP9A,KIF1B,QPCT,ATP10B,CHD9,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,IL17RB,ESRP1,NKX2-2	22	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	endometrioid endometrial adenocarcinoma	Endometrioid endometrial adenocarcinoma	1.30E-03	 	 	 	 	SALL4,PRKCQ,LINGO2,ATP9A,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	15	
Cancer, Organismal Injury and Abnormalities	head and neck neoplasia	Head and neck tumor	1.32E-03	 	 	 	 	KLF15,SALL4,PRKCQ,PIK3R5,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,ACTR3B,UBASH3B,GSE1,TTC9,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	36	
Cancer, Organismal Injury and Abnormalities	carcinoma	Carcinoma	1.38E-03	 	 	 	 	KLF15,SALL4,PRKCQ,RGS17,PIK3R5,TMEM163,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,ACTR3B,UBASH3B,GSE1,TTC9,KIF1B,CDK5R1,ATP10B,ITGA4,ANKS1B,ESRP1	41	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	hepatobiliary system cancer	Hepatobiliary system cancer	1.57E-03	 	 	 	 	ATP13A2,PRKCQ,ACTR3B,PIK3R5,TFPI2,B3GAT1,SH3BP5,LINGO2,UBASH3B,DIP2A,KIF1B,CDK5R1,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	23	
Cell-To-Cell Signaling and Interaction, Connective Tissue Development and Function	binding	Binding of fibroblast cell lines	1.63E-03	 	 	 	 	DMTN,CDK5R1,ITGA4	3	
Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal disorder	Colorectal disorder	1.63E-03	 	 	 	 	SALL4,PIK3R5,TFPI2,TMEM163,B3GAT1,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,TMPRSS2,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ESRP1	25	
Nervous System Development and Function	morphology	Morphology of nervous system	1.66E-03	 	 	 	 	ATP13A2,KIF1B,CDK5R1,DACT1,SALL4,PRKCQ,MAP1B,DPYSL5,NKX2-2	9	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	outgrowth	Outgrowth of axons	1.74E-03	 	 	 	 	CDK5R1,KIF1B,MAP1B	3	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Hematological System Development and Function, Immune Cell Trafficking	cell-cell adhesion	Cell-cell adhesion of leukocytes	1.78E-03	 	 	 	 	ITGA4,DEPTOR	2	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	extension	Extension of cellular protrusions	1.83E-03	 	 	 	 	CDK5R1,MAP1B,ITGA4,DPYSL5	4	
Cancer, Organismal Injury and Abnormalities	breast or colorectal cancer	Breast or colorectal cancer	1.85E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,B3GAT1,DEPTOR,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,TMPRSS2,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ESRP1	27	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of hippocampus	1.87E-03	 	 	 	 	CDK5R1,KIF1B,MAP1B	3	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	cancer	Liver cancer	1.87E-03	 	 	 	 	ATP13A2,PRKCQ,ACTR3B,PIK3R5,TFPI2,B3GAT1,SH3BP5,LINGO2,UBASH3B,DIP2A,KIF1B,CDK5R1,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,ANKS1B	22	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of cloaca	1.89E-03	 	 	 	 	DACT1	1	
Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of bronchial epithelial cells	1.89E-03	 	 	 	 	ITGA4	1	
Cell Cycle	G0/G1 phase transition	Arrest in G0/G1 phase transition of peripheral blood lymphocytes	1.89E-03	 	 	 	 	CHKA	1	
Hereditary Disorder, Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities	ataxia-oculomotor apraxia 3	Ataxia-oculomotor apraxia 3	1.89E-03	 	 	 	 	PIK3R5	1	
Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Okihiro syndrome	Autosomal dominant Okihiro syndrome	1.89E-03	 	 	 	 	SALL4	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	autosomal recessive spastic paraplegia type 78	Autosomal recessive spastic paraplegia type 78	1.89E-03	 	 	 	 	ATP13A2	1	
Cell Cycle, Gene Expression	binding	Binding of P1 element	1.89E-03	 	 	 	 	PRKCQ	1	
Cell Cycle, Gene Expression	binding	Binding of positive regulatory domain I	1.89E-03	 	 	 	 	PRKCQ	1	
Connective Tissue Disorders, Developmental Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	caudal agenesis	Caudal agenesis	1.89E-03	 	 	 	 	DACT1	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cell-cell adhesion	Cell-cell adhesion of PBMCs	1.89E-03	 	 	 	 	DEPTOR	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Charcot-Marie-Tooth disease type 2A1	Charcot-Marie-Tooth disease type 2A1	1.89E-03	 	 	 	 	KIF1B	1	
Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response, Tissue Development	accumulation	Delay in accumulation of Th1 cells	1.89E-03	 	 	 	 	PRKCQ	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	differentiation	Delay in differentiation of Th1 cells	1.89E-03	 	 	 	 	PRKCQ	1	
Cell Morphology, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cell spreading	Delay in initiation of cell spreading of neutrophils	1.89E-03	 	 	 	 	PRKCQ	1	
Cellular Development, Cellular Growth and Proliferation, Organ Development, Skeletal and Muscular System Development and Function, Tissue Development	growth	Delay in initiation of growth of myofiber	1.89E-03	 	 	 	 	PRKCQ	1	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	diameter	Diameter of primary dendrite	1.89E-03	 	 	 	 	DPYSL5	1	
Cellular Response to Therapeutics	drug resistance	Drug resistance of myeloma cell lines	1.89E-03	 	 	 	 	ITGA4	1	
Embryonic Development, Organismal Development, Tissue Development	formation	Formation of hindgut	1.89E-03	 	 	 	 	DACT1	1	
Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	IVIC syndrome	IVIC syndrome	1.89E-03	 	 	 	 	SALL4	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	lipofuscinosis	Lipofuscinosis of striatum	1.89E-03	 	 	 	 	ATP13A2	1	
Cellular Function and Maintenance, Cellular Movement, Nervous System Development and Function	localization	Localization of dentate granule cells	1.89E-03	 	 	 	 	CDK5R1	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Organismal Development, Tissue Development	morphogenesis	Morphogenesis of growth cone	1.89E-03	 	 	 	 	MAP1B	1	
Nervous System Development and Function, Organ Morphology, Organismal Development	morphology	Morphology of motor cortex	1.89E-03	 	 	 	 	CDK5R1	1	
Cellular Assembly and Organization, Nervous System Development and Function	origination	Origination of axons	1.89E-03	 	 	 	 	CDK5R1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Parkinson disease 9	Parkinson disease 9	1.89E-03	 	 	 	 	ATP13A2	1	
Cardiovascular Disease, Developmental Disorder, Gastrointestinal Disease, Hereditary Disorder, Organismal Injury and Abnormalities, Respiratory Disease	primary ciliary dyskinesia type 28 with situs inversus	Primary ciliary dyskinesia type 28 with situs inversus	1.89E-03	 	 	 	 	SPAG1	1	
Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Respiratory Disease	primary ciliary dyskinesia type 28 without situs inversus	Primary ciliary dyskinesia type 28 without situs inversus	1.89E-03	 	 	 	 	SPAG1	1	
Nervous System Development and Function, Organ Morphology	reorganization	Reorganization of molecular layer	1.89E-03	 	 	 	 	CDK5R1	1	
Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders	relapsing-remitting multiple sclerosis	Severe relapsing-remitting multiple sclerosis	1.89E-03	 	 	 	 	ITGA4	1	
Cell Morphology, Cellular Development, Nervous System Development and Function, Organ Morphology, Tissue Development	sprouting	Sprouting of mossy fiber cells	1.89E-03	 	 	 	 	CDK5R1	1	
Auditory Disease, Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	Townes-Brocks syndrome 2	Townes-Brocks syndrome 2	1.89E-03	 	 	 	 	DACT1	1	
Developmental Disorder, Endocrine System Disorders, Hereditary Disorder, Organismal Injury and Abnormalities, Reproductive System Disease	X-linked congenital bilateral aplasia of vas deferens	X-linked congenital bilateral aplasia of vas deferens	1.89E-03	 	 	 	 	ADGRG2	1	
Neurological Disease	neurological disorder	Progressive neurological disorder	1.89E-03	 	 	 	 	ATP13A2,KIF1B,QPCT,CDK5R1,MAP1B,ITGA4,FRMD4B,GRIA4,SLC16A3	9	
Nervous System Development and Function, Neurological Disease	abnormal morphology	Abnormal morphology of nervous system	1.98E-03	 	 	 	 	ATP13A2,CDK5R1,KIF1B,DACT1,PRKCQ,SALL4,MAP1B,NKX2-2	8	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	endometrial cancer	Endometrial cancer	2.02E-03	 	 	 	 	SALL4,PRKCQ,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	17	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colorectal cancer	Colorectal cancer	2.05E-03	 	 	 	 	SALL4,ACTR3B,PIK3R5,TFPI2,TMEM163,B3GAT1,SLC16A3,LINGO2,UBASH3B,DIP2A,GSE1,ATP9A,KIF1B,QPCT,ATP10B,CHD9,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,IL17RB,ESRP1,NKX2-2	24	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of commissure	2.11E-03	 	 	 	 	KIF1B,MAP1B	2	
Cancer, Organismal Injury and Abnormalities	metastasis	Secondary tumor	2.18E-03	 	 	 	 	GSE1,KIF1B,QPCT,CST7,TMPRSS2,PIK3R5,ITGA4,ESRP1,SLC16A3	9	
Behavior, Nervous System Development and Function	spatial memory	Spatial memory	2.26E-03	 	 	 	 	CDK5R1,B3GAT1,GRIA4	3	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	development	Development of genital tumor	2.45E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	21	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	hepatobiliary carcinoma	Hepatobiliary carcinoma	2.54E-03	 	 	 	 	ATP13A2,PRKCQ,ACTR3B,PIK3R5,B3GAT1,SH3BP5,LINGO2,UBASH3B,DIP2A,KIF1B,CDK5R1,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	22	
Neurological Disease, Organismal Injury and Abnormalities	progressive encephalopathy	Progressive encephalopathy	2.55E-03	 	 	 	 	ATP13A2,KIF1B,QPCT,CDK5R1,MAP1B,FRMD4B,GRIA4,SLC16A3	8	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	uterine tumor	Uterine tumor	2.78E-03	 	 	 	 	SALL4,PRKCQ,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	18	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	endometrial carcinoma	Endometrial carcinoma	2.82E-03	 	 	 	 	SALL4,PRKCQ,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	16	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	nonpituitary endocrine tumor	Nonpituitary endocrine tumor	2.84E-03	 	 	 	 	KLF15,SALL4,PRKCQ,PIK3R5,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,DIP2A,ATP9A,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,UBASH3B,GSE1,TTC9,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	34	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell rolling	Cell rolling of granulocytes	2.87E-03	 	 	 	 	PRKCQ,ITGA4	2	
Cancer, Organismal Injury and Abnormalities	neck neoplasm	Neck neoplasm	2.91E-03	 	 	 	 	KLF15,SALL4,PRKCQ,PIK3R5,B3GAT1,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,UBASH3B,GSE1,TTC9,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	34	
Cancer, Gastrointestinal Disease, Hepatic System Disease, Organismal Injury and Abnormalities	liver carcinoma	Liver carcinoma	2.95E-03	 	 	 	 	ATP13A2,PRKCQ,ACTR3B,PIK3R5,B3GAT1,SH3BP5,LINGO2,UBASH3B,DIP2A,KIF1B,CDK5R1,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,ANKS1B	21	
Organismal Injury and Abnormalities, Reproductive System Disease	endometrioma	Endometrioma	3.00E-03	 	 	 	 	PRKCQ,SLC16A3	2	
Cellular Assembly and Organization	formation	Formation of actin bundles	3.00E-03	 	 	 	 	DMTN,CDK5R1	2	
Cardiovascular System Development and Function, Cell-To-Cell Signaling and Interaction	binding	Binding of vascular endothelial cells	3.14E-03	 	 	 	 	DIP2A,ITGA4,DEPTOR	3	
Developmental Disorder, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Renal and Urological Disease, Renal and Urological System Development and Function	agenesis	Agenesis of kidney	3.14E-03	 	 	 	 	DACT1,SALL4	2	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis of brain	3.14E-03	 	 	 	 	ATP13A2,QPCT	2	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of brainstem	3.28E-03	 	 	 	 	KIF1B,MAP1B	2	
Cell Signaling, Post-Translational Modification	activation	Activation of Protein kinase	3.33E-03	 	 	 	 	CDK5R1,DEPTOR,SH3BP5,UBASH3B	4	
Cellular Movement	migration	Migration of lymphoma cell lines	3.58E-03	 	 	 	 	PRKCQ,ITGA4	2	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	outgrowth	Outgrowth of neurites	3.64E-03	 	 	 	 	CDK5R1,KIF1B,MAP1B,ITGA4,DPYSL5	5	
Cancer, Organismal Injury and Abnormalities	cancer	Cancer of secretory structure	3.73E-03	 	 	 	 	KLF15,SALL4,PRKCQ,PIK3R5,TMEM163,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,DIP2A,ATP9A,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,UBASH3B,GSE1,TTC9,KIF1B,CDK5R1,ATP10B,ITGA4,ANKS1B,ESRP1	36	
Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	abnormal morphology	Abnormal morphology of blind uterus	3.78E-03	 	 	 	 	DACT1	1	
Gastrointestinal Disease, Immunological Disease, Organismal Injury and Abnormalities	acute intestinal graft versus-host disease	Acute intestinal graft versus-host disease	3.78E-03	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	aggregation	Aggregation of cortical neurons	3.78E-03	 	 	 	 	CDK5R1	1	
Cell-mediated Immune Response, Hematological System Development and Function	anergy	Anergy of CD8+ T lymphocyte	3.78E-03	 	 	 	 	PRKCQ	1	
Cell-To-Cell Signaling and Interaction, Inflammatory Response	antibody-dependent cell-mediated cytotoxicity	Antibody-dependent cell-mediated cytotoxicity of lymph node cells	3.78E-03	 	 	 	 	ITGA4	1	
Cancer, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	neuroblastoma	Autosomal dominant neuroblastoma	3.78E-03	 	 	 	 	KIF1B	1	
Cell Cycle, Gene Expression	binding	Binding of CD28RE/AP response element	3.78E-03	 	 	 	 	PRKCQ	1	
Cell Signaling, Nucleic Acid Metabolism, Small Molecule Biochemistry	binding	Binding of cyclic AMP	3.78E-03	 	 	 	 	MAP1B	1	
Gastrointestinal Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	chronic pouchitis	Chronic pouchitis	3.78E-03	 	 	 	 	ITGA4	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Ophthalmic Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	congenital fibrosis of extraocular muscles type 1	Congenital fibrosis of extraocular muscles type 1	3.78E-03	 	 	 	 	MAP1B	1	
Connective Tissue Disorders, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	destruction	Destruction of knee joint	3.78E-03	 	 	 	 	PRKCQ	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of pontine nucleus	3.78E-03	 	 	 	 	MAP1B	1	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	development	Development of serotonergic neurons	3.78E-03	 	 	 	 	NKX2-2	1	
Neurological Disease, Organismal Injury and Abnormalities	dysplasia	Dysplasia of neurons	3.78E-03	 	 	 	 	CDK5R1	1	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis of mesencephalon	3.78E-03	 	 	 	 	ATP13A2	1	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis of striatum	3.78E-03	 	 	 	 	ATP13A2	1	
Inflammatory Disease, Neurological Disease, Skeletal and Muscular Disorders	relapsing-remitting multiple sclerosis	Highly active disease stage relapsing-remitting multiple sclerosis	3.78E-03	 	 	 	 	ITGA4	1	
Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities	hypoplasia	Hypoplasia of red nucleus	3.78E-03	 	 	 	 	NKX2-2	1	
Cellular Development	differentiation	Initiation of differentiation of neuroblastoma cell lines	3.78E-03	 	 	 	 	CHKA	1	
Cardiovascular System Development and Function, Cell Morphology, Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	innervation	Innervation of heart	3.78E-03	 	 	 	 	ITGA4	1	
Developmental Disorder, Hereditary Disorder, Metabolic Disease, Neurological Disease, Organismal Injury and Abnormalities	lipofuscinosis	Lipofuscinosis of hippocampus	3.78E-03	 	 	 	 	ATP13A2	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long term synaptic depression	Long term synaptic depression of excitatory synapses	3.78E-03	 	 	 	 	DPYSL5	1	
Cellular Movement	migration	Migration of cord blood cells	3.78E-03	 	 	 	 	ITGA4	1	
Cell Morphology, Nervous System Development and Function, Organ Morphology, Organismal Development, Tissue Morphology	morphology	Morphology of dentate granule cells	3.78E-03	 	 	 	 	CDK5R1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	nocturnal frontal lobe epilepsy type 5	Nocturnal frontal lobe epilepsy type 5	3.78E-03	 	 	 	 	SPAG1	1	
Small Molecule Biochemistry	phosphorylation	Phosphorylation of choline	3.78E-03	 	 	 	 	CHKA	1	
Cellular Assembly and Organization, Organ Morphology, Skeletal and Muscular System Development and Function, Tissue Morphology	quantity	Quantity of myonuclei	3.78E-03	 	 	 	 	PRKCQ	1	
Cancer, Neurological Disease, Organismal Injury and Abnormalities, Tissue Morphology, Tumor Morphology	size	Size of brain tumor	3.78E-03	 	 	 	 	B3GAT1	1	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	spinal muscular atrophy proximal adult dominant	Spinal muscular atrophy proximal adult dominant	3.78E-03	 	 	 	 	KIF1B	1	
Cancer, Immunological Disease, Organismal Injury and Abnormalities	spleen metastasis	Spleen metastasis	3.78E-03	 	 	 	 	ITGA4	1	
Cell Death and Survival, Organismal Survival	survival	Survival of Escherichia coli 25922	3.78E-03	 	 	 	 	TFPI2	1	
Cellular Movement, Hematological System Development and Function, Hypersensitivity Response, Immune Cell Trafficking	trafficking	Trafficking of eosinophils	3.78E-03	 	 	 	 	ITGA4	1	
Cellular Movement	transendothelial migration	Transendothelial migration of chronic lymphocytic leukemia cells	3.78E-03	 	 	 	 	ITGA4	1	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis	4.07E-03	 	 	 	 	ATP13A2,CDK5R1,QPCT	3	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colon cancer	Colon cancer	4.61E-03	 	 	 	 	ACTR3B,PIK3R5,TFPI2,TMEM163,B3GAT1,LINGO2,UBASH3B,DIP2A,GSE1,KIF1B,QPCT,ATP10B,CHD9,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,IL17RB,ESRP1,NKX2-2	21	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital tract adenocarcinoma	Female genital tract adenocarcinoma	4.75E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,SLC16A3,LINGO2,ATP9A,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	18	
Cell-To-Cell Signaling and Interaction, Renal and Urological System Development and Function	adhesion	Adhesion of kidney cell lines	5.04E-03	 	 	 	 	CDK5R1,ITGA4	2	
Cancer, Organismal Injury and Abnormalities	development	Development of adenocarcinoma	5.11E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,B3GAT1,LINGO2,DMTN,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	22	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	colon adenocarcinoma	Colon adenocarcinoma	5.15E-03	 	 	 	 	ACTR3B,PIK3R5,TMEM163,B3GAT1,LINGO2,UBASH3B,DIP2A,GSE1,KIF1B,QPCT,ATP10B,CHD9,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,IL17RB,ESRP1,NKX2-2	20	
Organismal Injury and Abnormalities	atresia	Atresia	5.22E-03	 	 	 	 	DACT1,SALL4	2	
Cellular Development	differentiation	Differentiation of neuroblastoma cell lines	5.22E-03	 	 	 	 	KIF1B,CHKA	2	
Cancer, Organismal Injury and Abnormalities	endometrioid carcinoma	Endometrioid carcinoma	5.27E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,LINGO2,ATP9A,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	16	
Gastrointestinal Disease, Inflammatory Disease	Crohn disease	Crohn disease	5.36E-03	 	 	 	 	PRKCQ,B3GAT1,ITGA4,FRMD4B	4	
Cellular Assembly and Organization	quantity	Quantity of nucleus	5.40E-03	 	 	 	 	PRKCQ,SALL4	2	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of genital tubercle	5.66E-03	 	 	 	 	DACT1	1	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of presomitic mesoderm	5.66E-03	 	 	 	 	DACT1	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Humoral Immune Response, Immune Cell Trafficking	adhesion	Adhesion of Ab-secreting B cells	5.66E-03	 	 	 	 	ITGA4	1	
Cancer, Hematological Disease, Organismal Injury and Abnormalities	bone marrow metastasis	Bone marrow metastasis	5.66E-03	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction, Cell-mediated Immune Response, Cellular Assembly and Organization, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell-cell adhesion	Cell-cell adhesion of T lymphocytes	5.66E-03	 	 	 	 	DEPTOR	1	
Gastrointestinal Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	Crohn disease of ileocolon	Crohn disease of ileocolon	5.66E-03	 	 	 	 	ITGA4	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of superior olivary nucleus	5.66E-03	 	 	 	 	CDK5R1	1	
Cellular Assembly and Organization, Developmental Disorder	ectopia	Ectopia of nucleus	5.66E-03	 	 	 	 	CDK5R1	1	
Behavior	endurance training	Endurance training	5.66E-03	 	 	 	 	KLF15	1	
Cellular Development	epithelial-mesenchymal transition	Epithelial-mesenchymal transition of endothelial cell lines	5.66E-03	 	 	 	 	ESRP1	1	
Tissue Development, Tissue Morphology	expansion	Expansion of neuroepithelium	5.66E-03	 	 	 	 	NKX2-2	1	
Gastrointestinal Disease, Inflammatory Disease, Organismal Injury and Abnormalities	fistulizing Crohn disease	Fistulizing Crohn disease	5.66E-03	 	 	 	 	ITGA4	1	
Nervous System Development and Function, Tissue Development	formation	Formation of axon bundle	5.66E-03	 	 	 	 	MAP1B	1	
Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Renal and Urological Disease, Renal and Urological System Development and Function	fusion	Fusion of kidney	5.66E-03	 	 	 	 	DACT1	1	
Infectious Diseases, Organismal Injury and Abnormalities, Renal and Urological Disease	HIV associated nephropathy	HIV associated nephropathy	5.66E-03	 	 	 	 	KLF15	1	
Organismal Injury and Abnormalities, Reproductive System Disease	hydrometrocolpos	Hydrometrocolpos	5.66E-03	 	 	 	 	DACT1	1	
Developmental Disorder, Organismal Injury and Abnormalities, Renal and Urological Disease	hypoplasia	Hypoplasia of ureter	5.66E-03	 	 	 	 	DACT1	1	
Cellular Development, Nervous System Development and Function, Tissue Development	differentiation	Initiation of differentiation of neurons	5.66E-03	 	 	 	 	CHKA	1	
Digestive System Development and Function, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	lack	Lack of anus	5.66E-03	 	 	 	 	DACT1	1	
Cardiovascular System Development and Function, Embryonic Development, Hematological System Development and Function, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	lymphangiogenesis	Lymphangiogenesis of thoracic duct	5.66E-03	 	 	 	 	ITGA4	1	
Cell Morphology, Cellular Assembly and Organization, Nervous System Development and Function	orientation	Orientation of dendrites	5.66E-03	 	 	 	 	CDK5R1	1	
Cellular Function and Maintenance, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	retention	Retention of monocytes	5.66E-03	 	 	 	 	ITGA4	1	
Nervous System Development and Function	segregation	Segregation of thalamic nucleus	5.66E-03	 	 	 	 	CDK5R1	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	stabilization	Stabilization of lamellipodia	5.66E-03	 	 	 	 	ITGA4	1	
Molecular Transport, Protein Trafficking	transport	Transport of reporter protein	5.66E-03	 	 	 	 	MAP1B	1	
Developmental Disorder, Organismal Injury and Abnormalities, Renal and Urological Disease	urethral atresia	Urethral atresia	5.66E-03	 	 	 	 	DACT1	1	
Cancer, Endocrine System Disorders, Organismal Injury and Abnormalities	epithelial thyroid cancer	Thyroid carcinoma	5.73E-03	 	 	 	 	KLF15,SALL4,PRKCQ,PIK3R5,B3GAT1,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,DIP2A,ATP9A,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,UBASH3B,GSE1,TTC9,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	33	
Gastrointestinal Disease, Organismal Injury and Abnormalities	megacolon	Megacolon	5.77E-03	 	 	 	 	DACT1,SALL4	2	
Behavior, Nervous System Development and Function	memory	Memory	5.77E-03	 	 	 	 	CDK5R1,QPCT,B3GAT1,GRIA4	4	
Cancer, Organismal Injury and Abnormalities	extracranial solid tumor	Extracranial solid tumor	5.79E-03	 	 	 	 	KLF15,SALL4,PRKCQ,RGS17,PIK3R5,TMEM163,B3GAT1,TFPI2,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,ACTR3B,UBASH3B,GSE1,TTC9,KIF1B,CDK5R1,ATP10B,ITGA4,ANKS1B,ESRP1	41	
Organismal Injury and Abnormalities	pathological cyst	Pathological Cyst	5.87E-03	 	 	 	 	DACT1,PRKCQ,SLC16A3	3	
Cell-To-Cell Signaling and Interaction, Embryonic Development	adhesion	Adhesion of embryonic cell lines	5.96E-03	 	 	 	 	DMTN,ITGA4	2	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of olfactory bulb	6.15E-03	 	 	 	 	CDK5R1,MAP1B	2	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	migration	Migration of phagocytes	6.15E-03	 	 	 	 	QPCT,PRKCQ,PIK3R5,ITGA4	4	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	skin cancer	Skin cancer	6.19E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,B3GAT1,CHKA,DPYSL5,LINGO2,ATP9A,QPCT,DACT1,CHD9,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	27	
Cancer, Organismal Injury and Abnormalities	genitourinary adenocarcinoma	Genitourinary adenocarcinoma	6.25E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,SH3BP5,SLC16A3,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,GRIA4,ATP13A2,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	25	
Cancer, Dermatological Diseases and Conditions, Organismal Injury and Abnormalities	cutaneous melanoma	Cutaneous melanoma	6.40E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,B3GAT1,CHKA,DPYSL5,LINGO2,ATP9A,QPCT,DACT1,CHD9,MAP1B,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	26	
Behavior	learning	Learning	6.49E-03	 	 	 	 	ATP13A2,QPCT,CDK5R1,B3GAT1,GRIA4	5	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	non-germinomatous germ cell tumor	Non-germinomatous germ cell tumor	6.74E-03	 	 	 	 	SALL4,ESRP1	2	
Cancer, Organismal Injury and Abnormalities	melanoma	Melanoma	7.11E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,B3GAT1,DEPTOR,CHKA,DPYSL5,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,ACTR3B,UBASH3B,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	29	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	formation	Formation of filopodia	7.21E-03	 	 	 	 	PRKCQ,MAP1B,DPYSL5	3	
Cancer, Organismal Injury and Abnormalities	head and neck carcinoma	Head and neck carcinoma	7.23E-03	 	 	 	 	KLF15,SALL4,PRKCQ,PIK3R5,B3GAT1,DEPTOR,CHKA,DPYSL5,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,DACT1,CST7,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,NKX2-2,ATP13A2,ZNF239,UBASH3B,GSE1,TTC9,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	34	
Hematological System Development and Function, Lymphoid Tissue Structure and Development, Tissue Morphology	quantity	Quantity of natural killer T lymphocytes	7.35E-03	 	 	 	 	PRKCQ,IL17RB	2	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	T-cell large granular lymphocytic leukemia	T-cell large granular lymphocytic leukemia	7.35E-03	 	 	 	 	B3GAT1,FRMD4B	2	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of cingulate gyrus	7.54E-03	 	 	 	 	MAP1B	1	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of parietal lobe	7.54E-03	 	 	 	 	MAP1B	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of bone marrow-derived dendritic cells	7.54E-03	 	 	 	 	ITGA4	1	
Gastrointestinal Disease, Organismal Injury and Abnormalities	atresia	Atresia of anal canal	7.54E-03	 	 	 	 	SALL4	1	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of lymphoma cell lines	7.54E-03	 	 	 	 	UBASH3B	1	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	behavioral variant frontotemporal dementia	Behavioral variant frontotemporal dementia	7.54E-03	 	 	 	 	GRIA4	1	
Cell-To-Cell Signaling and Interaction	binding	Binding of Pseudomonas aeruginosa	7.54E-03	 	 	 	 	TFPI2	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Hematopoiesis	binding	Binding of T lymphoblasts	7.54E-03	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	binding	Binding of bone-marrow-derived monocyte/macrophage precursor cells	7.54E-03	 	 	 	 	ITGA4	1	
Neurological Disease	chromatolysis	Chromatolysis	7.54E-03	 	 	 	 	CDK5R1	1	
Amino Acid Metabolism, Post-Translational Modification, Small Molecule Biochemistry	conversion	Conversion of glutamine	7.54E-03	 	 	 	 	QPCT	1	
Gastrointestinal Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	Crohn disease of colon	Crohn disease of colon	7.54E-03	 	 	 	 	ITGA4	1	
Cancer, Cell-To-Cell Signaling and Interaction, Inflammatory Response	cytotoxic reaction	Cytotoxic reaction of neuroblastoma cell lines	7.54E-03	 	 	 	 	CDK5R1	1	
Cellular Compromise, Inflammatory Response	degranulation	Degranulation of basophils	7.54E-03	 	 	 	 	IL17RB	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of inferior olivary nucleus	7.54E-03	 	 	 	 	CDK5R1	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of mitral cell layer	7.54E-03	 	 	 	 	CDK5R1	1	
Cellular Compromise	fragmentation	Fragmentation of cellular membrane	7.54E-03	 	 	 	 	DMTN	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Skeletal and Muscular System Development and Function	fusion	Fusion of skeletal muscle satellite cells	7.54E-03	 	 	 	 	PRKCQ	1	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	lack	Lack of Purkinje's layer of cerebellum	7.54E-03	 	 	 	 	CDK5R1	1	
Cell Morphology, Nervous System Development and Function, Neurological Disease	lack	Lack of oligodendrocytes	7.54E-03	 	 	 	 	NKX2-2	1	
Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Renal and Urological Disease, Renal and Urological System Development and Function	lack	Lack of urinary bladder	7.54E-03	 	 	 	 	DACT1	1	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	primary pancreatic ductal adenocarcinoma	Primary pancreatic ductal adenocarcinoma	7.54E-03	 	 	 	 	CDK5R1	1	
Cellular Movement, Nervous System Development and Function	scattering	Scattering of granule cells	7.54E-03	 	 	 	 	CDK5R1	1	
Cellular Assembly and Organization	segregation	Segregation of nucleus	7.54E-03	 	 	 	 	CDK5R1	1	
Digestive System Development and Function, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of large intestine	7.56E-03	 	 	 	 	DACT1,SALL4	2	
Cell Morphology	morphology	Morphology of cellular protrusions	7.83E-03	 	 	 	 	DMTN,CDK5R1,MAP1B,DPYSL5	4	
Cellular Compromise, Lipid Metabolism, Small Molecule Biochemistry	peroxidation	Peroxidation of lipid	8.21E-03	 	 	 	 	KLF15,SH3BP5	2	
Cancer, Organismal Injury and Abnormalities	pelvic adenocarcinoma	Pelvic adenocarcinoma	8.25E-03	 	 	 	 	ATP13A2,SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	23	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cellular infiltration	Cellular infiltration by lymphocytes	8.40E-03	 	 	 	 	PRKCQ,ITGA4,IL17RB	3	
Nervous System Development and Function, Organ Morphology, Organismal Development	size	Size of brain	9.03E-03	 	 	 	 	CDK5R1,KIF1B,MAP1B	3	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	cell-cell contact	Cell-cell contact	9.08E-03	 	 	 	 	CDK5R1,DACT1,PRKCQ,ITGA4,DEPTOR,LINGO2	6	
Cellular Development, Cellular Growth and Proliferation, Renal and Urological System Development and Function	cell proliferation	Cell proliferation of kidney cell lines	9.36E-03	 	 	 	 	QPCT,SALL4,CHKA	3	
Cell-To-Cell Signaling and Interaction	aggregation	Aggregation of cells	9.41E-03	 	 	 	 	DMTN,CDK5R1,PRKCQ,UBASH3B	4	
Cellular Function and Maintenance, Hematological Disease, Hematological System Development and Function, Tissue Development	function	Abnormal function of dense granule in blood platelets	9.42E-03	 	 	 	 	PRKCQ	1	
Developmental Disorder, Tissue Morphology	abnormal morphology	Abnormal morphology of dilated allantois	9.42E-03	 	 	 	 	ITGA4	1	
Embryonic Development, Nervous System Development and Function, Ophthalmic Disease, Organ Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Development, Visual System Development and Function	abnormal morphology	Abnormal morphology of disorganized outer nuclear layer	9.42E-03	 	 	 	 	MAP1B	1	
Connective Tissue Development and Function, Connective Tissue Disorders, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders, Skeletal and Muscular System Development and Function, Tissue Development	abnormal morphology	Abnormal morphology of ilium	9.42E-03	 	 	 	 	DACT1	1	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of inferior olivary nucleus	9.42E-03	 	 	 	 	MAP1B	1	
Cell-To-Cell Signaling and Interaction, Cellular Compromise, Tumor Morphology	adhesion	Adhesion of small cell lung cancer cells	9.42E-03	 	 	 	 	ITGA4	1	
Cell Cycle	G0/G1 phase transition	Arrest in G0/G1 phase transition of leukemia cell lines	9.42E-03	 	 	 	 	CHKA	1	
Cell-To-Cell Signaling and Interaction	binding	Binding of Escherichia coli 25922	9.42E-03	 	 	 	 	TFPI2	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	binding	Binding of monocyte-derived dendritic cells	9.42E-03	 	 	 	 	ITGA4	1	
Cellular Compromise	degradation	Degradation of autophagosomes	9.42E-03	 	 	 	 	ATP13A2	1	
Cell-To-Cell Signaling and Interaction	delamination	Delamination of Purkinje's layer of cerebellum	9.42E-03	 	 	 	 	CDK5R1	1	
Carbohydrate Metabolism, Molecular Transport, Small Molecule Biochemistry	deposition	Deposition of proteoglycan	9.42E-03	 	 	 	 	B3GAT1	1	
Digestive System Development and Function, Embryonic Development, Organ Development, Organismal Development, Tissue Development	development	Development of anorectum	9.42E-03	 	 	 	 	SALL4	1	
Nervous System Development and Function, Tissue Development	development	Development of fiber tract	9.42E-03	 	 	 	 	MAP1B	1	
Cancer, Cellular Growth and Proliferation, Organismal Functions, Organismal Injury and Abnormalities, Tumor Morphology	inhibition	Inhibition of mammary tumor cells	9.42E-03	 	 	 	 	ATP9A	1	
Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	lack	Lack of external genitalia	9.42E-03	 	 	 	 	DACT1	1	
Cell Morphology, Cellular Development, Embryonic Development, Nervous System Development and Function, Tissue Development	lamination	Lamination of neurons	9.42E-03	 	 	 	 	CDK5R1	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Compromise, Cellular Function and Maintenance	loss	Loss of microtubules	9.42E-03	 	 	 	 	MAP1B	1	
Nervous System Development and Function	memory extinction	Memory extinction	9.42E-03	 	 	 	 	CDK5R1	1	
Cellular Movement	mobility	Mobility of embryonic cell lines	9.42E-03	 	 	 	 	DMTN	1	
Digestive System Development and Function, Embryonic Development, Organismal Development, Tissue Development	morphogenesis	Morphogenesis of embryonic hindgut	9.42E-03	 	 	 	 	DACT1	1	
Neurological Disease, Organismal Injury and Abnormalities	pharmacologically induced seizure	Pharmacologically induced seizure	9.42E-03	 	 	 	 	GRIA4	1	
Tissue Morphology	quantity	Quantity of E. coli	9.42E-03	 	 	 	 	TFPI2	1	
Tissue Morphology	quantity	Quantity of acute myeloblastic leukemia cells	9.42E-03	 	 	 	 	SALL4	1	
Cell-To-Cell Signaling and Interaction, Cellular Movement	recruitment	Recruitment of leukemia cell lines	9.42E-03	 	 	 	 	ITGA4	1	
Gastrointestinal Disease, Inflammatory Disease	Crohn disease	Refractory Crohn disease	9.42E-03	 	 	 	 	ITGA4	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	tumorigenesis	Tumorigenesis of reproductive tract	9.63E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	20	
Cellular Assembly and Organization	binding	Binding of cellular membrane	9.82E-03	 	 	 	 	DMTN,PRKCQ	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital neoplasm	Female genital neoplasm	9.86E-03	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,FRMD4B,GRIA4,ANKS1B,ESRP1	20	
Cell Signaling, Molecular Transport, Vitamin and Mineral Metabolism	mobilization	Mobilization of Ca2+	1.00E-02	 	 	 	 	DMTN,PRKCQ,RGS17,SH3BP5	4	
Cellular Movement	invasion	Invasion of tumor cell lines	1.03E-02	 	 	 	 	GSE1,CDK5R1,PRKCQ,PIK3R5,TFPI2,ITGA4,ESRP1	7	
Cell-To-Cell Signaling and Interaction, Connective Tissue Development and Function	adhesion	Adhesion of fibroblast cell lines	1.03E-02	 	 	 	 	DMTN,CDK5R1	2	
Cellular Movement	transmigration	Transmigration of myeloid cells	1.03E-02	 	 	 	 	PRKCQ,ITGA4	2	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of mononuclear leukocytes	1.03E-02	 	 	 	 	QPCT,PRKCQ,ITGA4,DEPTOR,IL17RB	5	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Inflammatory Response	aggregation	Aggregation of blood platelets	1.07E-02	 	 	 	 	DMTN,PRKCQ,UBASH3B	3	
Cellular Movement, Nervous System Development and Function	guidance	Guidance of axons	1.07E-02	 	 	 	 	CDK5R1,PRKCQ,DPYSL5	3	
Cell Morphology, Cellular Assembly and Organization	morphology	Morphology of filaments	1.08E-02	 	 	 	 	DMTN,MAP1B	2	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of hindgut	1.13E-02	 	 	 	 	DACT1	1	
Cell Morphology, Nervous System Development and Function, Neurological Disease, Tissue Morphology	abnormal morphology	Abnormal morphology of serotonergic neurons	1.13E-02	 	 	 	 	NKX2-2	1	
Developmental Disorder, Embryonic Development, Organismal Development, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease, Tissue Morphology	abnormal morphology	Abnormal morphology of urogenital sinus	1.13E-02	 	 	 	 	DACT1	1	
Developmental Disorder, Hereditary Disorder, Organismal Injury and Abnormalities, Reproductive System Disease	androgen insensitivity	Androgen insensitivity	1.13E-02	 	 	 	 	FRMD4B	1	
Cell Death and Survival	apoptosis	Apoptosis of basophils	1.13E-02	 	 	 	 	IL17RB	1	
Cancer, Cell-To-Cell Signaling and Interaction, Organismal Injury and Abnormalities	binding	Binding of chronic lymphocytic leukemia cells	1.13E-02	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction	binding	Binding of cord blood cells	1.13E-02	 	 	 	 	ITGA4	1	
Cardiovascular Disease, Organismal Injury and Abnormalities	bleeding	Bleeding of heart	1.13E-02	 	 	 	 	ITGA4	1	
Cell Morphology, Cellular Compromise	deformability	Deformability of red blood cells	1.13E-02	 	 	 	 	DMTN	1	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	arrangement	Ectopic arrangement of cerebellar granule cell	1.13E-02	 	 	 	 	CDK5R1	1	
Cardiovascular System Development and Function, Connective Tissue Development and Function, Embryonic Development, Organ Development, Organismal Development, Tissue Development	formation	Formation of epicardium	1.13E-02	 	 	 	 	ITGA4	1	
Cellular Growth and Proliferation, Hematological System Development and Function	inhibition	Inhibition of monocytes	1.13E-02	 	 	 	 	ITGA4	1	
Cell Morphology, Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	lack	Lack of trophoblast giant cells	1.13E-02	 	 	 	 	SALL4	1	
Gastrointestinal Disease, Inflammatory Disease	Crohn disease	Moderate Crohn disease	1.13E-02	 	 	 	 	ITGA4	1	
Auditory Disease, Inflammatory Disease, Organismal Injury and Abnormalities	otitis media with effusion	Otitis media with effusion	1.13E-02	 	 	 	 	SALL4	1	
Endocrine System Development and Function, Organ Morphology, Tissue Morphology	quantity	Quantity of gamma cells	1.13E-02	 	 	 	 	NKX2-2	1	
Embryonic Development, Hair and Skin Development and Function, Organ Development, Organismal Development, Tissue Development	re-epithelialization	Re-epithelialization of skin	1.13E-02	 	 	 	 	DMTN	1	
Gastrointestinal Disease, Inflammatory Disease	Crohn disease	Severe Crohn disease	1.13E-02	 	 	 	 	ITGA4	1	
Cellular Movement	migration	Migration of myeloid cells	1.14E-02	 	 	 	 	PRKCQ,PIK3R5,ITGA4	3	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastroesophageal adenocarcinoma	Gastroesophageal adenocarcinoma	1.14E-02	 	 	 	 	GSE1,ATP9A,SPAG1,RGS17,TFPI2,ITGA4,DEPTOR,CHKA,ESRP1,LINGO2	10	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of Purkinje's layer of cerebellum	1.18E-02	 	 	 	 	CDK5R1,MAP1B	2	
Organismal Injury and Abnormalities, Renal and Urological Disease	structural renal abnormality	Structural renal abnormality	1.19E-02	 	 	 	 	DACT1,SALL4,DEPTOR	3	
Cell Death and Survival	cell death	Cell death of leukemia cell lines	1.19E-02	 	 	 	 	PRKCQ,SALL4,ITGA4,CHKA	4	
Neurological Disease, Organismal Injury and Abnormalities	brain atrophy	Brain atrophy	1.21E-02	 	 	 	 	CDK5R1,GRIA4	2	
Nervous System Development and Function	thermal nociception	Thermal nociception	1.21E-02	 	 	 	 	CDK5R1,GRIA4	2	
Developmental Disorder	agenesis	Agenesis	1.29E-02	 	 	 	 	DACT1,SALL4,MAP1B	3	
Neurological Disease, Skeletal and Muscular Disorders	neuromuscular disease	Neuromuscular disease	1.29E-02	 	 	 	 	ATP13A2,KIF1B,ZNF239,CDK5R1,MAP1B,ITGA4,FRMD4B	7	
Carbohydrate Metabolism, Cellular Function and Maintenance, Molecular Transport, Small Molecule Biochemistry	import	Import of D-glucose	1.31E-02	 	 	 	 	CDK5R1,KLF15	2	
Embryonic Development, Nervous System Development and Function, Ophthalmic Disease, Organ Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Development, Visual System Development and Function	abnormal morphology	Abnormal morphology of disorganized inner nuclear layer	1.32E-02	 	 	 	 	MAP1B	1	
Embryonic Development, Nervous System Development and Function, Ophthalmic Disease, Organ Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Development, Visual System Development and Function	abnormal morphology	Abnormal morphology of fundus of eye	1.32E-02	 	 	 	 	PRKCQ	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Hypersensitivity Response, Immune Cell Trafficking, Inflammatory Response	adhesion	Adhesion of bone marrow-derived mast cells	1.32E-02	 	 	 	 	ITGA4	1	
Hair and Skin Development and Function	appearance	Appearance of hair	1.32E-02	 	 	 	 	MAP1B	1	
Cellular Movement, Hematological System Development and Function, Hypersensitivity Response, Immune Cell Trafficking	cell rolling	Arrest in cell rolling of eosinophils	1.32E-02	 	 	 	 	ITGA4	1	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell rolling	Cell rolling of Th1 cells	1.32E-02	 	 	 	 	ITGA4	1	
Cellular Compromise, Hematological System Development and Function	enucleation	Enucleation of erythroblasts	1.32E-02	 	 	 	 	DMTN	1	
Cellular Assembly and Organization, Cellular Compromise	formation	Formation of Lewy bodies	1.32E-02	 	 	 	 	ATP13A2	1	
Cell Morphology, Digestive System Development and Function, Endocrine System Disorders, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	lack	Lack of beta islet cells	1.32E-02	 	 	 	 	NKX2-2	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long term synaptic depression	Long term synaptic depression of collateral synapses	1.32E-02	 	 	 	 	CDK5R1	1	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	neuroinflammation	Neuroinflammation of brain	1.32E-02	 	 	 	 	CDK5R1	1	
Hair and Skin Development and Function	pigmentation	Pigmentation of eye	1.32E-02	 	 	 	 	PRKCQ	1	
Tissue Morphology	quantity	Quantity of Pseudomonas aeruginosa	1.32E-02	 	 	 	 	TFPI2	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	sirenomelia	Sirenomelia	1.32E-02	 	 	 	 	DACT1	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	tumorigenesis	Tumorigenesis of prostatic adenocarcinoma	1.32E-02	 	 	 	 	TMPRSS2	1	
Cellular Development	differentiation	Differentiation of nervous system	1.36E-02	 	 	 	 	CDK5R1,KLF15,MAP1B,CHKA,NKX2-2	5	
Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of head	1.42E-02	 	 	 	 	CDK5R1,KIF1B,PRKCQ,SALL4,MAP1B,ITGA4,ESRP1	7	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	nervous system neoplasm	Nervous system neoplasm	1.44E-02	 	 	 	 	KIF1B,SPAG1,TMPRSS2,ACTR3B,B3GAT1,TFPI2,FRMD4B,IL17RB,NKX2-2	9	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	inflammation	Inflammation of airway	1.47E-02	 	 	 	 	SPAG1,ITGA4,FRMD4B,IL17RB	4	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of cortical subplate	1.50E-02	 	 	 	 	CDK5R1	1	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of tail bud	1.50E-02	 	 	 	 	DACT1	1	
Gastrointestinal Disease, Inflammatory Disease	Crohn disease	Active stage Crohn disease	1.50E-02	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction, Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	adhesion	Adhesion of Th1 cells	1.50E-02	 	 	 	 	ITGA4	1	
Cancer, Cell Death and Survival, Organismal Injury and Abnormalities, Tumor Morphology	apoptosis	Apoptosis of multiple myeloma cells	1.50E-02	 	 	 	 	DEPTOR	1	
Cancer, Endocrine System Disorders, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	pheochromocytoma	Autosomal dominant pheochromocytoma	1.50E-02	 	 	 	 	KIF1B	1	
Cardiovascular System Development and Function, Cell-To-Cell Signaling and Interaction	binding	Binding of high endothelial postcapillary venule	1.50E-02	 	 	 	 	ITGA4	1	
Cellular Compromise, Neurological Disease, Organismal Injury and Abnormalities	dysfunction	Dysfunction of neurons	1.50E-02	 	 	 	 	KIF1B	1	
Neurological Disease, Organismal Injury and Abnormalities	gliosis	Gliosis of cerebellum	1.50E-02	 	 	 	 	ATP13A2	1	
Cellular Assembly and Organization	growth	Growth of filopodia	1.50E-02	 	 	 	 	DPYSL5	1	
Cell Morphology, Digestive System Development and Function, Gastrointestinal Disease, Nervous System Development and Function, Neurological Disease, Tissue Morphology	lack	Lack of enteric neurons	1.50E-02	 	 	 	 	SALL4	1	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	migration	Migration of effector memory T lymphocytes	1.50E-02	 	 	 	 	ITGA4	1	
Cellular Movement, Connective Tissue Development and Function	mobility	Mobility of fibroblast cell lines	1.50E-02	 	 	 	 	DMTN	1	
Connective Tissue Disorders, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	non-specific interstitial pneumonia	Non-specific interstitial pneumonia	1.50E-02	 	 	 	 	FRMD4B	1	
Developmental Disorder, Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	periventricular nodular heterotopia	Periventricular nodular heterotopia	1.50E-02	 	 	 	 	MAP1B	1	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities, Tumor Morphology	chronic lymphocytic leukemia	Progressive chronic lymphocytic leukemia	1.50E-02	 	 	 	 	ITGA4	1	
Cellular Movement	cell movement	Cell movement of squamous cell carcinoma cell lines	1.51E-02	 	 	 	 	ITGA4,ESRP1	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	female genital tract cancer	Female genital tract cancer	1.51E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	19	
Cell Morphology, Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Nervous System Development and Function, Neurological Disease, Tissue Morphology	abnormal morphology	Abnormal morphology of synapse	1.54E-02	 	 	 	 	DACT1,PRKCQ	2	
Cellular Assembly and Organization, Cellular Compromise	formation	Formation of cellular inclusion bodies	1.54E-02	 	 	 	 	ATP13A2,CDK5R1	2	
Organismal Survival	viability	Viability	1.57E-02	 	 	 	 	CDK5R1,MAP1B	2	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	cell-cell adhesion	Cell-cell adhesion	1.57E-02	 	 	 	 	CDK5R1,ITGA4,DEPTOR	3	
Cellular Development	differentiation	Differentiation of tumor cell lines	1.59E-02	 	 	 	 	CDK5R1,KIF1B,SALL4,CHKA	4	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	transmigration	Transmigration of phagocytes	1.60E-02	 	 	 	 	PRKCQ,ITGA4	2	
Neurological Disease, Organismal Injury and Abnormalities	astrocytosis	Astrocytosis	1.63E-02	 	 	 	 	ATP13A2,CDK5R1	2	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	apoptosis	Apoptosis of cortical neurons	1.69E-02	 	 	 	 	CDK5R1,MAP1B	2	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	AMPA mediated synaptic current	AMPA mediated synaptic current	1.69E-02	 	 	 	 	GRIA4	1	
Cell Morphology, Hematological System Development and Function, Immunological Disease, Lymphoid Tissue Structure and Development	abnormal morphology	Abnormal morphology of effector T lymphocytes	1.69E-02	 	 	 	 	PRKCQ	1	
Cellular Assembly and Organization, Neurological Disease	accumulation	Accumulation of amyloid-beta plaques	1.69E-02	 	 	 	 	CDK5R1	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	action potential	Action potential of motor endplates	1.69E-02	 	 	 	 	PRKCQ	1	
Cellular Development	differentiation	Differentiation of hippocampal cells	1.69E-02	 	 	 	 	CDK5R1	1	
Developmental Disorder, Neurological Disease	ectopia	Ectopia of neurons	1.69E-02	 	 	 	 	CDK5R1	1	
Gastrointestinal Disease, Organismal Injury and Abnormalities	diarrhea	Grade 3-4 diarrhea	1.69E-02	 	 	 	 	ITGA4	1	
Embryonic Development, Organismal Development, Tissue Development	growth	Growth of embryoblast	1.69E-02	 	 	 	 	SALL4	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	inhibitory postsynaptic potential	Inhibitory postsynaptic potential of neurons	1.69E-02	 	 	 	 	GRIA4	1	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	lack	Lack of hippocampal commissure	1.69E-02	 	 	 	 	MAP1B	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Nervous System Development and Function, Organismal Development, Tissue Development	polarization	Polarization of hippocampal neurons	1.69E-02	 	 	 	 	MAP1B	1	
Gastrointestinal Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	severe active ulcerative colitis	Severe active ulcerative colitis	1.69E-02	 	 	 	 	ITGA4	1	
Nervous System Development and Function, Organ Morphology, Organismal Development	size	Size of anterior commissure	1.69E-02	 	 	 	 	MAP1B	1	
Cell Morphology, Cellular Compromise, Nervous System Development and Function, Neurological Disease, Organismal Injury and Abnormalities, Tissue Morphology	swelling	Swelling of axons	1.69E-02	 	 	 	 	CDK5R1	1	
Cancer, Organismal Injury and Abnormalities	anogenital cancer	Anogenital cancer	1.70E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,DEPTOR,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,ATP13A2,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	27	
Cell Death and Survival	cell viability	Cell viability of cervical cancer cell lines	1.71E-02	 	 	 	 	PRKCQ,CHKA,ANKS1B	3	
Cellular Assembly and Organization, Cellular Function and Maintenance, Nervous System Development and Function, Tissue Morphology	quantity	Quantity of neurites	1.72E-02	 	 	 	 	CDK5R1,MAP1B	2	
Tissue Morphology	quantity	Quantity of cells	1.78E-02	 	 	 	 	DMTN,KIF1B,CDK5R1,SALL4,PRKCQ,MAP1B,PIK3R5,TFPI2,IL17RB,NKX2-2,UBASH3B	11	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	migration	Migration of monocytes	1.81E-02	 	 	 	 	QPCT,ITGA4	2	
Organismal Survival	perinatal death	Perinatal death	1.83E-02	 	 	 	 	CDK5R1,KIF1B,DACT1,MAP1B,ESRP1	5	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	disorder of basal ganglia	Disorder of basal ganglia	1.84E-02	 	 	 	 	ATP13A2,ZNF239,CDK5R1,KIF1B,MAP1B,FRMD4B	6	
Behavior	exploratory behavior	Exploratory behavior	1.84E-02	 	 	 	 	MAP1B,GRIA4	2	
Cancer, Organismal Injury and Abnormalities	neoplasia	Neoplasia of melanoma cell lines	1.84E-02	 	 	 	 	ITGA4,IL17RB	2	
Nervous System Development and Function, Neurological Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of anterior horn of the spinal cord	1.88E-02	 	 	 	 	KIF1B	1	
Digestive System Development and Function, Endocrine System Disorders, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of disorganized islets of Langerhans	1.88E-02	 	 	 	 	NKX2-2	1	
Neurological Disease, Organismal Injury and Abnormalities	atrophy	Atrophy of forebrain	1.88E-02	 	 	 	 	CDK5R1	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	dynamics	Dynamics of actin cytoskeleton	1.88E-02	 	 	 	 	ESRP1	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	formation	Formation of cortical lamina	1.88E-02	 	 	 	 	CDK5R1	1	
Cell Signaling, Small Molecule Biochemistry	generation	Generation of nitrite	1.88E-02	 	 	 	 	ITGA4	1	
Cancer, Dermatological Diseases and Conditions, Inflammatory Disease, Metabolic Disease, Organismal Injury and Abnormalities	juvenile xanthogranuloma	Juvenile xanthogranuloma	1.88E-02	 	 	 	 	ATP9A	1	
Small Molecule Biochemistry	metabolism	Metabolism of choline	1.88E-02	 	 	 	 	CHKA	1	
Cell Cycle	senescence	Senescence of bone cancer cell lines	1.88E-02	 	 	 	 	CDK5R1	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	genital tumor	Genital tumor	1.89E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,ATP13A2,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	25	
Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities	hypoplasia	Hypoplasia of brain	1.94E-02	 	 	 	 	MAP1B,NKX2-2	2	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of granulocytes	1.95E-02	 	 	 	 	PRKCQ,PIK3R5,ITGA4,IL17RB	4	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	migration	Migration of mononuclear leukocytes	1.95E-02	 	 	 	 	QPCT,PRKCQ,ITGA4,DEPTOR	4	
Cell Death and Survival, Neurological Disease, Organismal Injury and Abnormalities	cell death	Cell death of cerebral cortex cells	1.97E-02	 	 	 	 	ATP13A2,CDK5R1,MAP1B	3	
Inflammatory Disease, Inflammatory Response, Neurological Disease, Organismal Injury and Abnormalities	encephalitis	Encephalitis	2.06E-02	 	 	 	 	CDK5R1,PRKCQ,ITGA4,UBASH3B	4	
Molecular Transport, Small Molecule Biochemistry	accumulation	Accumulation of lactic acid	2.06E-02	 	 	 	 	SLC16A3	1	
Post-Translational Modification	carbonylation	Carbonylation of protein	2.06E-02	 	 	 	 	SH3BP5	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	dysgerminoma	Dysgerminoma	2.06E-02	 	 	 	 	SALL4	1	
Cancer, Organismal Injury and Abnormalities	metastasis	Metastasis of pancreatic cancer cell lines	2.06E-02	 	 	 	 	ESRP1	1	
Cellular Assembly and Organization	quantity	Quantity of autophagic vacuoles	2.06E-02	 	 	 	 	KLF15	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	release	Release of exosomes	2.06E-02	 	 	 	 	ATP13A2	1	
Cancer, Developmental Disorder, Organismal Injury and Abnormalities, Reproductive System Disease	yolk sac tumor	Yolk sac tumor	2.06E-02	 	 	 	 	SALL4	1	
Organismal Development	abnormal morphology	Abnormal morphology of tail	2.07E-02	 	 	 	 	DACT1,SALL4	2	
Cell-To-Cell Signaling and Interaction, Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	adhesion	Adhesion of T lymphocytes	2.10E-02	 	 	 	 	ITGA4,DEPTOR	2	
Cardiovascular System Development and Function, Cell-To-Cell Signaling and Interaction	adhesion	Adhesion of vascular endothelial cells	2.10E-02	 	 	 	 	ITGA4,DEPTOR	2	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	familial motor neuron disease	Familial motor neuron disease	2.13E-02	 	 	 	 	ATP13A2,KIF1B	2	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders	Alzheimer disease or frontotemporal dementia	Alzheimer disease or frontotemporal dementia	2.18E-02	 	 	 	 	QPCT,CDK5R1,FRMD4B,GRIA4,SLC16A3	5	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastric cancer	Gastric cancer	2.18E-02	 	 	 	 	GSE1,ATP9A,RGS17,TFPI2,ITGA4,DEPTOR,CHKA,ESRP1,LINGO2	9	
Cellular Movement, Immune Cell Trafficking	migration	Leukocyte migration	2.20E-02	 	 	 	 	QPCT,PRKCQ,PIK3R5,ITGA4,DEPTOR,IL17RB,SLC16A3	7	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of neurites	2.20E-02	 	 	 	 	CDK5R1,MAP1B,DPYSL5	3	
Ophthalmic Disease, Organismal Injury and Abnormalities	ocular motility disorder	Ocular motility disorder	2.20E-02	 	 	 	 	PIK3R5,MAP1B	2	
Cancer, Organismal Injury and Abnormalities	primary tumor	Primary tumor	2.20E-02	 	 	 	 	CDK5R1,SALL4,IL17RB,SLC16A3	4	
Cellular Movement	cell movement	Cell movement of myeloid cells	2.24E-02	 	 	 	 	QPCT,PRKCQ,PIK3R5,ITGA4,IL17RB	5	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of cortical marginal zone	2.25E-02	 	 	 	 	CDK5R1	1	
Cardiovascular Disease, Cardiovascular System Development and Function, Connective Tissue Development and Function, Connective Tissue Disorders, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Morphology	abnormal morphology	Abnormal morphology of epicardium	2.25E-02	 	 	 	 	ITGA4	1	
Digestive System Development and Function, Gastrointestinal Disease, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities	abnormal morphology	Abnormal morphology of rectum	2.25E-02	 	 	 	 	SALL4	1	
Auditory Disease, Neurological Disease	conductive hearing loss	Conductive hearing loss	2.25E-02	 	 	 	 	SALL4	1	
Cellular Development	differentiation	Differentiation of breast cancer cell lines	2.25E-02	 	 	 	 	CHKA	1	
Cellular Development, Renal and Urological System Development and Function	differentiation	Differentiation of podocytes	2.25E-02	 	 	 	 	KLF15	1	
Cellular Assembly and Organization, Neurological Disease, Organismal Development, Tissue Development	formation	Formation of amyloid-beta plaques	2.25E-02	 	 	 	 	QPCT	1	
Cellular Assembly and Organization, Cellular Compromise, Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	formation	Formation of neurofibrillary tangles	2.25E-02	 	 	 	 	CDK5R1	1	
Embryonic Development, Organismal Development, Tissue Morphology	fusion	Fusion of allantois	2.25E-02	 	 	 	 	ITGA4	1	
Embryonic Development, Organismal Development, Tissue Morphology	fusion	Fusion of chorion	2.25E-02	 	 	 	 	ITGA4	1	
Connective Tissue Disorders, Hematological Disease, Organismal Injury and Abnormalities	spherocytosis	Spherocytosis	2.25E-02	 	 	 	 	DMTN	1	
Cancer, Organismal Injury and Abnormalities	pelvic tumor	Pelvic tumor	2.26E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,ATP13A2,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	26	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	synaptic transmission	Synaptic transmission of nervous tissue	2.27E-02	 	 	 	 	KIF1B,ANKS1B	2	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	breast or gynecological cancer	Breast or gynecological cancer	2.33E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,DEPTOR,SLC16A3,LINGO2,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,MAP1B,SPATA6,ITGA4,FRMD4B,GRIA4,IL17RB,ANKS1B,ESRP1	22	
Cell Morphology, Cellular Development	branching	Branching of cells	2.33E-02	 	 	 	 	CDK5R1,DACT1,MAP1B,DPYSL5	4	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	cell movement	Cell movement of phagocytes	2.34E-02	 	 	 	 	QPCT,PRKCQ,PIK3R5,ITGA4,IL17RB	5	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	peripheral nervous system neoplasm	Peripheral nervous system neoplasm	2.34E-02	 	 	 	 	KIF1B,TMPRSS2	2	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of dendrites	2.41E-02	 	 	 	 	MAP1B,DPYSL5	2	
Cell Signaling	acetylcholine receptor signaling, muscarinic pathway	Acetylcholine receptor signaling, muscarinic pathway	2.43E-02	 	 	 	 	CDK5R1	1	
Cell Morphology, Hematological System Development and Function	polarization	Polarization of leukocyte cell lines	2.43E-02	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	binding	Binding of neutrophils	2.44E-02	 	 	 	 	PRKCQ,ITGA4	2	
Cancer, Organismal Injury and Abnormalities	neoplasia	Neoplasia of tumor cell lines	2.45E-02	 	 	 	 	GSE1,ITGA4,IL17RB,ESRP1	4	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of lymphocytes	2.47E-02	 	 	 	 	PRKCQ,ITGA4,DEPTOR,IL17RB	4	
Cellular Movement, Hematological System Development and Function, Hypersensitivity Response, Immune Cell Trafficking	cell movement	Cell movement of eosinophils	2.48E-02	 	 	 	 	ITGA4,IL17RB	2	
Cancer, Organismal Injury and Abnormalities	precancerous condition	Precancerous condition	2.48E-02	 	 	 	 	PRKCQ,FRMD4B	2	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	gastric adenocarcinoma	Gastric adenocarcinoma	2.49E-02	 	 	 	 	ATP9A,RGS17,TFPI2,ITGA4,DEPTOR,CHKA,ESRP1,LINGO2	8	
Gastrointestinal Disease, Organismal Injury and Abnormalities	abnormality	Abnormality of large intestine	2.49E-02	 	 	 	 	DACT1,SALL4,ITGA4,IL17RB	4	
Cancer, Organismal Injury and Abnormalities	malignant genitourinary solid tumor	Malignant genitourinary solid tumor	2.58E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,DEPTOR,SH3BP5,SLC16A3,LINGO2,DIP2A,DMTN,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,FRMD4B,GRIA4,IL17RB,ATP13A2,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	28	
Cell Morphology, Cellular Function and Maintenance	autophagy	Autophagy of cells	2.59E-02	 	 	 	 	DACT1,PRKCQ,DEPTOR,UBASH3B	4	
Cellular Compromise	acidification	Acidification of lysosome	2.62E-02	 	 	 	 	ATP13A2	1	
Embryonic Development, Nervous System Development and Function, Organ Development, Organismal Development, Tissue Development	development	Development of anterior horn of the spinal cord	2.62E-02	 	 	 	 	NKX2-2	1	
Cellular Movement	diapedesis	Diapedesis	2.62E-02	 	 	 	 	ITGA4	1	
Cardiovascular Disease, Hematological Disease, Hereditary Disorder, Metabolic Disease, Organismal Injury and Abnormalities	familial combined hyperlipidemia	Familial combined hyperlipidemia	2.62E-02	 	 	 	 	FRMD4B	1	
Cell Morphology, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Renal and Urological Disease, Renal and Urological System Development and Function	hypertrophy	Hypertrophy of mesangial cells	2.62E-02	 	 	 	 	DEPTOR	1	
Auditory Disease, Inflammatory Response, Organismal Injury and Abnormalities	inflammation	Inflammation of ear	2.62E-02	 	 	 	 	SALL4	1	
Gastrointestinal Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	moderate active ulcerative colitis	Moderate active ulcerative colitis	2.62E-02	 	 	 	 	ITGA4	1	
Organ Morphology, Skeletal and Muscular System Development and Function	number	Number of caudal vertebra	2.62E-02	 	 	 	 	DACT1	1	
Cell Cycle	senescence	Senescence of sarcoma cell lines	2.62E-02	 	 	 	 	CDK5R1	1	
Neurological Disease, Skeletal and Muscular Disorders	progressive neuromuscular disease	Progressive neuromuscular disease	2.62E-02	 	 	 	 	ATP13A2,KIF1B,MAP1B,ITGA4	4	
Cancer, Organismal Injury and Abnormalities, Renal and Urological Disease	urinary tract cancer	Urinary tract cancer	2.63E-02	 	 	 	 	DMTN,ATP9A,KIF1B,QPCT,DACT1,CHD9,PIK3R5,TFPI2,ITGA4,ANKS1B,ESRP1	11	
Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities, Respiratory Disease	asthma	Asthma	2.67E-02	 	 	 	 	ITGA4,FRMD4B,IL17RB	3	
Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Renal and Urological Disease, Renal and Urological System Development and Function	abnormal morphology	Abnormal morphology of kidney	2.71E-02	 	 	 	 	DACT1,SALL4,DEPTOR	3	
Cancer, Endocrine System Disorders, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatic tumor	Pancreatic tumor	2.71E-02	 	 	 	 	PIK3R5,TFPI2,CHKA,DPYSL5,DIP2A,KIF1B,CDK5R1,ATP10B,CST7,CHD9,MAP1B,FRMD4B,ESRP1	13	
Cell Morphology	sprouting	Sprouting	2.74E-02	 	 	 	 	CDK5R1,DACT1,MAP1B,DPYSL5	4	
Endocrine System Disorders, Organ Morphology, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	abnormal morphology	Abnormal morphology of vas deferens	2.80E-02	 	 	 	 	DACT1	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Inflammatory Response, Organismal Injury and Abnormalities	Churg-Strauss syndrome	Churg-Strauss syndrome	2.80E-02	 	 	 	 	IL17RB	1	
Behavior, Nervous System Development and Function	context memory	Context memory	2.80E-02	 	 	 	 	QPCT	1	
Cancer, Organismal Injury and Abnormalities	metastasis	Metastasis of stomach cancer cell lines	2.80E-02	 	 	 	 	GSE1	1	
Behavior	rotation behavior	Rotation behavior	2.80E-02	 	 	 	 	SH3BP5	1	
Cellular Assembly and Organization, Cellular Function and Maintenance, Organismal Development	secretion	Secretion of dense granule	2.80E-02	 	 	 	 	DMTN	1	
Molecular Transport, Small Molecule Biochemistry	secretion	Secretion of lactic acid	2.80E-02	 	 	 	 	SLC16A3	1	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	cell movement	Cell movement of leukocytes	2.82E-02	 	 	 	 	QPCT,PRKCQ,PIK3R5,ITGA4,DEPTOR,IL17RB	6	
Cellular Development, Nervous System Development and Function, Tissue Development	differentiation	Differentiation of neurons	2.83E-02	 	 	 	 	CDK5R1,MAP1B,CHKA,NKX2-2	4	
Nervous System Development and Function, Tissue Morphology	quantity	Quantity of neurons	2.83E-02	 	 	 	 	CDK5R1,KIF1B,MAP1B,NKX2-2	4	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking	adhesion	Adhesion of granulocytes	2.85E-02	 	 	 	 	PRKCQ,ITGA4	2	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance, Nervous System Development and Function	extension	Extension of axons	2.85E-02	 	 	 	 	CDK5R1,MAP1B	2	
Neurological Disease, Organismal Injury and Abnormalities, Psychological Disorders, Skeletal and Muscular Disorders	Parkinson disease	Parkinson's disease	2.86E-02	 	 	 	 	ATP13A2,KIF1B,MAP1B	3	
Cancer, Organismal Injury and Abnormalities	embryonal tumor	Embryonal tumor	2.89E-02	 	 	 	 	KIF1B,SALL4,TMPRSS2,FRMD4B,NKX2-2	5	
Cellular Development, Cellular Growth and Proliferation, Nervous System Development and Function, Tissue Development	development	Development of neurons	2.92E-02	 	 	 	 	CDK5R1,DACT1,MAP1B,DPYSL5,NKX2-2,LINGO2	6	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	hereditary neuropathy	Hereditary neuropathy	2.94E-02	 	 	 	 	ATP13A2,KIF1B,MAP1B	3	
Developmental Disorder	midline defect	Midline defect	2.98E-02	 	 	 	 	DACT1,SALL4,ESRP1	3	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of cortical plate	2.98E-02	 	 	 	 	CDK5R1	1	
Auditory Disease, Neurological Disease	absent pinna reflex	Absent pinna reflex	2.98E-02	 	 	 	 	SALL4	1	
Cell Morphology, Cellular Movement, Reproductive System Development and Function	cell spreading	Cell spreading of gonadal cell lines	2.98E-02	 	 	 	 	ITGA4	1	
Cellular Assembly and Organization, Cellular Function and Maintenance	depolarization	Depolarization of plasma membrane	2.98E-02	 	 	 	 	GRIA4	1	
Cellular Development, Endocrine System Development and Function	differentiation	Differentiation of beta islet cells	2.98E-02	 	 	 	 	NKX2-2	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	extension	Extension of filopodia	2.98E-02	 	 	 	 	ITGA4	1	
Organismal Injury and Abnormalities, Skeletal and Muscular Disorders	fatigue	Fatigue of muscle	2.98E-02	 	 	 	 	KLF15	1	
Cellular Assembly and Organization	function	Function of lysosome	2.98E-02	 	 	 	 	ATP13A2	1	
Cellular Assembly and Organization, Cellular Function and Maintenance, Organismal Development	secretion	Secretion of alpha granules	2.98E-02	 	 	 	 	DMTN	1	
Cancer, Organismal Injury and Abnormalities, Reproductive System Disease	genital tract cancer	Genital tract cancer	3.04E-02	 	 	 	 	ATP13A2,SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,KIF1B,QPCT,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,ITGA4,GRIA4,ANKS1B,ESRP1	24	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	neurogenic tumor	Neurogenic tumor	3.15E-02	 	 	 	 	KIF1B,TMPRSS2	2	
Connective Tissue Development and Function, Connective Tissue Disorders, Nervous System Development and Function, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Skeletal and Muscular Disorders, Skeletal and Muscular System Development and Function, Tissue Development	abnormal morphology	Abnormal morphology of sacral vertebra	3.17E-02	 	 	 	 	DACT1	1	
Cell-mediated Immune Response, Cellular Development, Cellular Function and Maintenance, Cellular Growth and Proliferation, Embryonic Development, Hematological System Development and Function, Hematopoiesis, Lymphoid Tissue Structure and Development, Organ Development, Organismal Development, Tissue Development	development	Development of natural killer T lymphocytes	3.17E-02	 	 	 	 	PRKCQ	1	
Embryonic Development, Organismal Development	development	Development of tail	3.17E-02	 	 	 	 	DACT1	1	
Cellular Compromise	disorganization	Disorganization of cytoskeleton	3.17E-02	 	 	 	 	CDK5R1	1	
Cellular Function and Maintenance	endocytosis	Endocytosis by neurons	3.17E-02	 	 	 	 	MAP1B	1	
Infectious Diseases, Organismal Development	growth	Growth of Influenza A virus	3.17E-02	 	 	 	 	TMPRSS2	1	
Cellular Function and Maintenance, Molecular Transport, Small Molecule Biochemistry	homeostasis	Homeostasis of Zn2+	3.17E-02	 	 	 	 	ATP13A2	1	
Cellular Development	maturation	Maturation of oligodendrocytes	3.17E-02	 	 	 	 	NKX2-2	1	
Cellular Development, Cellular Growth and Proliferation, Embryonic Development	proliferation	Proliferation of embryonic cell lines	3.20E-02	 	 	 	 	QPCT,SALL4,CHKA	3	
Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	migration	Migration of neutrophils	3.23E-02	 	 	 	 	PRKCQ,PIK3R5	2	
Cell-mediated Immune Response, Cellular Movement, Hematological System Development and Function, Immune Cell Trafficking	infiltration	Infiltration by T lymphocytes	3.27E-02	 	 	 	 	PRKCQ,ITGA4	2	
Cellular Development, Cellular Growth and Proliferation, Hair and Skin Development and Function	proliferation	Proliferation of epithelial cell lines	3.29E-02	 	 	 	 	QPCT,SALL4,CHKA	3	
Cancer, Hematological Disease, Immunological Disease, Organismal Injury and Abnormalities	T-cell leukemia	T-cell leukemia	3.31E-02	 	 	 	 	PRKCQ,B3GAT1,FRMD4B	3	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	excitatory postsynaptic potential	Excitatory postsynaptic potential	3.31E-02	 	 	 	 	DACT1,GRIA4	2	
Hereditary Disorder, Neurological Disease, Organismal Injury and Abnormalities	hereditary motor and sensory neuropathy	Hereditary motor and sensory neuropathy	3.31E-02	 	 	 	 	ATP13A2,KIF1B	2	
Neurological Disease, Skeletal and Muscular Disorders	motor dysfunction	Motor dysfunction	3.31E-02	 	 	 	 	ATP13A2,CDK5R1	2	
Post-Translational Modification	autoprocessing	Autoprocessing of protein	3.35E-02	 	 	 	 	TMPRSS2	1	
Cardiovascular System Development and Function, Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization	cell-cell adhesion	Cell-cell adhesion of vascular endothelial cells	3.35E-02	 	 	 	 	DEPTOR	1	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of growth cone	3.35E-02	 	 	 	 	DPYSL5	1	
Nervous System Development and Function, Organ Morphology, Organismal Development	size	Size of cerebellum	3.35E-02	 	 	 	 	CDK5R1	1	
Cellular Development, Cellular Growth and Proliferation	cell proliferation	Cell proliferation of tumor cell lines	3.42E-02	 	 	 	 	GSE1,CDK5R1,SALL4,PRKCQ,MAP1B,B3GAT1,TFPI2,CHKA,ESRP1,SLC16A3	10	
Cancer, Gastrointestinal Disease, Organismal Injury and Abnormalities	pancreatobiliary tumor	Pancreatobiliary tumor	3.43E-02	 	 	 	 	ATP13A2,PIK3R5,TFPI2,CHKA,DPYSL5,DIP2A,KIF1B,CDK5R1,ATP10B,CST7,CHD9,MAP1B,FRMD4B,ESRP1	14	
Cell-To-Cell Signaling and Interaction, Hematological System Development and Function, Immune Cell Trafficking, Inflammatory Response	activation	Activation of natural killer cells	3.43E-02	 	 	 	 	PRKCQ,ITGA4	2	
Cell Morphology, Nervous System Development and Function, Tissue Morphology	morphology	Morphology of axons	3.43E-02	 	 	 	 	CDK5R1,MAP1B	2	
Embryonic Development, Nervous System Development and Function, Ophthalmic Disease, Organ Development, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Tissue Development, Visual System Development and Function	abnormal morphology	Abnormal morphology of outer plexiform layer	3.53E-02	 	 	 	 	MAP1B	1	
Developmental Disorder, Embryonic Development, Organismal Development, Tissue Morphology	abnormal morphology	Abnormal morphology of paraxial mesoderm	3.53E-02	 	 	 	 	DACT1	1	
Cell-To-Cell Signaling and Interaction	binding	Binding of neuroblastoma cell lines	3.53E-02	 	 	 	 	GRIA4	1	
Cell-To-Cell Signaling and Interaction, Cellular Assembly and Organization, Nervous System Development and Function	cell-cell adhesion	Cell-cell adhesion of neurons	3.53E-02	 	 	 	 	CDK5R1	1	
Cell Morphology	morphology	Morphology of plasma membrane projections	3.53E-02	 	 	 	 	DMTN	1	
Cancer, Neurological Disease, Organismal Injury and Abnormalities	neuroblastoma	Neuroblastoma in autonomic ganglion	3.53E-02	 	 	 	 	TMPRSS2	1	
Cellular Movement, Nervous System Development and Function	positioning	Positioning of neurons	3.53E-02	 	 	 	 	CDK5R1	1	
Cell Morphology, Cellular Assembly and Organization, Nervous System Development and Function	thickness	Thickness of myelin sheath	3.53E-02	 	 	 	 	MAP1B	1	
Cancer, Organismal Injury and Abnormalities	pelvic cancer	Pelvic cancer	3.63E-02	 	 	 	 	SALL4,PRKCQ,PIK3R5,TFPI2,TMEM163,SH3BP5,SLC16A3,LINGO2,DIP2A,ATP9A,QPCT,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,SPATA6,GRIA4,ATP13A2,GSE1,KIF1B,ATP10B,ITGA4,ANKS1B,ESRP1	25	
Developmental Disorder	hypoplasia	Hypoplasia of organ	3.64E-02	 	 	 	 	DACT1,SALL4,MAP1B,NKX2-2	4	
Developmental Disorder, Neurological Disease, Organismal Injury and Abnormalities	congenital malformation	Congenital malformation of brain	3.66E-02	 	 	 	 	SALL4,MAP1B,NKX2-2	3	
Cancer, Organismal Injury and Abnormalities	epithelial cancer in situ	Carcinoma in situ	3.68E-02	 	 	 	 	DACT1,FRMD4B	2	
Cancer, Organismal Injury and Abnormalities	metastasis	Metastasis of tumor cell lines	3.68E-02	 	 	 	 	GSE1,ITGA4,ESRP1	3	
Cell Death and Survival	apoptosis	Apoptosis of leukemia cell lines	3.71E-02	 	 	 	 	PRKCQ,ITGA4,CHKA	3	
Cardiovascular System Development and Function, Cell-To-Cell Signaling and Interaction	attachment	Attachment of endothelial cells	3.72E-02	 	 	 	 	TFPI2	1	
Cardiovascular Disease, Immunological Disease, Inflammatory Disease, Organismal Injury and Abnormalities	experimental autoimmune myocarditis	Experimental autoimmune myocarditis	3.72E-02	 	 	 	 	PRKCQ	1	
Cell Morphology, Cellular Assembly and Organization, Cellular Function and Maintenance	extension	Extension of plasma membrane projections	3.72E-02	 	 	 	 	DPYSL5	1	
Cardiovascular System Development and Function, Cellular Movement, Immune Cell Trafficking	migration	Migration of lymphatic endothelial cells	3.72E-02	 	 	 	 	ITGA4	1	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	synaptic transmission	Synaptic transmission of neuromuscular synapse	3.72E-02	 	 	 	 	KIF1B	1	
Carbohydrate Metabolism, Lipid Metabolism, Small Molecule Biochemistry	synthesis	Synthesis of phosphatidylethanolamine	3.72E-02	 	 	 	 	CHKA	1	
Developmental Disorder, Organ Morphology, Organismal Development, Organismal Injury and Abnormalities, Reproductive System Development and Function, Reproductive System Disease	vaginal atresia	Vaginal atresia	3.72E-02	 	 	 	 	DACT1	1	
Cellular Development	differentiation	Differentiation of central nervous system cells	3.81E-02	 	 	 	 	CDK5R1,NKX2-2	2	
Connective Tissue Development and Function, Hematological System Development and Function, Hematopoiesis, Organismal Development, Tissue Morphology	quantity	Quantity of erythroid precursor cells	3.89E-02	 	 	 	 	DMTN,SALL4	2	
Cell-To-Cell Signaling and Interaction, Nervous System Development and Function	long-term potentiation	Long-term potentiation	3.90E-02	 	 	 	 	CDK5R1,B3GAT1,GRIA4	3	

Tox Functions for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Categories	Functions	Diseases or Functions Annotation	p-Value	Predicted Activation State	Activation z-score	Notes	Bias-corrected z-score	Molecules	# Molecules	
Liver Hyperplasia/Hyperproliferation	cancer	Liver cancer	1.87E-03	 	 	 	 	ATP13A2,PRKCQ,ACTR3B,PIK3R5,TFPI2,B3GAT1,SH3BP5,LINGO2,UBASH3B,DIP2A,KIF1B,CDK5R1,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,ANKS1B	22	
Liver Hyperplasia/Hyperproliferation	liver carcinoma	Liver carcinoma	2.95E-03	 	 	 	 	ATP13A2,PRKCQ,ACTR3B,PIK3R5,B3GAT1,SH3BP5,LINGO2,UBASH3B,DIP2A,KIF1B,CDK5R1,ATP10B,DACT1,CHD9,SPAG1,TMPRSS2,MAP1B,ITGA4,FRMD4B,GRIA4,ANKS1B	21	
Renal Hypoplasia	agenesis	Agenesis of kidney	3.14E-03	 	 	 	 	DACT1,SALL4	2	
Renal Proliferation	cell proliferation	Cell proliferation of kidney cell lines	9.36E-03	 	 	 	 	QPCT,SALL4,CHKA	3	
Cardiac Hemorrhaging	bleeding	Bleeding of heart	1.13E-02	 	 	 	 	ITGA4	1	
Renal Enlargement	hypertrophy	Hypertrophy of mesangial cells	2.62E-02	 	 	 	 	DEPTOR	1	
Cardiac Inflammation	experimental autoimmune myocarditis	Experimental autoimmune myocarditis	3.72E-02	 	 	 	 	PRKCQ	1	
Cardiac Dilation	dilation	Dilation of left ventricle	4.99E-02	 	 	 	 	KLF15	1	
Glomerular Injury, Renal Inflammation, Renal Nephritis	membranous glomerulonephritis	Membranous glomerulonephritis	4.99E-02	 	 	 	 	ITGA4	1	
Liver Necrosis/Cell Death	cell death	Cell death of hepatocytes	5.54E-02	 	 	 	 	PRKCQ,SH3BP5	2	
Cardiac Dilation, Cardiac Enlargement	idiopathic dilated cardiomyopathy	Idiopathic dilated cardiomyopathy	5.70E-02	 	 	 	 	CDK5R1	1	
Glomerular Injury	focal segmental glomerulosclerosis	Focal segmental glomerulosclerosis	6.77E-02	 	 	 	 	KLF15	1	
Cardiac Necrosis/Cell Death	apoptosis	Apoptosis of ventricular myocytes	6.95E-02	 	 	 	 	DIP2A	1	
Cardiac Necrosis/Cell Death	cell death	Cell death of cardiomyocytes	9.65E-02	 	 	 	 	DIP2A,SH3BP5	2	
Cardiac Arteriopathy	coronary artery disease	Coronary artery disease	1.01E-01	 	 	 	 	TMEM163,GRIA4	2	
Cardiac Stenosis	stenosis	Stenosis of aortic valve	1.06E-01	 	 	 	 	KLF15	1	
Nephrosis	familial nephrotic syndrome	Familial nephrotic syndrome	1.14E-01	 	 	 	 	ITGA4	1	
Renal Hydronephrosis	hydronephrosis	Hydronephrosis	1.66E-01	 	 	 	 	DACT1	1	
Increased Levels of Hematocrit	hematocrit	Increased Levels of Hematocrit	1.70E-01	 	 	 	 	DMTN	1	
Increased Levels of Red Blood Cells	quantity	Increased Levels of Red Blood Cells	1.85E-01	 	 	 	 	SALL4	1	
Cardiac Dysfunction, Cardiac Enlargement	hypertrophy	Hypertrophy of left ventricle	1.88E-01	 	 	 	 	KLF15	1	
Cardiac Enlargement	enlargement	Enlargement of heart	2.08E-01	 	 	 	 	CDK5R1,KLF15,DACT1	3	
Congenital Heart Anomaly	ventricular septal defect	Ventricular septal defect	2.33E-01	 	 	 	 	SALL4	1	
Cardiac Enlargement	hypertrophy	Hypertrophy of heart	2.36E-01	 	 	 	 	KLF15,DACT1	2	
Liver Damage	hepatic injury	Hepatic injury	2.58E-01	 	 	 	 	SH3BP5	1	
Cardiac Arrythmia	atrial fibrillation	Atrial fibrillation	2.66E-01	 	 	 	 	FRMD4B	1	
Liver Necrosis/Cell Death	apoptosis	Apoptosis of hepatocytes	2.68E-01	 	 	 	 	PRKCQ	1	
Cardiac Enlargement	hypertrophy	Hypertrophy of cardiomyocytes	2.68E-01	 	 	 	 	DACT1	1	
Cardiac Fibrosis	fibrosis	Fibrosis of heart	3.88E-01	 	 	 	 	KLF15	1	
Heart Failure	failure	Failure of heart	5.17E-01	 	 	 	 	KLF15	1	
Renal Necrosis/Cell Death	cell death	Cell death of kidney cell lines	5.47E-01	 	 	 	 	ATP13A2	1	
Hepatocellular carcinoma, Liver Hyperplasia/Hyperproliferation	hepatocellular carcinoma	Hepatocellular carcinoma	1.00E00	 	 	 	 	FRMD4B	1	

Regulator Effects for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM

Networks for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
ID	Analysis	Molecules in Network	Score	Focus Molecules	Top Diseases and Functions	
1	longFragmentHuman - 2020-01-20 08:06 PM	Actin,Akt,B3GAT1,CD3,CDK5R1,CHKA,CST7,CaMKII,DACT1,DEPTOR,DIP2A,DMTN,DPYSL5,ERK,ERK1/2,Focal adhesion kinase,GRIA4,IL17RB,ITGA4,Immunoglobulin,Jnk,KLF15,MAP1B,Mapk,NFkB (complex),NKX2-2,PI3K (complex),PI3K (family),PIK3R5,PRKCQ,SLC16A3,SPAG1,TFPI2,UBASH3B,calpain	53	21	Embryonic Development, Nervous System Development and Function, Organ Development	
2	longFragmentHuman - 2020-01-20 08:06 PM	ADGRG2,ATP13A2,ATP9A,Apon,CHD9,Crb3,DISP2,EGFR,ESRP1,FUT6,GGT6,GIN1,GPR149,GPR20,GSE1,HNF4A,KIF1B,MS4A8,NUDT18,PPP1R14D,PRSS22,PRSS42P,SALL4,SLC25A40,SLC26A11,SOX2,SPATA6,TGFB1,TMEM163,TMIGD1,TMPRSS11E,TMPRSS2,TTC22,VN1R1,dihydrotestosterone	26	12	Cancer, Cellular Response to Therapeutics, Organismal Injury and Abnormalities	
3	longFragmentHuman - 2020-01-20 08:06 PM	ABCC11,ACTR3B,ADGRG2,ANKS1B,CFTR,CUZD1,D-glucose,FRMD4B,GPR12,GPR139,GPR173,GPR88,HCRTR2,HTR5A,INHIBIN B,LINGO2,NFkB1-CRel,NPBWR1,PON2,PRR15L,PTGER3,QPCT,REL,RGS17,SH3BP5,SHOC1,SIGLEC8,STAT5A,SUSD2,TACR3,TLR4,TTC9,ZNF239,beta-estradiol,mir-802	21	10	Molecular Transport, Cell-To-Cell Signaling and Interaction, Cell Death and Survival	
4	longFragmentHuman - 2020-01-20 08:06 PM	ATP10B,PHACTR3	3	1	Gastrointestinal Disease, Inflammatory Disease, Cell Morphology	

My Lists for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
My Lists	 -log(p-value)	Ratio	Molecules 

Tox Lists for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
Ingenuity Toxicity Lists	 -log(p-value)	Ratio	Molecules 
TR/RXR Activation	1.96E00	2.38E-02	PIK3R5,SLC16A3
Increases Renal Proliferation	1.43E00	1.24E-02	SALL4,CHKA
NRF2-mediated Oxidative Stress Response	1.12E00	8.37E-03	PRKCQ,PIK3R5
NF-κB Signaling	1.04E00	7.46E-03	PRKCQ,PIK3R5
Cardiac Necrosis/Cell Death	9.48E-01	6.58E-03	DIP2A,SH3BP5
Liver Necrosis/Cell Death	9.07E-01	6.21E-03	PRKCQ,SH3BP5
VDR/RXR Activation	8.62E-01	1.28E-02	PRKCQ
Xenobiotic Metabolism Signaling	8.51E-01	5.73E-03	PRKCQ,PIK3R5
Cardiac Hypertrophy	8.03E-01	5.35E-03	KLF15,DACT1
Increases Liver Damage	7.87E-01	1.06E-02	SH3BP5
p53 Signaling	7.66E-01	1.01E-02	PIK3R5
Hepatic Cholestasis	5.24E-01	5.35E-03	PRKCQ
RAR Activation	5.13E-01	5.18E-03	PRKCQ
Cardiac Fibrosis	4.26E-01	4.05E-03	KLF15
Renal Necrosis/Cell Death	0E00	1.73E-03	ATP13A2

My Pathways for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
My Pathways	 -log(p-value)	Ratio	Molecules 

Analysis Ready Molecules for My Projects->hd_microarray->longFragmentHuman - 2020-01-20 08:06 PM
ID	Symbol
ENSG00000133627	ACTR3B
ENSG00000173698	ADGRG2
ENSG00000185046	ANKS1B
ENSG00000118322	ATP10B
ENSG00000159363	ATP13A2
ENSG00000054793	ATP9A
ENSG00000109956	B3GAT1
ENSG00000176749	CDK5R1
ENSG00000177200	CHD9
ENSG00000110721	CHKA
ENSG00000077984	CST7
ENSG00000165617	DACT1
ENSG00000155792	DEPTOR
ENSG00000160305	DIP2A
ENSG00000158856	DMTN
ENSG00000157851	DPYSL5
ENSG00000104413	ESRP1
ENSG00000114541	FRMD4B
ENSG00000152578	GRIA4
ENSG00000131149	GSE1
ENSG00000056736	IL17RB
ENSG00000115232	ITGA4
ENSG00000054523	KIF1B
ENSG00000163884	KLF15
ENSG00000174482	LINGO2
ENSG00000131711	MAP1B
ENSG00000125820	NKX2-2
ENSG00000275074	NUDT18
ENSG00000141506	PIK3R5
ENSG00000065675	PRKCQ
ENSG00000115828	QPCT
ENSG00000091844	RGS17
ENSG00000101115	SALL4
ENSG00000131370	SH3BP5
ENSG00000141526	SLC16A3
ENSG00000104450	SPAG1
ENSG00000132122	SPATA6
ENSG00000105825	TFPI2
ENSG00000152128	TMEM163
ENSG00000184012	TMPRSS2
ENSG00000133985	TTC9
ENSG00000154127	UBASH3B
ENSG00000196793	ZNF239

